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ABSTRACT 
NEXT-GEN TRANSCRIPTOMICS REVEALS VARIABLE GENE EXPRESSION IN 
STENOTROPHOMONAS MALTOPHILIA K279A WHEN GROWN IN CO-CULTURE 
WITH PSEUDOMONAS AERUGINOSA 2192 
 
David Jensen 
April 20, 2015 
 
We are constantly surrounded by bacteria, many of which are found in 
cohabitation with other species in the same niches. These organisms can be particularly 
problematic when they infect the human body. Cystic fibrosis (CF) is of significant 
concern because of the frequency that those suffering from this autosomal recessive 
disease have in colonization by these infectious agents. Affecting more than 30,000 
people in the U.S. alone. CF is due to a genetic mutation that causes a thick mucosal 
buildup in luminal surfaces. This viscous mucus creates a cultivation site for complex 
respiratory biofilms. Complications of CF include paralysis of respiratory cilia and an 
inability to absorb nutrients in the digestive tract. The study of these bacteria in mixed 
communities, which better represents their common modes of infection, is critical to 
understanding the mechanisms of virulence for these pathogens. Studying poly-microbial 
biofilm-forming organisms in monoculture has intrinsic inaccuracies. In this work, the 
phenotypes of opportunistic respiratory pathogens were observed in co-culture growth. P. 
aeruginosa 2192, Pseudomonas aeruginosa PAO1, S. maltophilia K279a, Burkholderia 
vii 
dolosa AU0158, B. cenocepacia K56-2 and Escherichia coli pEBFP showed limited 
growth defects when spotted proximally in pairwise comparisons, but when testing 
effects of their growth on established bacterial lawns, inhibitions were more pronounced. 
The transcriptome of P. aeruginosa 2192 and S. maltophilia K279a were characterized in 
in mono- or co-cultures in three in vitro conditions using high-throughput Next-Gen 
Sequencing. This resulted in hundreds of significant changes in gene expression which 
indicate that these two CF pathogens can sense and respond to each other. Of the genes 
up-regulated in S. maltophilia K279a in response to growth with P. aeruginosa 2192, 
seven constructs were made for future complete gene deletion generation. This work 
provides a model where genes up-regulated in response to mixed communities can be 
identified and complete gene deletions can be made for future co-culture growth 
experiments.  
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LITERATURE REVIEW 
Cystic Fibrosis 
Cystic fibrosis (CF) is the most common autosomal genetic disorder in the Caucasian 
population, (Davis, 1996) and it currently affects approximately about 30,000 people in 
the U.S. and over 70,000 worldwide (Cystic Fibrosis Foundation Patient Registry: 
Annual Data Report). CF is caused by a mutation in the CF transmembrane conductance 
regulator (CFTR) gene, which encodes an ATP-driven pump responsible for the flux of 
chloride ions across the apical membranes of mammalian cells (Sibley, 2006). Although 
there are over 800 different mutations that can be attributed to CFTR alteration, a single 
amino acid deletion (ΔF508) is associated with 70% of the cases resulting in CF 
(Zielinski, 1995; Cebotaru, 2008). This mutation results in the malformation of the CFTR 
protein which prevents chloride ions from entering the lumen of lungs and digestive tract 
organs. Without this chloride ion flux, water is not drawn to the lumen, causing a thick 
mucosal build up in the respiratory tract (Harris, 2007). This viscous accumulation 
prevents mucociliary clearance that normally aids in keeping the lungs pathogen-free 
(Matsui, 1998). The CFTR protein also functions in the gastrointestinal tract and holds 
particular relevance to infants and young children, where absorption of necessary 
macromolecules is limited due to the mucosal coating on the inside of the intestinal 
lumen. But because symptoms in the CF lung present themselves as more acute, much of 
the research is focused on the respiratory system (Bodewes, 2015) which was attributed 
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to 68% of CF deaths in 2013 (Cystic Fibrosis Foundation Patient Registry: Annual Data 
Report). The other 32% consist of transplant-related complications, liver disease and 
suicide. Over time, those who suffer from this disorder will see their lungs deteriorate in 
function (Winnie, 1991) and may be subject to the effects of cystic fibrosis-related 
diabetes (CFRD) due to the need for high caloric intakes. Reports of CFRD have 
increased significantly since 1986 when data collection began. This has been attributed to 
increased detection methods in younger CF patients along with increased life expectancy, 
which has allowed more time for the patients to develop CFRD. Those who have CFRD 
have a lower average body-mass index (BMI) than those who have not acquired CFRD. 
Tropic effects include retinopathy, kidney disease, neuropathy and microabluminuria, but 
are still less prevalent at less than 6% of occurrence (Cystic Fibrosis Foundation Patient 
Registry: Annual Data Report).  
 Even with these various complications, the prognosis of CF patients today is 
much different than it was just 30 years ago. In 1950 the median mortality age of those 
diagnosed with CF was 2 years old (Cystic Fibrosis Foundation Patient Registry: Annual 
Data Report, 2013). Since that time the average life expectancy has increased from 27 
years in 1986 to 38 years old in 2013. Currently, over half of the CF population in the 
U.S. is over the age of 18, and that number has been rising continually (Cystic Fibrosis 
Foundation Patient Registry: Annual Data Report, 2013). With 66% of all patients being 
diagnosed in the first year of life, treatment and prevention of infection are improving. 
Detection is also improving; with sequencing advancements, 97% of all CF patients are 
identified through genetic screenings (Cystic Fibrosis Foundation Patient Registry: 
Annual Data Report, 2013). These advances follow increased awareness of the disease 
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and the pathogens that regularly accompany it. Even with increased exposure in 
mainstream research, scientists are still just starting to understand the many complexities 
of what it is like to live with CF.  
  The main causative agent of physical decline in CF patients does not come 
directly from the genetic mutation itself, but rather the resulting conditions of mucous 
accumulation in the lungs and the opportunistic bacteria that take advantage of that 
environment (Lipuma, 2010). Through genetic screenings of the 97% of those who are 
known to have CF, Staphylococcus aureus is the most common bacterial species isolated 
from younger patients while Pseudomonas aeruginosa is responsible for up to 80% of the 
total biomass in the lungs of adults (Razvi, 2009). This may be because, as life 
expectancies are increasing, the likelihood for P. aeruginosa infection will increase 
accordingly. Bacterial diversity is also manifested geographically due to variability in 
treatment practices globally.  CF patients in the U.S. were shown to have less species 
diversity compared to United Kingdom CF patients (Stressmann, 2011). Treatment, diet, 
access to medical care and other lifestyle factors correlate with contracting a more 
diverse group of microbial colonizers. This diversity can increase the variables used in 
assessing treatment which makes effectively combating these pathogens much more 
difficult. It has also been shown that bacterial infections are not random, but that they are 
usually contracted in an age-specific fashion (Garber, 2008). S. aureus and Haemophilus 
influenzae tend to dominate as infectious agents in younger CF patients; as adults the 
common colonizers progresses to other species like Burkholderia cepacia, 
Stenotrophomonas maltophilia and P. aeruginosa (Hutchison, 1999). Other bacteria 
associated with chronic CF infections that do not classify as primary or dominant 
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pathogens include Streptococcus pneumoniae, Achromobacter xylosoxidans, and 
Klebseiella species. Fungi isolated from CF patients include Aspergillus, Candida, 
Chysonilia, Exophiala, Mucor and Penicillium species. However, not only do free-living 
pathogens and fungi find themselves in those suffering from CF, but viruses like 
adenoviruses, influenza, picornaviruses, respiratory syncytial virus and parainfluenza 
viruses also take advantage of this environment (Sibley 2006). Despite the ability for 
viruses and fungi to proliferate in the CF community, they are not as detrimental to host 
health in comparison to CF-associated bacteria. When these bacteria infect the CF lung 
they are often cohabitate with other bacteria. This makes them difficult to study because 
the effects of one bacterium can easily be misappropriated to another if they have similar 
phenotypes (Rogers, 2003; Harris, 2007).  
 New fields of research with their own methods and materials have been created to 
better understand these mixed communities. Collection methods such as expectorated 
mucus collection (Sibley, 2008), bronchoalveolar lavage (Harris, 2007) and throat swabs 
(Gilligan, 1991) have been employed, but as pointed out by multiple researchers, these 
collections may be misrepresentative of the actual bacterial populations within the lung 
due to contamination of oropharyngeal-associated microbes during collection (Goddard, 
2012; Gilligan, 1991; Thomassen, 1984). With advancements in identification of the 
oropharyngeal microflora, recommendations to adjust for the confounding strains are 
suggested. Researchers have used 16S rDNA sequencing techniques to establish 
phylogenetic diversity of microbes within CF patients which has shown promise, but new 
methods of collection are needed in order to produce a more representative model of the 
community ecology of the CF lung (Goddard, 2012).  
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 Many bacteria grow in bacteria-rich, pathogenic powerhouses called biofilms.  
Biofilms (which will be elaborated upon later in this review) are difficult to study not 
only because of their physical makeup consisting of multiple bacteria that can 
communicate and secrete an extracellular matrix, but because many of the 
microbiological techniques used to examine bacteria in the past rely upon examination of 
a single species. Therefore, little is known about how bacterial interactions shape the 
pathogenesis of CF (Peters, 2012). Researchers have sufficient evidence suggesting that 
major bacterial players like P. aeruginosa can alter the growth of other bacteria 
(Collinson, 1996; Baldan, 2014; Bragonzi, 2012; Eberl, 2004; Korganokar, 2013). Within 
the past decade, advances in identifying and quantifying these biofilm-forming virulent 
bacteria have been on the rise (Markle, 2013). Significant advancements in bacterial 
sequencing are being used to understand more about the composition of these biofilms 
(Rogers, 2004), and medical treatments are being tailored to treat individuals suffering 
from this highly variable disease.  
 The Cystic Fibrosis Foundation Annual Report from 2013 outlines prescribed 
medications that are recommended for use. Some of these treatments focus on breaking 
up or decreasing the viscosity of the mucous buildup in the lungs with the introduction of 
recombinant human DNA (rhDNA) (Hodson, 1995) or inhaled hypertonic saline 
solutions (Robinson, 1997). However, newer methods for treatment are focusing on the 
pathogens and are mainly antibiotic; some of these include clarithromycin-tobramycin 
and azithromycin (Solleti, 2014). Multiple treatments are usually administered due to the 
range of symptoms that present themselves in CF patients. Unfortunately these antibiotics 
are becoming less effective every year (Hill, 2005).  One such example of rising 
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resistance to antibiotics in the CF pathogens is Staphylococcus aureus , particularly the 
emergence of a methicillin-resistant strain that is one of the few bacteria that is increasing 
its occurrence of infection in CF.   
 
S. aureus 
 The most commonly found isolate in young CF patients is S. aureus (Razvi, 
2009). S. aureus, a Firmicute, are ubiquitous Gram-positive cocci carried by 37.2% of the 
human population as part of the commensal microflora (Kluytmans, 1997). As of 2013 it 
infected 56% of CF patients under the age of 2 years old, and by the age of 17, almost 
80% of the CF population were carriers at one time (Cystic Fibrosis Foundation Patient 
Registry: Annual Data Report, 2013). Even though found in about half as many cases 
(23% compared to 51%) as methicillin-sensitive S. aureus (MSSA), methicillin-resistant 
S. aureus (MRSA) has seen an increase among CF patients in their pre-teen years where 
loss of proper lung function (Goss, 2011), measured by forced expiratory volume (FEV1), 
is the result of this particularly harmful infection (Dasenbrook, 2008). MRSA is also 
garnering increased attention because of its ability to acquire resistance to antibiotics 
other than methicillin (Gross, 2011). With the knowledge that this bacterium has been 
associated with much of the adolescent mortality, the scientific community has widely 
adopted the use of anti-staphylococcal drugs as methods of treatment. Although, there has 
been a decrease of MSSA due to these agents, there is concern that it allows colonization 
of other harmful airway infections to occur, specifically P. aeruginosa (Goss, 2011), the 
most prevalent bacteria in adult CF patients. Despite the decrease in MSSA, MRSA is of 
continued concern because of difficulties in administering treatment. 
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 What makes S. aureus an organism of concern to researchers is its ability to not 
only opportunistically infect, but its ability to adapt to its environment. In most S. aureus 
nosocomial infections, the minority of transmission happens from patient-to-patient, so it 
is accepted that most of those infected with S. aureus obtain the infection from other non-
human vectors (Price, 2014). In vitro and murine CF models both confirmed that in the 
early infection stages S. aureus are susceptible to bacterial competition, but during 
chronic infections by other organisms S. aureus has increased fitness and is better 
adapted to outcompete other colonizing bacteria (Baldan, 2014). This is attributed to the 
ability that it has to retain pathogenicity after generations of growth within the lung. 
However, S. aureus is not an obligate respiratory pathogen. It can be found in boils, 
impetigo, septic arthritis, osteomyelitis, endocarditis and meningitis to name a few 
(Gordon, 2008).  Over time mammals have acquired specific defensins for such 
widespread pathogens, one of which is called type-II-secreted phospholipase A2 (sPLA2-
IIA) (Pernet, 2014). This hydrolase has little effect on Gram-negative bacteria; it 
possesses significant bactericidal effects on Gram-positive bacteria and is the chief 
defensive molecule against Staphylococcal infections found in intestinal secretions, 
human tears and leukocytes (Qu, 1998).  
 S. aureus has been of interest to researchers since its discovery during a Scottish 
knee surgery in 1880 (Ogston, 1984). Over a century later, researchers are still exploring 
characterization methods that will give them insight into what makes S. aureus a 
dangerous nosocomial infection. One of the most comprehensive tools that researchers 
have to identify the genetic makeup of S. aureus is genetic sequencing. Currently there 
are 56 published complete genome sequences of S. aureus with hundreds more in the 
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draft phase (Genomes Online Database, http://gold.jgi-psf.org). Sequencing of the S. 
aureus genome has proven useful in modern research because it enables researchers the 
ability to examine gene expression in monocultures and it has also given insight into 
polymicrobial interactions and genes that play key roles in virulence (Zhu, 2009; Baba, 
2008).   
 The virulence of S. aureus is directly connected with how it attaches to surfaces, 
invades host cells and causes harm using exotoxins. First, S. aureus uses adhesins to 
attach to host cells. The major class of these attachment proteins is anchored in the 
peptidoglycan of S. aureus. Attaching to extracellular matrix components of host cells, 
these are generally termed as microbial surface component recognizing adhesive matrix 
molecules (MSCRAMMs) (Speziale, 2009). This primary attachment allows attachment 
to human fibrinogen, collagen and fibronectin (Flock, 1987).  Characterized gene 
products of these MSCRAMMs are staphylococcal protein A (SpA), clumping factor 
(Clf), and fibronectin-binding protein A and B (FnbpA and FnbpB) (Lowy, 1998).  Once 
the pathogen has attached to a host cell, it produces exoproteins, which are the main 
components of pathogenicity in S. aureus infections. Some of these exoproteins are 
nucleases, lipases, proteases, collagenase, hyaluronidase α- and β-hemolysins, leukocidin 
and Panton-Valentine leukocidin (PVL) (Kaneko, 2004; Dinges, 2000).  These 
exoproteins can produce β-barrels in host plasma membranes and cause cellular leakage 
(Foster, 2005). Another common result of S. aureus infection is toxic shock syndrome 
(TSS).  The exotoxins associated with this infection are termed pyrogenic toxin 
superantigens (PTSAgs). Superantigenicity comes from the ability for this class of toxins 
to stimulate the extreme over-production of T-lymphocytes (Holtfreter, 2005).  Evasion 
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of host defenses can come from staphylococcal complement inhibitor (SCIN) which 
prevents the formation of the complement protein C3b on the invader’s surface and 
prevents opsonization and phagocytosis (Rooijakkers, 2005). Overall, S. aureus is 
considered a dangerous pathogen because of its multifactorial virulence factors. These 
factors make it difficult to prevent S. aureus attachment, obtaining nutrients by catalysis 
of host cells and evasion of host immune responses.   
 
Pseudomonas aeruginosa 
Shortly after the identification of S. aureus, P. aeruginosa was discovered in 
France and named after its blue-green coloration left on bandages (Wilson, 1998). In the 
year 2000, the first whole genome sequence of this organism was completed. Twenty six 
additional strains have been or are currently being sequenced since that time (Genomes 
Online Database, http://gold.jgi-psf.org). P. aeruginosa is aerobic and belongs to the 12-
member family Pseudomonadaceae of the Gammaproteobacteria. This bacillus accounts 
for 10-15% of nosocomial infections, which are notoriously difficult to treat because of 
their natural antibiotic resistance and the ability to acquire gene encoding antimicrobial 
resistance (Blanc, 1998; Pechere, 1999). This acquisition is particularly worrisome for 
healthcare providers because of its ability to acquire multiple types of resistance 
simultaneously (McGowan, 2006), which makes treatment much more difficult to 
optimize. For the immunosuppressed like those with severe burns or malnutrition, P. 
aeruginosa is a severe threat to overall health. Once considered ubiquitous, this Gram-
negative pathogen is the leading colonizer of CF patients over the age of 24 and is found 
in over 65% of cases reported (Cystic Fibrosis Foundation: Annual Data Report, 2013). 
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Not only is it the most prevalent in adult patients suffering from CF, but it also represents 
over 80% of total bacteria found in the lungs of each case reported (Folkesson, 2012). 
This gives insight into why it is generally accepted as one of the most dangerous and 
widely studied pathogens in the CF community.  
  Much of the research regarding P. aeruginosa concerns its virulence factors, how 
they affect host viability, what mechanisms are employed, and how they persist in the 
infection stages. Some of the virulence factors are: exotoxins, exoenzymes, proteases, 
lipopolysaccharides, pili, flagella, and mucoid exopolysaccharide (Passador, 1993). 
Flagella produced by P. aeruginosa are also significant virulence factors (Montie, 1987). 
Strains bearing mutations in the fliC gene (which encodes the monomer protein of the 
flagella) have shown to be significantly less infectious in an intranasal inoculation mouse 
infection model by a 30% decrease in mortality and greater than a 50% decrease in 
pneumonia. This is thought to be the case because the flagella can act as a tether to 
epithelial membranes (Feldman, 1998). Lipopolysaccharides and pili also aid in cellular 
attachment while exotoxins and enzymes are injected through Type III secretion system 
(T3SS) that provides a passage from the pathogen to healthy host tissues (Bleves, 2010).  
Two of these exotoxins secreted by the T3SS are ExoS and ExoT, both of which have 
GTPase-­‐activating	  protein	  and	  ADP ribosyltransferase activity (Barbieri, 2004)).  ExoS 
prevents actin production and ExoT discourages phagocytosis and in concert they work to 
promote apoptosis of healthy cells (Barbieri, 2004). Another exogenous effector is the 
phospholipase ExoU which can damage cellular membranes by folding into membrane 
binding, bridging and phospholipase domains while also modulating inflammatory 
response (Ballok, 2013). Results of inflamed tissues in the respiratory tract cause 
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coughing, pneumonia and, if spread to the bloodstream (septicemia), it can cause chills, 
disorientation, high fever and shock. Those who are immunosuppressed or suffering from 
CF are some of the most susceptible. Knowing these factors, a study showing P. 
aeruginosa isolated from CF sputum, inoculated in the infection models of 
Caenorhabditis elegans, Drosophila melanogaster, and Galleria mellonella had 
decreased ability to infect these models over the time of chronic infection. However P. 
aeruginosa did not lose its ability to cause acute infection in CF models (Lorè, 2012), 
showing specific pathogenicity even when selective pressures are temporarily removed.   
 Unidentified environmental pressures within CF lungs have the ability to turn 
initial infections from non-mucoid isolates into mucoid strains through the production of 
the exopolysaccharide alginate (Speert, 1990). With this ability for P. aeruginosa to alter 
its phenotype it can be better suited to persist in its environment because of the physical 
protection against phagocytosis and recognition by the immune response that this thick 
alginate provides. One way this is done is by conjugation. Evidence of this exists in 
islands of genetic homology that have been found in P. aeruginosa that correlate with 
Burkholderia cepacia, another respiratory pathogen, suggesting that there is a regular 
exchange of genetic material between the two organisms (Eberl, 2004).  
 Persistence is also a significant issue that researchers are trying to understand. P. 
aeruginosa not only has the ability of effectively infect, but also to elude the host 
immune response. CF isolates are frequently anti-phagocytic because of their ability to 
produce alginate, which inhibits opsonization, thus making it invisible to defensive 
resident alveolar macrophages (Passador, 1993). These polymers can also be produced in 
concert with an extracellular polysaccharide composed of multiple compounds (discussed 
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further in the biofilm section of this review) making a thick matrix of diverse components 
(Rasamiravaka, 2015). This persistence is not only against host defenses, but also against 
other respiratory pathogens.  
 Gram-positive bacteria have shown to enhance the virulence of P. aeruginosa in 
co-culture. In the presence of N-acetyl-D-glucosamine (GlcNAc), a component of 
peptidoglycan, P. aeruginosa produces an excretory pyocyanin that has shown to inhibit 
surrounding Gram-positive growth, while simultaneously increasing GlcNAc catabolism 
genes during in vitro growth (Koraonkar, 2011 and 2013; Whiley, 2013). In summary, P. 
aeruginosa is well adapted to opportunistic growth, specifically within the CF lung 
because of its defenses, environmental sensing and persistence mechanisms that all have 
the ability to influence expression and phenotype based on lifestyle constraints.  
 Due to these many virulence factors, it has been difficult to find a treatment that 
will prevent P. aeruginosa infections from causing such havoc in the CF community. The 
most common treatments of P. aeruginosa are antibiotics. The main types of anti-
pseudomonal antibiotics are fluoroquinolones that inhibit DNA gyrase, thus not allowing 
replication and transcription; penicillin derivatives, specifically those containing β-lactam 
rings, attributed to cell wall biosynthesis inhibition; and aminoglycosides, which inhibit 
bacterial translation by binding to and inhibiting the 30S subunit of the ribosome 
(Strateva, 2009). Even with the administration of these antibiotics, the lifestyle and 
adaptability of P. aeruginosa still make treatment difficult because of the ability to 
acquire multiple types antibiotic resistance from other organisms (Eberl, 2004). As 
antibiotics continue to be used for treatment of mutable bacteria, resistance is likely to 
increase such as has been seen with other antibiotics like penicillin over the past 50 years 
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(Aiello, 2006). As research techniques continue to advance and sequencing becomes 
more financially feasible, researchers strive to learn more about the pathogenicity of this 
nosocomial bacterium and how to effectively treat it. 
 
Stenotrophomonas maltophilia 
 A traditionally non-clinical strain of bacteria that is garnering interest among the 
scientific community due to its pathogenicity is S. maltophilia. This Gram-negative 
bacillus is commonly found in aqueous environments both inside and outside of 
hospitals. Like P. aeruginosa, S. maltophilia is also a multiple drug-resistant pathogen; 
this is probably because of genetic homology that these two Gammaproteobacteria share 
(Brooke, 2012). In fact, S. maltophilia was originally classified as Pseudomonas 
maltophilia (or Xanthomonas maltophilia) until about 20 years ago. Thanks to increased 
research in phylogeny, it was classified as the first member of the genus 
Stenotrophomonas (Denton, 1998). Since that time at least five other strains have been 
added to the genus. S. maltophilia has even been called one of the “most worrisome” of 
the unusual Gram-negative non-fermenters in nosocomial infections (Fihman, 2012). 
This worry comes from its known colonization of up to 16 percent of adolescent and 
adult CF patients, most of which comes from healthcare provider facilities (Cystic 
Fibrosis Foundation Patient Registry: Annual Data Report, 2013), and while not 
commonly an initial colonizer of the CF lung, it follows closely after the initial colonizers 
S. aureus and H. influenzae. S. maltophilia, has only been completely sequenced four 
times, but with 16 genome projects in the draft phase there is still interest in identifying 
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the virulence factors associated with this CF pathogen (Genomes Online Database, 
http://gold.jgi-psf.org).  
From this genome information have been able to better characterize S. maltophilia 
in respect to virulence factors. One such virulence factor is the gene spgM, which codes 
for a membrane-bound lipopolysaccharide. Its significance in virulence was elucidated 
when strains with spgM mutations showed a decrease of susceptibility to antimicrobial 
compounds (McKay, 2003).  Another ability that has shown to have a significant effect 
on virulence is the production of diffusible signal factors (DSF’s). One, identified as cis-
11-methyl-2-dodecenoic acid (Wang, 2004), is dependent upon the two component 
sensing proteins encoded by the rpfC and rpfG genes, which are transcribed in an operon 
(Slater, 2000). S. maltophilia possesses the ability to make DSFs that control extracellular 
proteases and genes encoding proteins that control aggregative behaviors like RpfF 
(Huang, 2007; Fouhy, 2007). When mutations of the rpfC and rpfG genes were made, 
protease activity decreased, motility was attenuated, susceptibility to antibiotics 
increased, and lipopolysaccharide production was altered (Fouhy, 2007). These data 
show that DSF’s play an important role in transcriptional control.  
Despite current S. maltophilia research, its prevalence has steadily increased 
(Razvi, 2009) as measured by increased surveillance of transmission, widespread 
implementation of microbiological techniques that aid in the identification, and oversight 
by organizations like the Cystic Fibrosis Foundation (Saiman, 2003). It can also be 
attributed to the successful treatment practices of P. aeruginosa, leaving CF patients with 
lungs that can be more easily colonized by S. maltophilia (Samoins, 2012).  
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 Most S. maltophilia infections are treated with antibiotics; but with its ability to 
obtain multi-drug resistance, it has been difficult to treat. Although initially considered 
non-virulent, S. maltophilia is a worrisome instigator of pulmonary deterioration (Waters, 
2012; Dasenbrook, 2008). Antibiotics used are similar to those used to treat P. 
aeruginosa infection, with fluoroquinolones being the chief agent (Samonis, 2012; Cystic 
Fibrosis Foundation: Annual Data Report 2013). Biocides are another treatment option 
that has been used, but research conducted over a decade ago in blood isolates has 
already shown decreasing susceptibility to the current dosages (Higgins, 2001). Most of 
S. maltophilia infections are found within the respiratory system, but others include 
vascular, intra-abdominal, bloodstream, urinary tract and soft tissue infections (Fihman, 
2012). Their variable nature in pathogenicity is attributed to the fact that they are motile, 
containing a few polar flagella, and can survive in poor nutrient environments (Brooke, 
2012). With increased research, the virulence factors of S. maltophilia are beginning to 
come to light. With continued work on the effects of this bacteria researchers hope to 
decrease its persistence in the CF lung.    
 
Biofilms 
 Bacteria frequently form structures called biofilms in environmental and host-
associated niches. The formation of a biofilm can be divided into three stages: 
attachment, colonization and growth (Donlan, 2001). Biofilms are formed on solid, moist 
surfaces by the attachment of a planktonic (free floating) cell. This individual will then 
initiate growth of a microcolony. Microcolonies are small isogenic aggregates of the 
attached cell which are expressing adherence factors, allowing them to stick to a surface; 
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this is the attachment stage. Once the microcolony is established the colonization stage 
has begun. This stage is where the diversity of the biofilm is cultivated (Conibear, 2009). 
In complex biofilms, there are: primary colonizers, which attach to a solid surface 
(Donlan, 2001); secondary colonizers, which can attach to the surface or the established 
growth via ligands, pili or fimbriae (Ryan, 2003); bridging bacteria which allow other 
species that would not otherwise incorporate into the biofilm to attach, usually by ligand-
surface protein interactions (Maestre-Reyna, 2013); and finally the species that attach to 
the bridging bacteria (Donlan, 2001; Maestre-Reyna, 2013). As these cells play differing 
rolls in the biofilm their numbers increase and the progression of the biofilm moves into 
the growth stage, where the maturation of the structure is enhanced by an extracellular 
matrix (Eberl, 2004). Some biofilms form from single species growth while others have 
dozens of different species arranged in highly organized arrangements called 
ultrastructures (Hung, 2013).  
Biofilms are found in a variety of locations including abiotic and biotic surfaces 
(Kostakioti, 2013). The biofilm-forming bacteria that cohabitate in a niche are aided in 
survival by extracellular matrix production (Hall-Stoodley, 2004). This matrix is 
composed primarily of polysaccharides that can increase bacterial resistance to 
phagocytosis, antibiotic killing, and that can increase cell-to-cell communication 
(Lyczak, 2002; Passador, 1993). However, this matrix has many other structural elements 
including colonic acid, extracellular DNA (eDNA), cellulose and polyglucosamine, all of 
which allow for bacteria to persist in close proximity to one another (Kostakioti, 2013).  
Despite the many advancements of drug delivery, biofilms have proven to be 
difficult targets for treatment. Because of the thick, viscous extracellular matrix produced 
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by these bacteria, it is difficult to get the intended drug in contact with the pathogens 
(Lyczak, 2002). The sharing of resistance among the bacteria that form biofilms 
exacerbates this treatment problem. A previous study demonstrated that under 
environmental constraints, Escherichia cloacae and P. aeruginosa could obtain 
resistance to multiple antibiotics through one transfer event even if the antibiotics were 
not chemically related (Sanders, 1984). Another transfer of genes that makes treatment 
difficult is the community acquisition of drug efflux pumps (Ma, 1994). Similar to the 
ABC family transporters, efflux pumps differ in the location of where binding proteins 
attach to comprise the holocomplex (Lyczak, 2002). Not all biofilm life is cohabitation; 
there is competition that exists and can shape the lifestyles of the species that reside 
therein. P. aeruginosa has an intrinsic ability to form biofilms, and because of its 
adhesion factors and rapid growth rate, it establishes primary colonization of the niche, 
and can outcompete other strains within the biofilm (Folsom, 2010). In the marine 
biofilm-forming bacterium Pseudoalteromonas tunicata extracellular inhibitory 
antibacterial toxins are released to inhibit other competitive organisms from incorporation 
into the biofilm (Rao, 2005).  
Bacteria within biofilms also compete by sending, receiving, and intercepting 
signaling factors associated with quorum sensing systems (which will be discussed 
further later in this review). Conversely, not all biofilm-associated organisms compete; 
some bacteria can work together to form biofilms. S. aureus is often found in 
polymicrobial biofilms with P. aeruginosa. With the stages of infection that many CF 
patients follow it would be expected that P. aeruginosa would outcompete S. aureus. 
However, S. aureus was found to increase its rate of microcolony formation in the 
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presence of P. aeruginosa supernatant (Yang, 2011). This fact shows just how complex 
these interactions are, and that bacterial competition relies on many factors and functions 
on a variable scale. Despite the research striving to characterize these complex structures 
and how they work, investigators still do not fully understand the interactions of these 
biofilm-forming bacteria (Baldan, 2014) but an increased awareness of what biofilms 
mean to the scientific community concerning their ubiquity, resilience, persistence and 
competition warrants further research into these complex structures.  
 
Bacterial communication  
For a single celled organism (like the CF-associated bacteria discussed in this 
paper) to survive in a variety of environments, it needs to be able to sense its 
environment. Without sensory mechanisms these organisms would not be able to 
appropriately respond to potentially selective environments. For that reason bacteria have 
evolved multiple types of sensors, receptors, fimbriae, adhesins and membrane-associated 
proteins that allow them to take information from their surroundings and make 
transcriptional adjustments. Compensatory measures can be taken by sensing 
environmental variables such as temperature, pH, osmolality and pressure. Not only do 
bacteria understand the makeup of their abiotic environment but they can also sense 
biotic factors in the surrounding area like other bacterial products. For this reason 
systems have evolved whereby bacteria can communicate with one another.  
The most common system associated with bacterial communication is quorum 
sensing (QS). First characterized in Vibrio fischeri, QS is a system in which bacteria can 
elicit a coordinated response to cellular density using concentrations of signaling 
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molecules (Ruby, 1996). In this seminal case, V. fischeri were found on the Hawaiian 
bobtail squid in light organs. It was found that these bacteria did not luminesce unless 
they reached a concentration threshold or “quorum”. Further investigation yielded that 
the autoinducer (AI) molecule, acyl homoserine lactone (AHL), was directly correlated 
with this luminescence, yielding characterization of the LuxI-R system. The LuxI-R 
system is composed of two main cellular components: LuxI- the synthase located in the 
cytoplasm, and LuxR- the receptor located on the cytoplasmic side of the plasma 
membrane (Kolibachuk, 1993). LuxI is constitutively synthesizing AHL, a freely 
diffusible signaling molecule that passes through the membrane into intercellular space. 
When another bacterium that is expressing the lux genes comes in contact with the signal 
AHL, it is taken up by the cell and the signal molecule binds allosterically to the LuxR 
active site. Once this is done the LuxR/AHL complex can bind to DNA, and can either 
activate or repress the transcription of target genes (Holcombe, 2011). One common 
outcome is inducing the transcription of the luxICDABE operon which produces proteins 
that function to give off light while inhibiting the luxR gene (Koch, 2005).  
Another QS system that has been best described in P. aeruginosa involve alkyl 
quinolones (AQs). Similar to AHL signaling systems used in other bacteria, AQs are 
freely diffusible signaling molecules that promote the variable production of targeted 
genes. Much of the mechanisms employed to sense the AQ and the AHL signaling 
molecules are similar, which gives rise to the hypothesis that there is possible cross 
communication between the two systems (Dekimpe, 2009). P. aeruginosa is reliant upon 
QS signals for virulence in host systems. It is believed that over 10% of the encoded 
genome is expressed under the direction of QS signaling molecules (Wagner, 2003).  
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As previously discussed, a QS system using DSFs has been characterized in S. 
maltophilia. A study looking at the communication between S. maltophilia and P. 
aeruginosa showed that an S. maltophilia DSF not only influenced biofilm formation, but 
also increased resistance to antimicrobial peptides (Ryan, 2008). The same signal can 
also increase the antibiotic susceptibility of other bacteria like Bacillus cereus (Deng, 
2014). This DSF, characterized as cis-11-methyl-2-dodecenoic acid, does not enter the 
cell and bind to a response regulator like AHL and AQ (Fouhy, 2007). Rather, this Gram-
negative communication molecule binds to a membrane sensor that activates a response 
regulator involving the synthesis of the second messenger cyclic di-GMP mediating the 
response while keeping the DSF external (Ryan, 2011). These are not novel molecules 
though. Their derivatives have been found to be structurally homologous to other QS 
signaling molecules (Deng, 2014). For Gram-positive bacteria, the most researched QS 
systems are peptide-based. There are no Gram-positive bacteria that have been shown to 
produce AHLs (de Kievit, 2000), but bacteria like S. aureus, Bacillus subtilis and 
Streptococcus pneumoniae produce secreted autoinducing peptides (AIP). These peptides 
are received by a two-component system (TCS) sensor kinase membrane receptor 
(Yarwood, 2003; de Kievit, 2000). When the AIP binds, the sensor kinase is 
phosphorylated, which activates a cytoplasmic messenger AgrA that in turn complexes 
and phosphorylates a transcriptional response regulator (Novick, 2008). With the aid of 
sequencing data, there is increased understanding of the specificity that exists between 
many Gram-positive bacteria involving their species-specific AIP and their 
corresponding TCS (Rocha-Estrada, 2010; http://www.ncbi.nlm.nih.gov).  
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In addition, there is one type of QS system that is not specific to Gram-positive or 
Gram-negative bacteria. The autoinducer 2 (AI-2) class is an important biofilm formation 
signal for Actinomyces oris, Streptococcus gordonii, and Porphyromonas gingivalis in 
the oral cavity (Jakubovics, 2010). These AI-2s have siderophoric properties, specifically 
chelation of boron (Chen, 2002). There is still speculation on the importance of binding 
boron as even its potential uses within the cell has not been well understood (Loomis, 
1992). But as a common QS molecule in both Gram-positive and negative bacteria, the 
AI-2 system is becoming a major target for researchers interested in QS systems because 
it is seen as a universal signal for interspecies communication. One point of interest is 
that boron is also found in some bacterial macrolides suggesting that it may be a good 
target for antibiotic therapy (Irschik, 1995).  
 With all the different forms of bacterial communication and the adaptability of 
pathogens found in biofilms containing QS signaling molecules, there are some strains 
that take advantage of signals not directly intended for them. This action has been coined 
bacterial “eavesdropping” (Ryan, 2008). One such biofilm bacterium that has shown such 
adaptability is P. aeruginosa. This Gram-negative CF pathogen does not have the AI-2 
LuxS synthase. However it can detect the signaling molecule and differentially express 
specific genes (Duan, 2003). Similarly, Klebsiella, Escherichia and Salmonella do not 
have the cellular machinery to produce AHLs. They do have LuxR-like proteins that act 
as receptors for AHL though. In the case of Salmonella, an operon coding proteins 
involved in defense against the host is activated using the surrounding bacterial signals to 
act as warnings (Ahmer, 1998). Some bacteria have even devised methods to fight 
against eavesdropping. In a newly characterized method, E. coli uses nanotubes to share 
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cytoplasmic products and nutrients exclusively with other E. coli (Pande, 2015), thus 
eliminating the ability for other bacteria to eavesdrop. There are many cases of 
eavesdropping in vastly different bacteria. One thing is for certain though, bacteria have 
evolved signals to react in their environment in a coordinated way to increase their 
overall fitness, whether they were the intended recipient or not (Duan, 2003). 
 
Next generation sequencing 
 Basically unchanged since the time of Robert Koch, the methods for determining 
bacterial identity have remained isolation on agar plates as well as a series of selective 
and/or differential growth tests (Zengler, 2009). Using advancements in technology, 
genetic sequencing has become a powerful tool that researchers are using to not only 
identify bacterial strains, but also gain a deeper understanding of how they function. In 
1972 sequence of a single gene coding for a bacteriophage MS2 coat protein was 
completed in Ghent, Germany (Min, 1972). It marked the beginning of the sequencing 
age and although it did not characterize an entire organism it provided a method of 
research that would revolutionize bacterial research. Five years later, the first genome 
fully sequenced, bacteriophage φX174, was completed by Fredrick Sanger (Sanger, 
1977). It took seven years before a full genome, that of the Epstein-Barr virus, was 
sequenced in 1984 using the primer extension method developed by Sanger. Since that 
time advancements in genetic sequencing processes have included direct-blotting-
electrophoresis which eliminated the need for radioactive isotopes for integration into 
immobilizing matrixes (Beck, 1984), and partial automation of the sequencing method 
(Smith, 1986). In 1995 the first full genome of a free-living entity, Haemophilus 
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influenzae, was sequenced (Fleischmann, 1995). Another significant event in genomics 
came in 2001, after decades of work and the cost of $2.7 billion. A draft of the human 
genome was complete in its initial sequencing by the Center for Genome Research 
(Lander, 2001). Since that time, hundreds of whole genomes have been submitted for 
publication or are currently being researched (http://www.ncbi.nlm.nih.gov). This is due, 
in part, to the increased optimization of sequencing processes. With the implementation 
of methods such as pyrosequencing (454) and base-by-base (Illumina HiSeq) the cost has 
been decreasing drastically, and it is projected to become more economical with 
continual advancements in this expanding field (Norton, 2012).  
In 2005, 454 introduced the first next-gen sequencing platform, using DNA 
fragments with attached adaptors on either end. Beads presenting primers complementary 
to the adaptors on the DNA fragments are introduced and after the DNA attach to the 
bead it is replicated so each bead is covered with fragment DNA. Each bead is separated 
into a well with a polymerase enzyme bead. The polymerase attaches to the DNA 
fragment and nucleotides are fed in waves. When one attach, light is emitted. When 
multiple of the same nucleotide is purportedly attached one after the other the light 
emitted is brighter.  Based on when the light is emitted a sequence can be determined 
from the light emission profile. As of 2010, the cost of 454 sequencing is about $0.02 per 
1000 bases, which makes it a high output, relatively inexpensive sequencing method 
(Balzer, 2010; Liu 2012). This method has also allowed us to obtain the whole genome 
sequences of multiple bacteria. Having these genomes as a reference proves useful when 
looking at the transcriptome of those bacteria so we can understand what is being 
expressed and when. 
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Within two years of 454 sequencing’s debut, Illumina sequencing was introduced 
to the scientific community. This is a base-by-base sequencing method that attaches DNA 
fragments to a slide that is covered with a lawn of primers. When the fragmented sample 
DNA, which has adapters on both ends that are complementary to the primers on the slide 
anneal, they will bend over and attach to the opposite side complementary primer. These 
are replicated multiple times leaving a cluster of copied fragment DNA attached to the 
slide. Primers are then added to the free side of the DNA and nucleotides bound to 
fluorescent moieties are washed over the slide. A laser that causes the emission of 
fluorescence detects the nucleotides attachment to the strand. The fluorescence pattern is 
then converted to a sequence for each cluster (Brown, 2012). Illumina sequencing reads 
are shorter fragments than 454 sequencing and therefore is not best suited for de novo 
sequencing, but can obtain the same number of reads within about half the time (Luo, 
2012).  Also the cost of Illumina sequencing is much less than 454 sequencing at about 
$0.001 per 1000 bases (Liu, 2012). Due to these and other sequencing methods, much 
time and money is being put into sequencing different organisms. This is indicative of the 
direction that bacterial research is taking, and with the versatility of the different types of 
sequencing methods, the data generated by these technologies will vastly increase our 
understanding of these studied organisms (Quail, 2012).  
Transcriptomics is also a segment of the genomics field that has become 
increasingly advanced. Next-gen sequencing offers the ability to identify the genes 
expressed by an organism under differing environmental conditions. Conditions that can 
cause a variable response or act as a selective pressure to bacteria are good scenarios for 
Next-Gen Sequencing. Transcriptomics is also valuable in understanding the 
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pathogenicity of microbes in different stages of infection by allowing researchers to see 
the variance of transcripts that bacteria express under specific conditions.  This gives 
researchers useful insight into which targets antimicrobial therapies might be best suited. 
The transcriptomics studies are providing genetic information that	   were previously 
unattainable. Now researchers are able to look at mixed samples and identify the types of 
bacteria within the sample with a high degree of statistical significance (Goddard, 2012; 
Sibley, 2008). As we attempt to understand the microbiome of diverse habitats, genetic 
sequencing has drastically reduced the cost and time of characterization in these 
environments. Given these advancements, the next giant step forward, comparable to the 
first sequenced gene or the human genome, is for beginning-to-end sequencing including 
in vitro/in vivo, and in silico methods to be integrated into one process for whole genome 
sequencing (Frese, 2013). Although this leap may seem far off, the advancements in 
genomic sequencing are increasing exponentially, not only in possible reads and accuracy 
but also in affordable price per base and automation. This project sought to use what we 
know about CF associated pathogens, their lifestyles and communication mechanisms in 
order to understand more about how they can influence each other in co-culture.     
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INTRODUCTION 
Bacteria have long been studied in order to understand how they infect hosts. As 
researchers have tried to address this question in the past, they would eliminate as many 
experimental variables as possible by studying virulent bacteria in monoculture. 
However, infectious bacteria are not always found in monoculture in vivo. During such 
infections, most bacteria are found in close association with other strains of differing 
genera. For this reason, poly-microbial studies have become increasingly important for 
revealing how bacteria influence each other, which may in turn hold clues to 
understanding how they affect the human population.   
One such human polymicrobial disease which is exacerbated by polymicrobial 
infections is Cystic Fibrosis (CF). As the most common genetic disorder in the Caucasian 
population, CF currently affects approximately 30,000 people in the United States and 
over 70,000 worldwide (Cystic Fibrosis Foundation Patient Registry: Annual Data 
Report, 2013). This disorder results from alterations in a specific  chloride channels in the 
lung, which results in the development of a thick mucus layer where bacteria colonize in 
biofilms. The most common infectious agents in CF lungs is Pseudomonas aeruginosa. 
In fact, over 95% of CF patients will be infected with P. aeruginosa at some point in their 
lives (Cystic Fibrosis Foundation Patient Registry: Annual Data Report, 2013). This is of 
great concern due to the virulent capabilities of P. aeruginosa. Another bacterium, 
Stenotrophomonas maltophilia, has been shown to be an alarming threat to CF patients 
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due to its increasing prevalence over the past decade (Stressmann, 2011; Fihman, 2012; 
Razvi, 2009). Infection with either species can lead to severe necrotizing pneumonia that 
can result in rapid pulmonary decline, sepsis and death.   
Evidence has suggested that the bacterial composition found in one part of the 
airway is not indicative of the whole respiratory tract (Goddard, 2012). Regardless of 
fluctuations in the cast of accessory microbes, there are only a handful of bacteria 
routinely isolated from the lower respiratory tracts of CF patients. This finding suggests 
that there are major “players” in CF pathogenesis. The advancements made in genetic 
sequencing are playing a significant role in understanding the genes that contribute to 
these species’ robustness in co-culture as well as their role in virulence. These findings 
increase the scope of bacterial research to include the effects of bacterial communication 
and what genes are essential for their cohabitation in the CF lung. These genes may 
provide answers to questions regarding how communication is linked to bacterial 
virulence. The genes transcribed by one bacterium in co-culture may inhibit opportunistic 
growth of another species and subsequent infection by mechanisms not yet understood. 
The aim of this research was to better understand how two CF pathogens, P. aeruginosa 
and S. maltophilia, sense and respond to each other. Using morphological tests and 
genetic approaches, genes were identified that were up-regulated when these strains were 
grown in co-culture. Follow-up experiments to generate mutations in up-regulated genes 
are still underway. The results from this work have demonstrated that numerous genes are 
differentially regulated in response to co-culture of these CF pathogens. This suggests 
that P. aeruginosa and S. maltophilia have the ability to sense and respond to each other 
either directly or indirectly when grown in co-culture. 
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MATERIALS AND METHODS 
 
Media and bacterial strains 
 Bacterial strains were maintained routinely in Luria Broth Lennox formulation 
(LB), which consisted of 1% tryptone, and 0.5% yeast extract and 0.5% NaCl (Lennox, 
1955). For growth assays, three additional media were also used: Tryptic soy agar 
(TSA)[1], consisting of 0.05% soya peptone and NaCl, and 1.5% casein peptone with pH 
adjusted to 7.3 (MacFaddin, 1985); Soil extract medium (SEM)[2] supplemented with 30 
mM glucose, containing 10% soil extract made by autoclaving 200 g of sieved UV-light 
sterilized corn root soil in 500 mL tap water for 20 min, then supplemented with 30 mM 
glucose, 0.05% CaCO3, pH adjusted to 6.8 and autoclaved for 45 minutes (Kilmer, 1982), 
approximately 50 mL of loose soil was obtained at 9:30 a.m. on May 23, 2013 from the 
roots of a corn stalk at the edge of a field (Latitude-Longitude: 38.326876,-85.460758) 
shaded by growing corn, with an air temperature of 13.9°C. Synthetic cystic fibrosis 
medium (SCFM)[3] was made by adding (per liter of medium) 100 mM amino acid 
stocks to a buffered base of 6.5 mL 0.2 M NaH2PO4, 6.25 mL 0.2 M Na2HPO4, 0.348 mL 
1 M KNO3, 0.122 g NH4Cl, 1.114g KCl, 3.03g NaCl, 10 mM MOPS and 779.6 mL 
MilliQ water.  The amino acid stocks were added to the buffered base in the following 
volumes: L-aspartate, 8.27 mL; L-threonine, 10.72 mL; L-serine, 14.46 mL; L-
glutamate·HCl, 15.49 mL; L-proline, 16.61 mL; L-glycine, 12.03 mL; L-alanine, 17.8 
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mL; L-cysteine·HCl, 1.6 mL; L-valine, 11.17 mL; L-methionine, 6.33 mL; L-isoleucine, 
11.2 mL; L-leucine, 16.09 ml; L-tyrosine, 8.02 mL; L-phenylalanine, 5.3 mL; L-
ornithine·HCl, 6.76 mL; L-lysine·HCl, 21.28 mL; L-histidine·HCl, 5.19 mL; L-
tryptophan, 0.13 mL; and L-arginine·HCl, 3.06 mL (tyrosine, aspartate, and tryptophan 
were resuspended in 1.0 M, 0.5 M, and 0.2 M NaOH, respectively). This was then 
adjusted to a pH of 6.8 and filter sterilized through a sterile 500 mL Corning Bottle-Top 
Filter with a pore size of 0.2 µm.  After filtration the sterile components of: 1.754 mL 1 
M CaCl2, 0.606 mL 1 M MgCl2, and 0.001g FeSO4·7H2O were added.  Three milliliters 1 
M D-glucose and 9.3 ml 1 M L-lactate (previously adjusted to a pH of 7.0) and the final 
volume was adjusted to 1 L with MilliQ water and stored in the dark at 4°C (Palmer, 
2007). All agar was made by adding 12 g/L bacteriological agar to each medium and 
autoclaved for 30 minutes. In the case of SCFM, 500 mL of a 2X stock of filter-sterilized 
ingredients described above was added to 500 mL of autoclaved water containing 12 g 
bacteriological agar. All bacterial strains were maintained at 37°C with shaking at 300 
rpm in liquid culture or on agar in a walk-in 37°C incubator as indicated. 
 P. aeruginosa PAO1 (a burn isolate), P. aeruginosa 2192 (a mucoid CF isolate), 
B. dolosa AU0158 (a CF isolate) and Escherichia coli pEBFP (a lab strain) were all 
obtained from the Stephen Lory lab collection at Harvard Medical School. S. maltophilia 
K279a (a blood isolate) was a gift from Nick Ciancotto at Northwestern University. B. 
cenocepacia K56-2 (a CF isolate) was obtained from John LiPuma (University of 
Michigan). S. aureus NRS77 was obtained through the Network of Antimicrobial 
Resistance in Staphylococcus aureus  from BEI Resources (http://www.narsa.net/). E. 
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coli DH5α was a gift from Michael Perlin (University of Louisville), and E. coli 
pRK2013 was obtained from Herbert Schweizer at Colorado State University. 
 
Proximal growth test 
To assess growth inhibition of differing bacterial strains, P. aeruginosa 2192, P. 
aeruginosa PAO1, S. maltophilia K279a, B. dolosa AU0158, B. cenocepacia K56-2, and 
E. coli pEBFP were grown in LB broth overnight at 37° C with shaking at 300 rpm. Ten 
microliter aliquots were spotted on LB agar plates with pairwise comparisons in three 
zones: isolated, proximal, and combined, in triplicate for each comparison. The plates 
were then incubated at 37°C overnight and colony morphology was observed after 
approximately 12 hours. Based on morphological observations, a designation of 
inhibition or no inhibition was made for each comparison and replicate. 
 
Co-culture lawn inhibition test 
After normalizing the concentration of each overnight liquid culture (using an 
Eppendorff BioPhotomoter 6131) to an optical density at 600 nanometers (O.D.600) of 
0.02, 25 µL of P. aeruginosa 2192, P. aeruginosa PAO1, S. maltophilia K279a, B. 
dolosa AU0158, B. cenocepacia K56-2 and Escherichia coli pEBFP were spread on LB 
and TSA plates making single species bacterial lawns. The plates were incubated at 37°C 
for three hours to allow a low-density lawn to establish. Ten microliters of each bacterial 
species were then spotted on top of the established lawns with the following dilutions 
O.D.600 1.0, 0.5 and 0.01. Broths matching the plate medium as well as sterile nutrient 
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broth were spotted as negative controls. Plates were dried and incubated overnight at 
37°C. Three biological replicates were performed for each comparison and medium.  
 
Growth curves  
Triplicate samples of P. aeruginosa 2192 and S. maltophilia K279a were grown 
overnight in an SCFM at 37°C shaken at 300 rpm. Twenty milliliters of fresh SCFM was 
inoculated with 1 mL of the overnight culture and shaken at 300 rpm at 37°C. At one-
hour time intervals, O.D.600 measurements were taken of three replicates and the averages 
computed via Microsoft Excel.  
Growth curves were then generated in SEM by overnight incubation with shaking 
at 300 rpm at 37°C of each bacterial strain to which 20 mL of fresh SEM broth was 
inoculated with 1 mL of overnight culture. At one-hour time intervals, O.D.600 
measurements were taken of three replicates and averages computed using Microsoft 
Excel.  
 Final growth curve generation was done by allowing each bacterial species (P. 
aeruginosa 2192, S. maltophilia K279a and Staphylococcus aureus NRS77) to grow 
overnight with shaking at 300 rpm at 37°C in LB broth. Fresh LB broth to was brought to 
an O.D.600 of 0.2 using an overnight culture in a total of 20 mL. At one-hour time 
intervals, O.D.600 readings were taken of three replicates and averages computed via 
Microsoft Excel.  
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RNA purification 
Pure cultures of P. aeruginosa 2192, S. maltophilia K279a and S. aureus NRS77 
were grown in LB broth, diluted to an O.D.600 of 0.1 in 20 mL of LB broth and incubated 
until the O.D.600 reached ~2.0. Aliquots totaling 2 mL of each of the following 
combinations were collected: P. aeruginosa 2192 monoculture, S. aureus NRS77 
monoculture, S. maltophilia K279a monoculture, P. aeruginosa 2192 + S. aureus NRS77 
co-culture, P. aeruginosa 2192 + S. maltophilia K279a co-culture, S. aureus NRS77 + S. 
maltophilia K279a co-culture, P. aeruginosa 2192 + S. maltophilia K279a + S. aureus 
NRS77 tri-culture. Each of the co-culture and tri-culture mixtures was combined with 
equal colony forming units (CFU) of their respective bacteria based on growth curve 
data. Each combination was prepared for the “plated” condition by dispensing the 
prepared 2 mL inoculum on a LB agar plate and allowed to incubate with the petri plate 
upright for 2.5 hours at 37°C. Each plate was then scraped and suspended in an additional 
1 mL of LB broth for hot phenol extraction. These samples were combined in their 
pairwise and tri-culture combinations with equal CFUs, diluted to an O.D.600 of 0.2 in 20 
mL of LB broth, and incubated at 37°C with shaking for the other two conditions. When 
the triplicate samples each reached mid-exponential phase (O.D.600 ~ 0.9), the “liquid 
log” sample was collected for RNA extraction. The remainder of the liquid culture 
incubated an additional 12 hours (“stationary” sample). Hot phenol extraction (Masse, 
2003) for each growth condition was performed by adding 700 µl of cell culture with 100 
µL 8X lysis solution (20 mM sodium acetate, 0.5% sodium dodecyl sulfate, 1 mM 
EDTA) preheated to 65°C. Eight hundred microliters of 65°C acid phenol (pH = 4.5, 
Ambion) was added and the reactions were incubated for 5 minutes with vortexing every 
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20 seconds. The lysate was centrifuged at 15,000 rpm for 15 minutes at 4°C. The 
supernatant above the protein phase containing nucleic acids was collected after two 
additional rounds of phenol:chloroform:isoamyl alcohol (25:24:1) extraction. The top 
lysate layer was then mixed with an equal volume of chloroform:isoamyl alcohol (24:1) 
by vortexing then re-centrifuged. The supernatant was precipitated with 3 volumes of 
95% ethanol at -80°C overnight with inversion of each tube after 4 hours. Samples were 
centrifuged at 15,000 rpm at 4°C for 10 minutes, the ethanol was poured off, the pellet 
rinsed with 500 µL of 75% ethanol, centrifuged for another 2 minutes at 15,000 rpm at 
4°C, and allowed to air dry in a ventilated chemical fume hood. Each pellet was 
resuspended in 30 µL RNase-free water. DNA was removed from the samples by treating 
with 50 µL 10X DNAse buffer and 5 µL DNAseI in 500 µL final volume. Reactions were 
incubated at 37°C for 1 hour and purified by phenol extraction and ethanol precipitation. 
The RNA quality was assessed using gel electrophoresis in a 1% agarose gel using SYBR 
Gold detection stain. RNA concentrations were then measured using a Thermo Scientific 
NanoDrop ND-2000c spectrophotometer. 
 
Library preparation for Illumina sequencing 
To enrich for mRNA from total RNA, each sample was purified using the 
MICROBExpress Bacterial mRNA Enrichment Kit (Life Technologies) that relies on the 
selective capture of bacteria rRNAs using magnetic beads bound to complementary 
oligonucleotides. To ensure specific 16S and 23S capture of each bacterial species in the 
sample custom multiplex oligonucleotides were constructed using DNA oligonucleotides 
(Integrated DNA Technologies) and used in place of the capture mix contained in the 
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MICROBExpress kit. Each oligonucleotide mix consisted of a poly adenosine sequence 
of 15 bases (for magnetic bead binding) followed by specific binding sequences that were 
found across the 16S and 23S rRNAs from P. aeruginosa 2192, S. maltophilia K279a and 
S. aureus NRS77: 16S rRNA binding oligonucleotides - (A)15CACTGGAA, 
(A)15GGATTAGA, (A)15TCGTGAGA, (A)15TTGTACAC; 23S rRNA binding 
oligonucleotides - (A)15GTACCGTG, (A)15AAAGGGAA, (A)15CCGTAACT, 
(A)15GCGAAATT, (A)15GAACGTCG. Enriched mRNA samples were prepared for 
Illumina sequencing by adjusting each to a concentration of 20 ng/µL with a total volume 
of 5 µL each. For cDNA conversion and amplification, the NEBNext Ultra RNA Library 
Prep Kit for Illumina (New England BioLabs) was used following manufacturer’s 
recommended protocols with two exceptions: the mRNA purification step was omitted, 
and Qiaquick PCR Purification Kit (Qiagen) was used for purification of the ligation in 
the place of AMPure XP Beads. New England BioLabs NEBNext Multiplex Oligos 
(Index Primer Set 1, New England BioLabs) were used for adding indices (“barcodes”).  
 
Sequencing and data analysis 
High-throughput Illumina sequencing was carried out at the University of 
Wisconsin-Madison Biotechnology Center DNA Sequencing Facility on 3 lanes (7 
barcoded samples/lane) of an Illumina HiSeq 2000 sequencer. Prior to sequencing, 
quality assessments of each library preparation were done for each sample using an 
Agilent Technologies 2100 Bioanalyzer. CLC Genomics Workbench (Qiagen) was used 
for sorting samples using the indices and alignment to each genome using the RNA-seq 
feature and standard default settings. Normalized output for each gene was expressed as 
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RPKM (reads per million reads per million reads). Libraries were assessed for the 
number of reads that aligned to single positions on each genome, gene coverage, and 
overall genome coverage to determine the quality of the data and identify comparisons 
that could be further investigated. S. maltophilia K279a mono-culture or P. aeruginosa 
2192 mono-culture versus the S. maltophilia K279a + P. aeruginosa 2192 co-culture 
were selected for further analysis. 
In silico experiments with CLC Genomics workbench were performed to compare 
the effect of culture conditions (whether community composition or environmental 
condition) using the “Set Up Experiment” function in the Transcriptomics Analysis 
menu. Each replicate compared co-culture growth to the monoculture sequence profiles 
in their respective condition. Statistical analysis for comparisons was performed using the 
Kal’s test for single samples and a Bonferroni multiple testing correction factor (for 
multiple comparison error rate), which provides a p-value for each gene comparison. 
PSORTb v3.0.2 (http://www.psort.org/) was used to predict protein localization for genes 
with significant fold changes (> 3-fold) and for all the predicted proteins in S. maltophilia 
K279a and chi-square tests were used to quantify significant differences between 
expected and observed frequencies in the predicted proteins. Likewise, clusters of 
orthologous gene (COG) functional classifications were assigned for each predicted 
protein, and comparisons between the genes with significant fold changes between mono- 
and co-culture and the entire predicted proteome of S. maltophilia K279a were 
statistically analyzed by chi-squared tests. The data used to select genes for further 
studies were 1) fold changes across differing growth conditions, 2) predicted PSORTb 
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subcellular locations and 3) predicted COG functional classifications. Fifteen genes were 
chosen for verification by qRT-PCR and mutant construction and analysis. 
 
Quantitative Real-Time Polymerase Chain Reaction 
 Primers for qRT-PCR were optimized in concentration and used to assess the 
relative abundance of gene transcripts from three replicates of each S. maltophilia K279a 
mono-culture and S. maltophilia K279a + P. aeruginosa 2192 co-culture mRNA samples 
and growth condition (liquid log, stationary, plated), which were freshly prepared in 
triplicate. For optimization, the primer concentrations tested were 50, 300 and 900 ng/µL 
in pairwise combinations using 104 PCR amplicons per reaction for template. The 
forward and reverse primer concentrations were selected by identifying which 
concentration of each would yield a single 300-400 bp amplicon that have a melting 
temperature of 80-90°C.  After optimization of primer concentrations, transcript levels in 
S. maltophilia K279a mono-culture and S. maltophilia K279a + P. aeruginosa 2192 co-
culture mRNA samples were assessed using quantified PCR products as a standard curve 
(108-102 amplicons per tube in a 10-fold dilution) or 20 ng of purified mRNA samples as 
templates, primers surrounding a ~50-150 bp region internal to each gene (and nested 
inside the PCR amplicons used for standard curves), and Power SYBR Green RNA-to-CT 
1-Step Kit (Life Technologies) in 15 µL final reaction volumes. Reactions contained 7.5 
µL Power SYBR Green RNA-to-CT 1-Step Kit One-Step solution (Life Technologies), 
0.12 µL RT-PCR mix (Life Technologies), 3.33 µL RNase-free water, 0.005 µL glycogen 
(20 mg/mL), 1 µL of template RNA/DNA and 0.36 µL of each internal primer. Running 
conditions for qRT-PCR were: 48°C for 30 minutes, 95°C for 10 minutes, (95°C x 15 
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sec, 60°C for 75 seconds)40 cycles, and 4°C hold. Each sample was run in triplicate and 
compared between conditions. Averages and standard deviations were calculated in 
Microsoft Excel.  
 
Mutant construction 
Overlap extension (SOE) (Horton, 1990) primers for differentially regulated 
genes in S. maltophilia K279a were created using sequences from the 500 base pairs 
upstream and downstream of each gene of interest retrieved from GenBank 
(http://www.ncbi.nlm.nih.gov/genbank/) and the KEGG database 
(http://www.genome.jp/kegg/). For each gene, 4 primers were made: one upstream primer 
with an artificial BamHI restriction enzyme recognition site embedded in the 5’ end 
(Primer 1), one chimeric primer that flanked the 3’ end of the upstream region fused 
directly to the 5’ end of the downstream region (Primer 2), one primer that was the 
reverse complement of the second primer (Primer 3), and a downstream primer 
corresponding to the 3’ end of the downstream region containing an artificial EcoRI 
restriction enzyme recognition site at its 5’ end (Primer 4). Oligonucleotides 
corresponding to each primer sequence were generated by Integrated DNA Technologies 
at 25 nanomole scale and standard desalting purification. The primers were diluted to a 
working stock of 10 pm/µL. First round SOE PCR generated the flanking DNA regions 
for each gene and was performed using Hotstar High Fidelity Polymerase (Qiagen) with 
the manufacturer’s recommended protocol. PCR amplicons generated were verified by 
1% agarose gel electrophoresis and purified by Qiaquick PCR Purification Kit (Qiagen). 
Second round SOE PCR used 2 µL of the purified Round 1 SOE PCR products (upstream 
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and downstream regions) for templates and flanking primers and Primers 1 and 4 for each 
gene. Second round PCR products were verified by 1% agarose gel electrophoresis and 
purified by Qiaquick PCR Purification Kit. Restriction digests were performed using 
BamHI-HF and EcoRI-HF (New England BioLabs) on the purified Round 2 PCR 
products and the pEX18Tc vector (Hoang, 1998; Zhang, 2001; Yang, 2009) according to 
the manufacturer’s recommended protocols except reactions were incubated overnight at 
37°C. Two microliters of Calf Intestinal Phosphatase (New England BioLabs) was added 
to the vector digest and an additional 3 µL of each enzyme was added to the inserts to 
“boost” each reaction. Inserts and the vector were incubated at 37°C for another hour and 
then at 65°C for 20 minutes to inactivate the restriction enzymes. Samples were purified 
using the Qiagen PCR Purification Kit and eluted into 50 µL DNase-free water. Ligation 
reactions containing 1 µL 10X T4 DNA ligase buffer (New England BioLabs), 1 µL T4 
DNA ligase, 1 µL of the vector, and 3X or 10X molar excess of each insert in 10 µl final 
reaction volumes were incubated at 18°C overnight in a thermocycler. Negative controls 
for ligations were prepared in parallel that lacked insert (to check for single cut or uncut 
vectors) or lacked insert and ligase (to check for uncut vectors only). Reactions were first 
transformed into chemically competent Escherichia coli DH5α cells (Hanahan, 1985) by 
adding all 10 µL of each ligation reaction to 50 µL of thawed or fresh competent cells 
then incubated on ice for 30 minutes, heat shocked for 45 seconds at 42°C, then returned 
to ice. In parallel, transformations containing 1 µL of pEX18Tc uncut vector was used as 
a positive control or no DNA was added as a negative control. One milliliter of room 
temperature LB broth was added to each transformation, and the samples were shaken at 
37°C for 1 hour at 300 rpm. Aliquots of 100 µL were plated on LB agar with 10 µg/mL 
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tetracycline (Tet 10) and 20 µg/mL 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside 
(X-gal, Gold Biotechnology). The remaining 900 µl was centrifuged and resuspended in 
100 µL of LB broth and plated on Tet 10 + X-gal LB agar. Colonies were assessed for 
white color (suggesting the lacZα fragment surrounding the multiple cloning site was 
disrupted) and verified by colony PCR with SOE primers 1 and 4. Freezer stocks were 
made from each successful ligated and transformed colony, by adding 1 mL of LB broth 
containing 40% glycerol to 1 mL overnight culture, and freezing in cryovials at -80°C. 
Plasmids were purified from each freezer stock using a QIAprep Spin Miniprep kit 
(Qiagen). Isolated plasmid samples were verified for purity and sent to Macrogen 
(http://www.macrogenusa.net/) for Sanger sequencing. Sequences of each transformed 
plasmid were compared to the expected sequences using BioEdit Biological Sequence 
Alignment Editor [http://www.mbio.ncsu.edu/bioedit/bioedit.html]. The percent 
correlation between Macrogen sequences and a synthesized theoretical sequence were 
calculated to assess the success of each insertion. 
For transformation, electrocompetent S. maltophilia K279a cells were prepared 
following the method outlined by Ye et al. (2014) with a few modifications. To prepare 
competent cells, 100 µL of overnight cultured S. maltophilia K279a were inoculated into 
5 mL of fresh LB medium and incubated at 37°C for 30 minutes.  When O.D.600 values 
reached 0.4, 4.5 mL of the cultures were placed on wet ice for 30 minutes. The cells were 
then pelleted by 15,000 rpm centrifugation at 4°C for 5 minutes. The supernatant was 
poured off and the pellet was washed three times with 3 mL of ice-cold 10% glycerol 
(v/v). Finally, pellets were resuspended in 300 µL fresh 10% glycerol and stored at -
80°C. For transformations, 50 µL of electrocompetent cells were mixed with 2 µL of 
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plasmid DNA (200 ng/µL) and placed on ice for 5 minutes. The mixture was then 
transferred to a 0.1-cm cuvette and electroporated with a single pulse using a Bio-Rad 
Micropulser 2.0 and set to 1.8 kv (setting: Ec1).  After the pulse, the mixture was 
immediately suspended in 950 µL fresh LB medium and incubated at 37°C for one hour. 
Bacterial suspensions were then plated on antibiotic (Tet 10) plates in dilutions of LB at 
1, 1:10, 1:100 and 1:1,000 (cell suspension to nutrient broth). After 24 hours plates were 
removed from incubation where colonies were counted and recorded.  
For bacterial tri-parental conjugation three strains of bacteria were used. The 
recipient S. maltophilia K279a, donor strain of chemically competent E. coli DH5α and 
the helper strain E. coli pRK2013.  Transformed E. coli DH5α containing pEX18Tc with 
gene deletion sequences and E. coli pRK2013 were grown under selection (Tet 10 and 
Kan 50 respectively) on LB agar overnight. S. maltophilia K279a was also grown 
overnight, but on LB agar with no selection. S. maltophilia K279a was heat shocked at 
42°C for 2 hours in a standing tube while LB mating plates were dried at 37°C for 30 
minutes. Two hundred microliters of both E. coli pRK2013 and E. coli DH5α were mixed 
with 400 µL S. maltophilia K279a and centrifuged at 15,000 rpm for 5 minutes. Mixture 
supernatant was then poured off and the pellet resuspended in 100 µL fresh LB. The 
suspension was then plated on a dried LB agar plate and incubated overnight at 37°C. 
The mating mixture was scraped from the LB plate and resuspended in 2 mL LB. 
Aliquots of 400, 100 and 10 µL were spread on selection plates (Tet 10, Carb 75) and 
incubated overnight at 37°C.  Single colonies were counted after 24 hour incubation.	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RESULTS 
Proximal growth test 
In order to study the effect of co-culture on P. aeruginosa, S. maltophilia, 
Burkholderia cepacia complex isolates, and E. coli (a lab strain control), we conducted 
experiments in which two strains were compared in isolated (Zone 1), proximal (Zone 2), 
or combined situations (Zone 3) to identify morphological changes that may occur when 
strains are grown near each other. These microbes can be found within similar niches and 
that was why they were chosen for these tests. For this, each strain was grown overnight 
in a nutrient rich medium and small aliquots were spotted on plates as shown in Figure 
1A. All strains were tested in a pairwise fashion. For all pairwise comparisons after 
overnight incubation, Zones 1 and 2 showed no growth inhibition or changes in 
morphology for P. aeruginosa 2192 (a mucoid CF strain), P. aeruginosa PAO1 (a non-
mucoid strain), S. maltophilia K279a, B. dolosa AU0158, B. cenocepacia K56-2 and E. 
coli pEBFP on any another strain (Table 1). As a note, E. coli pEBFP was chosen over 
the wild-type in this experiment for possible fluorescent identification in future assays. 
Observable growth inhibition was only seen between P. aeruginosa PAO1 and P. 
aeruginosa 2192 in which it appeared that P. aeruginosa PAO1 inhibited the growth of 
P. aeruginosa 2192 (Figure 1B). This was evident by the absence of P. aeruginosa 2192 
when the combined sample was re-streaked and colony isolation only yielded non-
mucoid colonies. This result suggests that P. aeruginosa PAO1 may be an inhibitor of  
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Figure 1. Proximal growth test. (A) Example layout for a proximal growth plate 
test.  (B) Pairwise comparisons were performed for the bacterial strains P. aeruginosa 
2192, P. aeruginosa PAO1, S. maltophilia K279a, B. dolosa AU0158, B. cenocepacia 
K56-2, and E. coli pEBFP. Zone 1- Isolated growth; Zone 2- Proximal growth; Zone 3- 
Combined growth. Example proximal growth test in which P. aeruginosa 2192 (left) was 
plated with P. aeruginosa PAO1 (right).   
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Strain 
P. 
aeruginosa  P. aeruginosa  
S. 
maltophilia B. dolosa  
B. 
cenocepacia E. coli  
2192 PAO1 K279a AU0158 K56-2 pEBFP 
P. aeruginosa 
2192 
P. aeruginosa  ^   PAO1 
S. maltophilia  x x K279a 
B. dolosa  x x x AU0158 
B. cenocepacia  x x x x 
K56-2 
E. coli  
x x x x x pEBFP 
Table 1. Growth inhibition during proximal growth test. 
^ - direction indicating the inhibited bacteria 
x – No inhibition of growth 
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other Pseudomonas species but not of the other bacterial species tested; however, this 
bacterial inhibition may be due to the growth medium or concentration of the 
inoculations. 
 
Co-culture lawn inhibition test 
 As a comparison to the proximal growth tests, strains were compared by 
inoculating high-density spots onto established lawns of bacteria to look for growth 
inhibition. This method is known as the spot-lawn assay and has been conducted in 
previous published research (Aguirre-von-Wobeser, 2014; Lo Giudice, 2007; 
Benkerroum, 1993).  
Pairwise comparisons of all strains on LB medium were plated as shown in Figure 
2A. All positive controls of bacterial lawns spotted with the same bacterium as on the 
lawn displayed growth. All six bacterial strains grew on established S. maltophilia 
K279a, B. cenocepacia K56-2 and E. coli pEBFP lawns (Table 2). Of those spotted 
bacteria that grew on established lawns, there was growth of the lawn directly up to the 
edge of the spotted region showing no discernable zones of inhibition. This suggests that 
there were no molecules produced by the spotted bacteria that were diffusible through the 
medium that could inhibit the growth of the established lawn bacteria. Conversely, none 
of the tested bacterial strains showed growth on the P. aeruginosa PAO1 lawn indicating 
that P. aeruginosa PAO1 actively suppressed the growth of the five other strains. Limited 
growth of E. coli pEBFP and S. maltophilia K279 was observed on P. aeruginosa 2192 
and B. dolosa AU0158 lawns suggesting that P. aeruginosa 2192 and B. dolosa AU0158  
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Figure 2. Co-culture growth on single species lawn.  (A) Layout of co-culture 
growth on bacterial lawns. Strains spotted on top of lawn are indicated.  Approximate 
numbers of bacteria from each strain indicated on right for each spot. (B) Columns of 
individual bacterial species decreasing in concentration plated on an established lawn of 
single bacteria. Example plate shown here in which P. aerguinosa PAO1 was used for 
lawn on TSA medium.   
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Lawn Strain 
Strain 
P. 
aeruginosa  P. aeruginosa  
S. 
maltophilia B. dolosa  
B. 
cenocepacia E. coli  
2192 PAO1 K279a AU0158 K56-2 pEBFP 
Sp
ot
te
d 
St
ra
in
 
P. aeruginosa O* N# O O O O 2192 
P. aeruginosa  O O O O O O PAO1 
S. maltophilia  N N O N O O K279a 
B. dolosa  O N O O O O AU0158 
B. cenocepacia  O N O O O O 
K56-2 
E. coli  
N N O N O O pEBFP 
Table 2. Morphological growth observations in spotted series on established bacterial lawn (LB). 
* O - Observed growth 
# - N - No observed growth 
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may slightly inhibit the growth of E. coli and S. maltophilia strains. The spot lawn assays 
were also replicated on an additional nutrient-rich medium, tryptic soy agar (TSA) to 
verify the results. The results were the same for growth on LB agar with two exceptions: 
E. coli pEBFP and S. maltophilia K279a showed no growth on B. cenocepacia K56-2 
lawns; and B. dolosa AU0158 exhibited growth on the P. aeruginosa PAO1 lawn (Table 
3). These results suggest that the medium on which the strains are plated may play a 
slight role in growth inhibition, as growth inhibition was different between TSA and LB 
media.  
 We conclude from these experiments that when grown in low-density lawns, P. 
aeruginosa PAO1 is an inhibitor of the tested strains and likewise is capable of growing 
on lawns of all the tested strains. P. aeruginosa PAO1 is known to produce a variety of 
toxins, siderophores and other compounds that may play a role in inhibiting growth of 
other strains; however, the mechanism for the growth inhibition in these studies remains 
to be explored. In both assays, E. coli pEBFP and S. maltophilia K279a do not inhibit the 
growth of any other strain. This was expected for E. coli pEBFP which is a lab strain that 
perhaps has lost the ability to compete with other bacteria. However, S. maltophilia 
K279a is a recent human isolate from the blood stream and S. maltophilia is commonly 
found in soils; thus it is surprising that it does not inhibit the growth of other strains.  
 P. aeruginosa, and S. maltophilia are simultaneously isolated from CF patients in 
many clinics. In addition, S. aureus is another CF pathogen that commonly exists in co-
infections in CF patients; yet how it interacts with P. aeruginosa and S. maltophilia has 
not yet been studied. To address this, the transcriptomes of these species were analyzed to 
identify those genes whose expression changes in co-culture with other pathogens. 
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Lawn Strain 
Strain 
P. 
aeruginosa  P. aeruginosa  
S. 
maltophilia B. dolosa  
B. 
cenocepacia E. coli  
2192 PAO1 K279a AU0158 K56-2 pEBFP 
Sp
ot
te
d 
St
ra
in
 
P. aeruginosa O* N# O O O O 2192 
P. aeruginosa  O O O O O O PAO1 
S. maltophilia  N N O N N O K279a 
B. dolosa  O O O O O O AU0158 
B. cenocepacia  O N O O O O 
K56-2 
E. coli  
N N O N N O pEBFP 
Table 3. Morphological growth observations in spotted series on established bacterial lawn (TSA). 
* O - Observed growth 
# - N - No observed growth 
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Growth curves 
 To further understand the growth dynamics of pathogens that are common in the 
CF model we chose to include S. aureus in our research. To identify conditions under 
which CF pathogens could be grown, growth curves were performed with P. aeruginosa, 
S. aureus and S. maltophilia. This was done in order to identify which medium would be 
best suited for polymicrobial analysis as our previous experiments had differing results 
depending on the growth medium (Tables 2 and 3). The strains chosen from the proximal 
growth, and co-culture lawn tests were P. aeruginosa 2192 (chosen because it is a CF 
isolate rather than PAO1 which is a burn/lab isolate and because of the global inhibitory 
effects that P. aeruginosa PAO1 on the other tested strains) and S. maltophilia K279a, a 
blood isolate from a septic cancer patient (Crossman, 2008). S. aureus NRS77 is a blood 
isolate from a septic patient (Sassi, 2014). All three of these isolates were chosen because 
their genome sequences were publicly available; however no genomes are available for 
CF isolates of S. aureus or S. maltophilia.  
 Over 24 hours, S. aureus NRS77, P. aeruginosa 2192 and S. maltophilia K279a 
were grown in an artificial CF sputum medium (SCFM) that nutritionally mimics CF 
sputum. The P. aeruginosa growth in this medium yields a similar transcriptomic 
response as cells grown in actual CF sputum (Palmer, 2005; Palmer, 2007). The growth 
rate of S. maltophilia K279a was significantly lower than the P. aeruginosa 2192 growth 
rate (Table 4). The generation time durring exponential growth of P. aeruginosa 2192 
was significantly faster than that of S. maltophilia K279a. S. maltophilia K279a also had 
a lower growth yield after 24 hours compared to P. aeruginosa 2192 (Supplementary 
Table 1, Figure 3). S. aureus NRS77 on the other hand showed a slight decrease in 
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optical density from its inoculum O.D.600 value (Figure 3). From this we conclude that S. 
aureus NRS77 would not grow in SCFM media and suggests that the SCFM medium 
could not be used to study co-culture growth of S. aureus NRS77. The lack of growth in 
this medium could be due to its sterile, limited nutrient composition. Each component 
added was filter sterilized and a defined amount of amino acids were included. Whereas 
in other nutrient rich media like TSA and LB there are compounds like yeast extract that 
contain partially digested proteins, vitamins, etc. that may allow for better growth of S. 
aureus NRS77.  
 To test to see if there was a growth medium that would provide similar growth 
rates and/or stationary O.D.600 measurements better than SCFM medium for all three 
tested strains, a SEM growth curve was constructed for each bacterial species. The SEM 
media mimics soil conditions, where P. aeruginosa and S. maltophilia are naturally 
found. Despite S. aureus NRS77 not commonly being found in the soil, we decided to see 
if it would grow in this medium with the supplementation of 30 mM of glucose. In this 
medium, S. maltophilia K279a was the fastest growing strain, where P. aeruginosa 2192 
had slower growth (Figure 4). S. aureus NRS77 showed no statistical evidence of growth 
in this medium (Supplementary Table 2 and Table 4). These data lead us to believe that 
the best growth medium to be used in co-culture experiments would have to be a 
previously defined medium in which S. aureus was know to grow. 
The nutrient medium LB allows the growth of many bacterial strains. In this 
nutrient broth, each bacterial sample grew in logarithmic fashion (Figure 5). S. aureus 
NRS77 showed exponential growth and, after 24 hours obtained final O.D.600 values that  
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Figure 3.  Growth curves of P. aeruginosa 2192 (mucoid strain), S. aureus 
NRS77 and S. maltophilia K279a grown in artificial CF sputum medium.  Optical density 
at 600 nm (O.D.600) was measured for three biological replicates over the course of 24 
hours.  Averages were calculated and plotted for each strain.  Error bars represent one 
standard deviation of the data. Dashed lines representative of time-points where data was 
not collected. 
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Figure 4.  Growth curves of P. aeruginosa 2192 (mucoid strain), S. maltophilia K279a, 
and S. aureus NRS77 grown in soil extract medium supplemented with 30 mM glucose.  
Optical density at 600 nm (O.D.600) was measured for two biological replicates over the 
course of 24 hours.  Averages were calculated and plotted for each strain.  Error bars 
represent one standard deviation of the data. Dashed lines representative of time-points 
where data was not collected. 
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were more similar to that observed in P. aeruginosa 2192  and S. maltophilia K279a than 
they were in both SEM and SCFM media (Supplementary Table 3). P. aeruginosa PAO1 
typically grows in LB at a high rate within doubling times of 20-30 minutes. In our 
experiment, the mucoid strain exhibited a much slower growth rate and doubling time, 
perhaps due to the energy costs of producing high levels of alginate. S. maltophilia 
K279a also exhibited exponential growth but was significantly lower than both P. 
aeruginosa 2192 and S. aureus NRS77 in final O.D.600 value (Figure 5, Table 4). A 
reason why S. maltophilia K279a may have had a lower growth than the others in a 
nutrient rich broth could be due to the optimal growth temperature for S. maltophilia 
(35°C), and we grew these bacteria at 37°C, the optimal temperatures for P. aeruginosa 
and S. aureus (Denton, 1998; Barbier, 2014; Rajkovic, 2006). Despite the stationary 
phases and generation times being different from each other, each bacterial strain in this 
tested medium grew at an exponential rate and achieved significant levels of growth in 
comparison with the SCFM and SEM growth curves and have thereby shown to be more 
useful than either media in further experiments.  
 
Transcriptomic analysis 
 In order to obtain transcriptome information from P. aeruginosa 2192, S. 
maltophilia K279a and S. aureus NRS77, mono-, co- and tri-culture samples were 
prepared in an LB medium. The three conditions tested were: logarithmic phase in LB 
broth (“liquid log”), stationary phase in LB broth (“stationary”), or grown on LB agar for 
2.5 hours (“plated”). Cells were harvested and the total RNA was isolated as described in  
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Figure 5.  Growth curves of P. aeruginosa 2192, S. maltophilia K279a and S. aureus 
NRS77 grown in LB medium.  Optical density at 600 nm (O.D.600) was measured for two 
biological replicates over the course of 24 hours.  Averages were calculated and plotted 
for each strain.  Error bars represent one standard deviation of the data. Dashed lines 
representative of time-points where data was not collected. 
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Table 4. Growth rate, generation time and final O.D.600 of P. aeruginosa 2192, S. maltophilia 
K279a, and S. aureus NRS77 in SCFM, SEM and LB medium. 
Media& Strain& Growth&rate&(/min)& Genera3on&3me&(min)& Sta3onary&O.D.600&&
SCFM*&
P.#aeruginosa#2192# 0.00783 ± 0.000161  89.1 ± 1.83  2.426&±&0.08&
S.#maltophilia#K279a# 0.00700 ± 0.000264  99.77 ± 3.69  2.194&±&0.01&
S.#aureus#NRS77# NG✚& NG& NG&
SEM#&
P.#aeruginosa#2192# 0.001428 ± 0.000041  180.24 ±10.41  1.107&±&&.001&
S.#maltophilia#K279a# 0.002729 ± 0.00018  144.5 ± 2.98  .632&±&&.103&
S.#aureus#NRS77# NG& NG& NG&
LB!&
P.#aeruginosa#2192# 0.003878 ± 0.000224  180.24 ± 10.41 5.15&±&.056&
S.#maltophilia#K279a# 0.00483 ± 0.001 144.49 ± 2.979  2.83&±&1.0&
S.#aureus#NRS77# 0.00616 ± 0.000105  113.2 ± 1.93  5.83&±&.007&
*&M&Synthe3c&Cys3c&Fibrosis&Medium&
#&M&Soil&Extract&Medium&
!&M&Luria&Broth&
✚ M&No&growth&
&
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the Materials and Methods section. Total RNA was examined for its quality after DNaseI 
treatment by quantifying it on a spectrophotometer (Supplementary Table 4) and by 
agarose gel electrophoresis (Supplementary Figure 1). Gel electrophoresis yielded bands 
approximately corresponding to the expected 16S and 23S rRNA sizes of 1.5 and 2.9 kb 
respectively for most samples. S. aureus NRS77 also had bands at the expected sizes that 
were subtly discernable to the naked eye, but not reproducible using the Versadoc Gel 
Imaging apparatus (Supplementary Figure 1). Even though this detection was minimal, 
the concentration obtained was still suitable for continuation in purification and 
sequencing preparation. Each sample was then fragmented, converted to double-stranded 
DNA and ligated to Illumina-compatible multiplex oligonucleotides. These 
oligonucleotides incorporated a six base pair barcode on each adaptor-ligated cDNA 
(Supplementary Table 5). Each combination of strains was given a unique barcode. For 
example, all fragmented cDNAs from P. aeruginosa 2192 grown in monoculture were 
labeled with a CGTGAT barcode. In combination with another strain, the barcode would 
be different. Final purified cDNAs were assessed for quality using a spectrophotometer 
prior to sequencing to establish whether there was sufficient quantity and quality for 
submission (Supplementary Table 6). S. aureus NRS77 values in the plated and 
stationary conditions were not as high as P. aeruginosa 2192 or S. maltophilia K279a but 
did meet or exceed the 10 ng/µL threshold set for submission. Each sample was then 
submitted to the University of Wisconsin-Madison’s DNA Sequencing Facility for 
sequencing on an Illumina Hi-Seq 2000 machine following quality assessments via an 
Agilent Bioanalyzer performed at the facility (Supplementary Figure 2).  
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The resultant reads were then aligned to the P. aeruginosa 2192, S. maltophilia 
K279a and S. aureus NRS77 genome sequences to verify that each sample contained 
RNAs corresponding to the appropriate strains (Table 5). Corresponding with a ten-to-
twenty-fold coverage of genes within each genome, a 50,000 read lower threshold was 
established as the minimum number of reads in order for any combination and condition 
to be considered for further analysis. Sequenced samples aligned to genomes showed that 
despite an adequate number of reads in the plated and stationary liquid monoculture 
samples, S. aureus NRS77 was not represented by more than 50,000 reads in any of the 
co- or tri-culture experiments, thereby excluding S. aureus NRS77 sequencing data from 
further analysis. P. aeruginosa 2192 and S. maltophilia K279a on the other hand, were 
found in both plated and log liquid conditions to have reads exceeding the set minimum 
for statistical interpretation in both their monoculture and co-culture sequence data. The 
assessment of the libraries based on aligned reads to each genome yielded some overlap 
between monocultures of P. aeruginosa 2192 and S. maltophilia K279a, even when there 
was theoretically no S. maltophilia K279a in the sample. This however, may have been 
an aberration in the sequence alignment software. In the computation of reads, if there 
were paralogous genes in the genome to which the read could be aligned successfully, the 
read would be seen as redundant and automatically discarded (as the program can not 
discern which gene was expressed using this read thus it is removed from further 
analysis). This would artificially decrease the reads attributed to P. aeruginosa 2192 to 
these genes. P. aeruginosa 2192 is a pathogen that has been shown to possess such 
redundancies (Recinos, 2012).  
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Table 6 displays the number of genes with at least a single aligned read. This was done to 
examine the percent of the genes in the genome that are represented in each sample. In 
each monoculture sample of P. aeruginosa 2192, genes with at least one read were near 
90%, which is strong support for the sequenced sample correctly representing the 
supposed species in that sample. In the case of S. maltophilia K279a however, while the 
reads aligned in the stationary phase are high at 96%, the percent of more than one read 
in the plated and liquid log conditions are low at 6 and 44 percent, respectively. Despite 
these values being low, the genes aligned to the genome in both of these conditions for S. 
maltophilia K279a are high (Table 5). This can once again be attributed to paralogs being 
credited with the read and may be an effect of the sequencing software. The tri-culture 
sample had one or more reads for 89% and above in the S. maltophilia K279a genome, 
and 91% for P. aeruginosa 2192 in all three conditions. In tri-culture, S. aureus NRS77 
had at least one read corresponding with each gene for 47% of the genes in the plated, 
33% of the genes in the stationary and 40% for the genes in the log liquid conditions. 
This was less than half of the other two bacteria in the sample. This may have been the 
case due to possible growth inhibition by S. maltophilia K279a and/or P. aeruginosa 
2192. This is confirmed also by the data in Table 5 which shows a low number of aligned 
reads to the S. aureus NRS77 genome from the tri-culture sample.  
The fold coverage of each sample for the respective genomes showed that there 
was fold coverage exceeding 10X for P. aeruginosa 2192, and S. maltophilia K279a in 
all growth conditions (Table 7). In S. aureus NRS77 monoculture there was high fold 
coverage in the stationary phase of 87.79X and a low in the log liquid condition of 5.39X, 
with a 23.35X fold coverage in the plated condition.  However, in tri- and co-culture 
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Reference genome 
Culture used to 
prepare RNA/
cDNA* 
P. aeruginosa 2192 S. aureus NRS77 S. maltophilia K279a 
Pl
at
ed
 
PA 5,533 (89%) 1,003 (35%) 3,163 (71%) 
SA 1,596 (26%) 2,623 (91%) 1,144 (26%) 
SM 1,128 (18%) 1,566 (55%) 253 (6%) 
PA+SA 1,039 (17%) 197 (7%) 469 (11%) 
PA+SM 5,180 (83%) 788 (27%) 3,781 (85%) 
SA+SM 330 (5%) 66 (2%) 579 (13%) 
PA+SA+SM 5,667 (91%) 1,357 (47%) 4,073 (92%) 
St
at
io
na
ry
 L
iq
ui
d PA 5,833 (94%) 1,052 (37%) 2,867 (65%) 
SA 727 (12%) 2,799 (97%) 733 (17%) 
SM 2,722 (44%) 488 (17%) 4,249  (96%) 
PA+SA 2,172 (35%) 414 (14%) 1,005 (23%) 
PA+SM 4,544 (73%) 345 (12%) 4,158 (94%) 
SA+SM 666 (11%) 129 (4%) 2,392  (54%) 
PA+SA+SM 5,671 (91%) 946 (33%) 4,343 (98%) 
L
og
 L
iq
ui
d 
PA 5,180 (83%) 929 (32%) 2,932 (66%) 
SA 927 (15%) 1,952 (68%) 728 (16%) 
SM 1,269 (20%) 321 (11%) 1,930 (44%) 
PA+SA 1,118 (18%) 98 (3%) 397 (9%) 
PA+SM 5,106 (82%) 538 (19%) 3,605 (81%) 
SA+SM 2,034 (33%) 680 (24%) 3,486 (79%) 
PA+SA+SM 5,700 (91%) 1,155 (40%) 3,922 (89%) 
    
Total # of genes 
in genome 6,233 2,872 4,430 
Table 6. Number and percent of genes in each reference genome with >0 reads aligned  
* PA- P. aeruginosa 2192; SM- S. maltophilia K279a; SA- S. aureus NRS77  
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Table 7.  Fold coverage of reference genomes by Illumina reads. 
    Reference genome 
  
 Culture used to 
prepare RNA/
cDNA* P. aeruginosa 2192 S. aureus NRS77 S. maltophilia K279a 
Pl
at
ed
 
PA 16.85 0.73 35.57 
SA 0.45 23.53 4.32 
SM 0.29 0.13 47.49 
PA+SA 0.54 0.1 2.14 
PA+SM 8.94 0.51 39.87 
SA+SM 0.07 0.03 5.87 
PA+SA+SM 14.11 1.1 67.02 
St
at
io
na
ry
 L
iq
ui
d PA 18.02 0.72 25.26 
SA 0.27 87.79 3.51 
SM 1.36 0.3 35.26 
PA+SA 3.72 0.37 3.72 
PA+SM 5.65 0.16 38.82 
SA+SM 0.17 0.06 27.15 
PA+SA+SM 18.49 0.62 82.99 
L
og
 L
iq
ui
d 
PA 10.8 0.68 27.72 
SA 0.23 5.39 3.4 
SM 0.41 0.18 56.38 
PA+SA 0.49 0.05 18.78 
PA+SM 8.91 0.32 29.96 
SA+SM 0.65 0.48 11.32 
PA+SA+SM 15.94 0.9 48.76 
* PA- P. aeruginosa 2192; SM- S. maltophilia K279a; SA- S. aureus NRS77  
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experiments, S. aureus NRS77 showed a relatively smaller increase in fold coverage as 
all values for combination growth were at or below 1.10X in comparison to the other 
bacteria in the combination. Co-culture of P. aeruginosa 2192 and S. maltophilia K279a 
in all conditions had fold coverage of 5X or higher. Despite the fold coverage not being 
highly convincing of S. aureus NRS77 mRNA presence in combination samples, the data 
for P. aeruginosa 2192 and S. maltophilia K279a are indicative that the harvested mRNA 
from the mono- and co-culture samples indicative of their respective mRNA being found 
in the sample. This, taken with the data from Tables 4 and 5, indicate that genes in the 
combination samples of P. aeruginosa 2192 and S. maltophilia K279a are the most 
suitable to interpret in comparison to their monoculture growth in the plated and liquid 
log conditions.  
 
Genes up-regulated in S. maltophilia K279a in response to co-culture with P. aeruginosa 
2192 
In order to identify the genes that were differentially regulated in S. maltophilia K279a 
when grown in the presence of P. aeruginosa 2192, the CLC Genomics Workbench 
analysis program was used. The in silico experiment of the co-culture P. aeruginosa 2192 
and S. maltophilia K279a yielded S. maltophilia K279a genes that were up-regulated 
when compared to their monoculture growth, many of which displayed p-values of <0.05. 
An empirical limit was placed on the generated data to identify the genes with a fold 
change of 25 or higher. These data consisted of 140 up-regulated genes of S. maltophilia 
K279a in co-culture growth with P. aeruginosa 2192 compared to monoculture growth in 
the plated condition (Table 8). The same combination in the liquid log condition resulted 
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in 170 upregulated genes with the same fold increase (Table 9). Between the two data 
sets there were 84 common genes that were up-regulated in S. maltophilia K279a (Table 
10). Many of these genes encode membrane-associated	  proteins, which was expected in 
co-culture growth. In both conditions some genes were found to come from the same 
operon. The genes smeF and smeE, for example, are located in the smeDEF operon 
(Zhang, 2001). This illustrates the fact that not only individual genes, but also operons 
can be up-regulated for a suite of coordinated responses (Alonso, 2001). In this case the 
smeDEF operon contains multidrug resistance genes that encode for a membrane protein 
(SmeF), an acriflavin resistance protein (SmeE) and a multidrug efflux pump (SmeD) 
(Zhang, 2001). 
 
Genes down-regulated in S. maltophilia K279a in response to co-culture with P. 
aeruginosa 2192 
The same experiment as above was conducted to identify the down-regulated 
genes of S. maltophilia K279a when grown in combination with P. aeruginosa 2192. 
Because there were no genes down-regulated to an equal degree as those up-regulated, 
the empirical limit of fold change was adjusted a five-fold decrease with a statistical 
significance of a p-value <0.05. In either the plated or liquid log conditions there were no 
genes that were down-regulated more than this value in S. maltophilia K279a when 
grown in combination with P. aeruginosa 2192. This leads us to believe that decreasing 
gene transcription from relative rates in monoculture growth is non-advantageous for S. 
maltophilia K279a when in co-culture with P. aeruginosa 2192 regardless of condition. 
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Gene$
Fold$
change$
SM$means$ SM+PA$means$ Annota5on$
rplK% 119.1$ 11.08$ 1,319.59$ 50S$ribosomal$protein$L11$$
rplS% 98.85$ 11.82$ 1,168.82$ 50S$ribosomal$protein$L19$$
gyrA% 88.13$ 1.75$ 154.3$ DNA$gyrase$subunit$A$
acpP_1% 78.6$ 19.81$ 1,556.79$ hypothe5cal$protein$
smeF% 76.22$ 3.39$ 258.61$ mul5drug$resistance$outer$membrane$protein$$
purL% 71.46$ 1.22$ 87.43$ phosphoribosylformylglycinamidine$synthase$$
sodA_2% 71.46$ 7.77$ 555$ manganese$superoxide$dismutase$
accC% 70.27$ 3.47$ 244.15$ bio5n$carboxylase$$
Smlt0184$ 69.08$ 16.5$ 1,140.07$ conserved$hypothe5cal$protein$$
9g% 61.93$ 3.67$ 227.14$ trigger$factor$$
lon% 60.74$ 1.94$ 117.94$ ATPOdependent$protease$$
rplL% 59.55$ 25.76$ 1,534.16$ 50S$ribosomal$subunit$protein$L7/L12$$
Smlt1498$ 57.17$ 1.95$ 111.27$ outer$membrane$protein$$
parC% 55.97$ 2.12$ 118.57$ DNA$topoisomerase$IV$subunit$A$
lysS% 52.4$ 3.14$ 164.74$ lysylOtRNA$synthetase$$
alaS% 51.21$ 1.79$ 91.89$ alanylOtRNA$synthetase$$
fliC% 51.21$ 3.89$ 199.37$ flagellin$$
hupB% 51.21$ 17.41$ 891.67$ DNAObinding$protein$HUObeta$$
pnp% 51.21$ 9.02$ 461.69$ polyribonucleo5de$phosphorylase$$
carB% 50.62$ 2.93$ 148.38$ carbamoylOphosphate$synthase$large$chain$$
pheT% 50.02$ 2$ 99.82$ phenylalanylOtRNA$synthetase$beta$chain$$
qoxA% 47.64$ 4.57$ 217.52$ transmembrane$ubiquinol$oxidase$subunit$2$
precursor$$
rpsG% 47.64$ 20.06$ 955.45$ 30S$ribosomal$protein$S7$$
nuoB% 46.45$ 8.56$ 397.8$ NADH$dehydrogenase$I$chain$B$$
gltX% 45.26$ 3.39$ 153.22$ glutamylOtRNA$synthetase$$
dnaJ% 45.26$ 4.23$ 191.22$ chaperone$DnaJ$protein$$
eno% 45.26$ 3.68$ 166.37$ enolase$$
glyA% 45.26$ 3.79$ 171.55$ serine$hydroxymethyltransferase$$
nuoJ% 44.07$ 7.23$ 318.81$ NADHOubiquinone$oxidoreductase,$chain$J$$
Smlt3703$ 43.67$ 27.48$ 1,199.83$ pep5doglycanOassociated$lipoprotein$$
pyrG% 42.87$ 2.85$ 122.4$ CTP$synthase$$
Smlt0716$ 42.87$ 2.85$ 122.4$ ABC$transporter$component$protein$$
pps% 42.87$ 4.14$ 177.6$ 7$phosphoenolpyruvate$synthase$$
sucD% 42.87$ 16.28$ 697.94$ succinylOCoA$synthetase$alpha$chain$$
fusA% 41.85$ 31.07$ 1,300.29$ elonga5on$factor$G$$
dnaX% 41.68$ 2.34$ 97.41$ DNA$polymerase$III$subunit$Tau$$
smeE% 40.69$ 9.13$ 371.6$ acriflavin$resistance$protein$B$$
Smlt2059$ 40.49$ 3.92$ 158.81$ PQQ$containing$lipoprotein$$
Smlt0982$ 40.49$ 4.73$ 191.52$ isocitrate/isopropylmalate$dehydrogenase$$
rpsT% 40.1$ 52.82$ 2,117.65$ 30S$ribosomal$protein$S20$$
Table 8. Up-regulated S. maltophilia K279a genes when grown in the presence of P. 
aeruginosa 2192 in plated conditions compared to monoculture ( >25-fold increase).  
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Gene$ Fold$change$ SM$means$ SM+PA$means$Annota5on$
pilY1& 39.3$ 1.25$ 49.3$ PilY1$protein$$
e(S& 39.3$ 6.36$ 250.09$ electron$transfer$flavoprotein$subunit$beta$$
speA& 39.3$ 2.52$ 98.84$ biosynthe5c$arginine$decarboxylase$$
rplJ& 38.41$ 35.41$ 1,359.91$ 50S$ribosomal$subunit$protein$L10$$
rpoC& 38.31$ 13.51$ 517.69$ DNAPdirected$RNA$polymerase$beta'$chain$$
atpF& 38.11$ 10.09$ 384.61$ ATP$synthase$B$chain$$
rluB& 38.11$ 2.92$ 111.21$ ribosomal$large$subunit$pseudouridine$synthase$B$$
rpsN& 38.11$ 15.53$ 592$ 30S$ribosomal$protein$S14$$
guaB& 37.52$ 6.52$ 244.61$ inosineP5'Pmonophosphate$dehydrogenase$$
cspG& 36.92$ 22.64$ 835.68$ cold$shock$protein$$
smeP& 36.92$ 1.5$ 55.5$ drugPresistance$cell$envelopePrelated$protein$$
Smlt1368$ 36.92$ 2.06$ 76.07$ conserved$hypothe5cal$protein$$
lipA& 35.73$ 4.7$ 167.98$ lipoic$acid$synthetase$$
metG& 35.73$ 2.29$ 81.69$ methionylPtRNA$synthetase$$
nuoM& 35.73$ 3.15$ 112.55$ NADH$dehydrogenase$I$chain$M$$
smeH& 35.73$ 3$ 107.01$ mul5drug$resistance$efflux$pump$$
sppA& 35.73$ 2.47$ 88.32$ protease$IV$$
topA& 35.73$ 1.91$ 68.12$ DNA$topoisomerase$I$$
atpD& 35.13$ 27.03$ 949.54$ ATP$synthase$beta$chain$$
cyoA& 34.54$ 5.26$ 181.81$ cytochrome$O$ubiquinol$oxidase$subunit$II$$
nusG& 34.54$ 8.47$ 292.64$ transcrip5on$an5termina5on$protein$$
pcm_2& 34.54$ 7.34$ 253.35$ hypothe5cal$protein$
Smlt0083$ 34.54$ 2.09$ 72.29$ TonB$dependent$receptor$protein$$
Smlt2132$ 34.54$ 3.1$ 107.09$ aldehyde$dehydrogenase$$
lpdA& 33.94$ 5.26$ 178.37$ dihydrolipoamide$dehydrogenase$$
icd& 33.74$ 6.41$ 216.46$ isocitrate$dehydrogenase$$
leuS& 33.74$ 5.4$ 182.06$ leucylPtRNA$synthetase$$
accB& 33.35$ 9.9$ 330.23$ bio5n$carboxyl$carrier$protein$of$acetylPCoA$carboxylase$$
ahpF& 33.35$ 2.98$ 99.5$ alkyl$hydroperoxide$reductase$subunit$F$$
carA& 33.35$ 4.02$ 134.1$ carbamoylPphosphate$synthase$small$chain$$
prfC& 33.35$ 2.96$ 98.76$ pep5de$chain$release$factor$$
Smlt3526$ 32.58$ 194.58$ 6,339.70$ outer$membrane$lipoprotein$$
accD& 32.16$ 5.35$ 172.13$ acetylPcoenzymeAcarboxylase$carboxyl$transferase$subunit$beta$$
glmU& 32.16$ 3.47$ 111.73$ UDPPNPacetylglucosamine$synthesis$bifunc5onal$protein$$
rnE& 32.16$ 4.33$ 139.21$ ribonuclease$E$$
appB& 32.16$ 8.25$ 265.36$ transmembrane$cytochrome$bdPII$oxidase$subunit$II$$
rplQ& 32.16$ 37.14$ 1,194.13$ 50S$ribosomal$protein$L17$$
Smlt3330$ 32.16$ 3.04$ 97.79$ NPacetylmuramoylPLPalanine$amidase$$
rplO& 31.86$ 42.82$ 1,364.26$ 50S$ribosomal$protein$L15$$
Table 8 ctd. Up-regulated S. maltophilia K279a genes when grown in the presence of P. 
aeruginosa 2192 in plated conditions compared to monoculture ( >25-fold increase).  
  
71 
 
Gene$ Fold$change$SM$means$ SM+PA$means$ Annota5on$
exbD1& 30.96$ 11.16$ 345.51$ biopolymer$transport$ExbD1$protein$$
narK& 30.96$ 3.35$ 103.73$ Major$Facilitator$Superfamily$transmembrane$nitrite$
extrusion$protein$$
metK& 30.96$ 7.84$ 242.88$ SLadenosylmethionine$synthetase$$
recG& 30.96$ 2.25$ 69.69$ ATPLdependent$DNA$helicase$$
rpsR& 30.96$ 20.58$ 637.17$ 30s$ribosomal$subunit$protein$S18$$
Smlt3796$ 30.96$ 4.15$ 128.44$ conserved$hypothe5cal$exported$protein$$
moaA& 30.96$ 4.85$ 150.04$ molybdenum$cofactor$biosynthesis$protein$A$
betB& 29.77$ 3.23$ 96.08$ betaine$aldehyde$dehydrogenase$$
comL& 29.77$ 5.35$ 159.38$ competence$lipoprotein$precursor$$
Smlt2039$ 29.77$ 4.58$ 136.34$ deiminase$$
frr& 29.77$ 8.56$ 255$ ribosome$recycling$factor$$
7sI& 29.77$ 2.58$ 76.71$ penicillinLbinding$protein$3$precursor$$
secF& 29.77$ 4.85$ 144.27$ proteinLexport$membrane$protein$SecF$$
Smlt3472$ 29.77$ 1.23$ 36.71$ conserved$hypothe5cal$exported$protein$$
rpsS& 29.18$ 35.21$ 1,027.37$ 30S$ribosomal$protein$S19$$
rplT& 29.18$ 26.41$ 770.53$ 50S$ribosomal$protein$L20$$
rpsM& 29.18$ 26.63$ 777.01$ 30S$ribosomal$protein$S13$$
rpsA& 28.81$ 59.21$ 1,705.70$ 30S$ribosomal$protein$S1$$
cysS& 28.58$ 3.45$ 98.67$ cysteinylLtRNA$synthetase$$
Smlt4628$ 28.58$ 2.21$ 63.25$ conserved$hypothe5cal$exported$protein$$
fdnG& 28.58$ 1.55$ 44.27$ formate$dehydrogenaseLo,$major$subunit$$
hflX& 28.58$ 3.63$ 103.63$ GTPLbinding$phageLrelated$protein$$
serS& 28.58$ 3.71$ 106.06$ serylLtRNA$synthetase$$
Smlt4339$ 28.58$ 4.45$ 127.21$
branchedLchain$alpha$keto$acid$dehydrogenase$E1$
beta$subunit$$
Smlt4575$ 28.58$ 3.4$ 97.19$ cytochrome$oxidase$subunit$I$$
tufB& 28.29$ 15.96$ 451.55$ elonga5on$factor$Tu$(EfLTu)$$
rplN& 28.19$ 77.29$ 2,178.50$ 50S$ribosomal$protein$L14$$
rplB& 27.89$ 68.89$ 1,921.20$ 50S$ribosomal$protein$L2$$
atpC_2& 27.39$ 31.07$ 851.01$ hypothe5cal$protein$
gcvT& 27.39$ 4.27$ 116.98$ aminomethyltransferase$$
minD& 27.39$ 11.74$ 321.49$ septum$siteLdetermining$protein$$
Smlt2781$ 27.39$ 4.92$ 134.79$
molybdenum$cofactor$biosynthesis$protein$($secreted$
protein)$$
Smlt3210$ 27.39$ 11.28$ 308.91$ outer$membrane$an5gen$protein$$
Smlt4670$ 27.39$ 6.02$ 165.02$ ABC$transporter$ATPLbinding$protein$
rmlB& 27.39$ 4.5$ 123.3$ dTDPLglucose$4,6Ldehydratase$$
Smlt3652$ 27.39$ 3.39$ 92.94$ betaLlactamase$protein$$
rplE& 26.44$ 43.77$ 1,157.23$ 50S$ribosomal$protein$L5$$
dapF& 26.2$ 5.58$ 146.18$ diaminopimelate$epimerase$$
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smeG% 26.2$ 3.7$ 97$ RND$family$acriflavine$resistance$protein$A$precursor$$
adhB% 26.2$ 3.53$ 92.46$ alcohol$dehydrogenase$cytochrome$c$subunit$$
argS% 26.2$ 5.63$ 147.48$ arginylLtRNA$synthetase$$
gcvH% 26.2$ 12$ 314.5$ glycine$cleavage$system$H$protein$$
rpmH% 26.2$ 67.42$ 1,766.57$ 50S$ribosomal$protein$L34$$
Smlt0777$ 26.2$ 1.89$ 49.48$ conserved$hypothe5cal$protein$$
Smlt2831$ 26.2$ 4.14$ 108.39$ transmembrane$LINOLEOYLLCoA$DESATURASE$(DELTA(6)LDESATURASE)$$
qoxB% 25.9$ 9.49$ 245.76$ quinol$oxidase$subunit$1$$
surA% 25.61$ 7.07$ 181.12$ survival$protein$SurA$precursor$$
groES% 25.61$ 33.01$ 845.22$ 10$kDa$chaperonin$$
dxs% 25.01$ 2.49$ 62.31$ 1LdeoxyLdLxyluloseL5Lphosphate$synthase$$
mtcC% 25.01$ 4.01$ 100.32$ cystathionine$beta/gammaLlyase$$
Smlt0277$ 25.01$ 6.95$ 173.8$ twoLcomponent$transcrip5onal$regulator$response$regulatory$protein$$
Smlt1133$ 25.01$ 3.18$ 79.57$ pep5dase$$
Smlt1704$ 25.01$ 3.62$ 90.47$ transmembrane$CorC/HlyC$family$transporter$$
Smlt3195$ 25.01$ 3.36$ 83.96$ conserved$hypothe5cal$protein$$
Smlt3481$ 25.01$ 11.57$ 289.25$ conserved$hypothe5cal$protein$$
Smlt3854$ 25.01$ 5.52$ 138.07$ YicC$family$protein$$
Smlt4263$ 25.01$ 5.51$ 137.83$ ATPLdependent$RNA$helicase$$
tpiA% 25.01$ 6.29$ 157.25$ triosephosphate$isomerase$$
aroC% 25.01$ 4.31$ 107.68$ chorismate$synthase$$
folE% 25.01$ 7.77$ 194.25$ GTP$cyclohydrolase$I$$
rho% 25.01$ 7.42$ 185.61$ transcrip5on$termina5on$factor$$
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Table 9. Up-regulated S. maltophilia K279a genes when grown in the presence of P. 
aeruginosa 2192 in liquid log conditions compared to monoculture ( >25-fold increase).  
  
Gene$
Fold$
change$
SM$means$ SM+PA$means$Annota5on$
rplV% 114.57$ 11.71$ 1,341.30$ 50S$ribosomal$protein$L22$$
betA% 94.65$ 2.38$ 225.16$ choline$dehydrogenase$$
Smlt0685$ 84.69$ 0.55$ 46.92$ repe55ve$surface$protein$$
metG% 79.7$ 1.93$ 153.49$ methionylKtRNA$synthetase$$
lpdA% 74.72$ 2.21$ 165.38$ dihydrolipoamide$dehydrogenase$$
sucB% 74.72$ 3.33$ 248.69$ dihydrolipoamide$succinyltransferase$E2$component$$
gyrB% 69.74$ 1.63$ 113.51$ DNA$gyrase$subunit$B$$
rpsH% 64.76$ 10.03$ 649.82$ 30S$ribosomal$protein$S8$$
rplX% 64.76$ 25.18$ 1,630.69$ 50S$ribosomal$protein$L24$$
Smlt0184$ 64.76$ 13.9$ 900.28$ conserved$hypothe5cal$protein$$
Smlt0383$ 64.76$ 4.48$ 290.02$ histone$H1Klike$protein$$
mgtA% 64.76$ 1.45$ 93.94$ transmembrane$Mg(2+)$transport$ATPase$$
putA% 59.78$ 1.24$ 74.35$ bifunc5onal$PutA$protein$$
gltA% 59.78$ 6.27$ 374.55$ citrate$synthase$$
clpB% 59.78$ 1.55$ 92.55$ heat$shock$chaperone$ClpB$$
rpsM% 54.8$ 11.21$ 614.54$ 30S$ribosomal$protein$S13$$
cirA% 54.8$ 1.87$ 102.57$ colicin$I$receptor$precursor$$
Smlt3905$ 54.8$ 2.71$ 148.34$ TonB$dependent$receptor$$
groEL% 53.97$ 14.56$ 785.69$ GroEL$protein$$
metH1% 49.81$ 1.46$ 72.74$ 5KmethyltetrahydrofolateKKhomocysteine$
methyltransferase$$
atpH% 49.81$ 7.58$ 377.74$ ATP$synthase$delta$subunit$protein$$
Smlt1001$ 49.81$ 1.29$ 64.42$ autotransporter$$
exbB1% 49.81$ 10.51$ 523.48$ biopolymer$transport$exbB$protein$$
Smlt0025$ 49.81$ 1.93$ 96.21$ conserved$hypothe5cal$protein$$
phaAB% 49.81$ 1.41$ 70.43$ K(+)/H(+)$an5porter$subunit$A/B$(pH$adapta5on$
potassium$efflux$system$protein$A/B)$$
Smlt4151$ 49.81$ 1.48$ 73.54$ TonB$dependent$receptor$$
pdhB% 47.32$ 4.66$ 220.45$ dihydrolipoamide$acetyltransferase$component$of$
pyruvate$dehydrogenase$complex$$
groES% 44.83$ 13.9$ 623.27$ 10$kDa$chaperonin$$
asnS% 44.83$ 2.87$ 128.67$ 2$asparaginylKtRNA$synthetase$$
Smlt2834$ 44.83$ 1.7$ 76.32$ autotransporter$protein$$
Smlt4687$ 44.83$ 3.42$ 153.42$ conserved$hypothe5cal$protein$
Smlt4045$ 44.83$ 1.84$ 82.42$ exported$tailKspecific$protease$precursor$$
Smlt0136$ 44.83$ 1.08$ 48.33$ ferredoxin$oxidoreductase$$
Smlt0654$ 44.83$ 1.21$ 54.1$ helicase$$
mdh% 44.83$ 4.06$ 181.87$ malate$dehydrogenase$$
Smlt3703$ 44.83$ 15.43$ 691.72$ pep5doglycanKassociated$lipoprotein$$
Smlt0187$ 44.83$ 4.11$ 184.1$ peroxidase$$
phaD% 44.83$ 2.61$ 116.86$ pH$adapta5on$potassium$efflux$protein$$
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GpT$ 44.83$ 1.4$ 62.65$ phage$tail$protein$$
frr$ 44.83$ 7.21$ 323.43$ ribosome$recycling$factor$$
Smlt4678$ 44.83$ 2.57$ 115.06$ RmuC$family$protein$
Smlt0882$ 44.83$ 1.24$ 55.61$
sensor$his5dine$kinase/response$regulator$fusion$
protein$$
acpP_1$ 44.83$ 16.68$ 747.92$ hypothe5cal$protein$
nusA$ 42.34$ 5.3$ 224.24$ N$u5liza5on$substance$protein$A$
Smlt1515$ 39.85$ 3.77$ 150.24$
2,3,4,5OtetrahydropyridineO2Ocarboxylate$NO
succinyltransferase$$
Smlt4518$ 39.85$ 4.13$ 164.66$ ABC$transporter$ATPObinding$protein$$
lon$ 39.85$ 1.64$ 65.18$ ATPOdependent$protease$$
Smlt4656$ 39.85$ 1.18$ 47.19$ conserved$hypothe5cal$protein$
serA$ 39.85$ 3.03$ 120.6$ DO3Ophosphoglycerate$dehydrogenase$$
Smlt2530$ 39.85$ 1.57$ 62.57$ DNA$ligase$family$protein$$
Smlt0198$ 39.85$ 2.37$ 94.64$
electron$transfer$flavoproteinOubiquinone$
oxidoreductase$$
recB$ 39.85$ 1.09$ 43.35$ exodeoxyribonuclease$V$beta$chain$$
Smlt3167$ 39.85$ 3.24$ 129.01$ NADOdependent$glutamate$dehydrogenase$$
nuoN$ 39.85$ 2.74$ 109.21$ NADH$dehydrogenase$I$chain$N$$
Smlt3181$ 39.85$ 2.97$ 118.19$ nucleo5de$sugar$dehydrogenase$$
bglX$ 39.85$ 1.84$ 73.36$ periplasmic$betaOglucosidase$precursor$$
RRM1$ 39.85$ 3.44$ 137.08$ ribonucleosideOdiphosphate$reductase$large$subunit$$
sucD$ 39.85$ 9.14$ 364.28$ succinylOCoA$synthetase$alpha$chain$$
Smlt0891$ 39.85$ 9.67$ 385.4$ transmembrane$preprotein$translocase$subunit$$
Smlt1331$ 39.85$ 2.38$ 94.8$ transmembrane$protein$$
Smlt0196$ 39.85$ 1.09$ 43.52$ twoOcomponent$sensor/response$regulator$protein$$
Smlt1542$ 39.85$ 1.32$ 52.71$
twoOcomponent$system$sensor$kinase/response$
regulator$fusion$protein$with$GGDEF$signalling$
domain$$
maeB$ 37.36$ 3.49$ 130.53$ NADPOdependent$malic$enzyme$$
Smlt1976$ 36.53$ 1.51$ 55.32$ conserved$hypothe5cal$protein$$
dxs$ 34.87$ 2.1$ 73.17$ 1OdeoxyOdOxyluloseO5Ophosphate$synthase$$
Smlt4670$ 34.87$ 5.07$ 176.95$ ABC$transporter$ATPObinding$protein$
acsA$ 34.87$ 4.12$ 143.63$ acetylOcoenzyme$A$synthetase$$
hrpB$ 34.87$ 1.6$ 55.73$ ATPOdependent$helicase$$
ctpA$ 34.87$ 2.76$ 96.35$ carboxyOterminal$processing$protease$precursor$$
Smlt1978$ 34.87$ 4.29$ 149.64$ conserved$hypothe5cal$protein$$
Smlt3859$ 34.87$ 1.76$ 61.23$ conserved$hypothe5cal$protein$$
Smlt1246$ 34.87$ 1.86$ 64.91$ exported$pep5dase$$
Smlt2728$ 34.87$ 2.46$ 85.86$ exported$surface$an5gen$protein$$
mdoD$ 34.87$ 2.49$ 86.99$ glucan$biosynthesis$protein$d$precursor$$
msbA$ 34.87$ 2.29$ 79.82$ lipidAexport$ATPObinding/permease$$
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ispB% 34.87$ 4.01$ 139.75$ octaprenylBdiphosphate$synthase$$
Smlt3229$ 34.87$ 1.87$ 65.27$ pep5dyl$dipep5dase/oligopep5dase$$
Smlt1866$ 34.87$ 3.98$ 138.92$ phageBrelated$protein$$
Smlt1906$ 34.87$ 3.52$ 122.79$ phageBrelated$protein$$
pilY1% 34.87$ 1.06$ 36.85$ PilY1$protein$$
pdhA% 34.87$ 3.7$ 128.91$ pyruvate$dehydrogenase$E1$component,$alpha$
subunit$$
Smlt4430$ 34.87$ 1.76$ 61.48$ RhsBfamily$exported$protein$$
rnE% 34.87$ 2.43$ 84.77$ ribonuclease$E$$
rnr% 34.87$ 1.56$ 54.43$ ribonuclease$R$(RNase$R)$$
Smlt2364$ 34.87$ 5.3$ 184.67$ SapCBrelated$protein$$
Smlt0107$ 34.87$ 1.66$ 57.74$
sensor$his5dine$kinase$transcrip5onal$regulatory$
protein$twoBcomponent$regulator$$
Smlt4410$ 34.87$ 1.67$ 58.1$ TonB$dependent$ferric$enterobac5n$receptor$$
Smlt0626$ 34.87$ 2.05$ 71.6$ transmembrane$protein$$
Smlt1462$ 34.87$ 1.65$ 57.6$ transmembrane$protein$$
pilF% 34.87$ 2.31$ 80.51$ type$IV$pilus$assembly$protein$$
Smlt3626$ 34.87$ 1.13$ 39.46$ hypothe5cal$
rpsC% 33.45$ 38.13$ 1,275.37$ 30S$ribosomal$protein$S3$$
rplY% 33.21$ 19.44$ 645.45$ 50S$ribosomal$protein$L25$$
pilL% 33.21$ 1.8$ 59.73$ gliding$mo5lity$sensor$his5dine$kinase$response$
regulator$fusion$transcrip5onal$regulatory$protein$$
smeH% 33.21$ 3.78$ 125.67$ mul5drug$resistance$efflux$pump$$
acnB% 32.38$ 3.09$ 100.03$ aconitate$hydratase$2$$
nuoD% 32.38$ 6.12$ 198.23$ NADH$dehydrogenase$I$chain$D$$
Smlt0490
A$
32.38$ 1.87$ 60.64$ hypothe5cal$
rpsQ% 31.13$ 59.31$ 1,846.72$ 30S$ribosomal$protein$S17$$
Smlt0387$ 30.89$ 69.87$ 2,158.05$ conserved$hypothe5cal$protein$$
rpmJ2% 29.89$ 31.78$ 949.74$ 50S$ribosomal$protein$L36$$
bioF% 29.89$ 3.27$ 97.77$ 8BaminoB7Boxononanoate$synthase$$
adhC% 29.89$ 3.61$ 107.81$ alcohol$dehydrogenase$classBIII$$
gcvT% 29.89$ 3.6$ 107.52$ aminomethyltransferase$$
Smlt4577$ 29.89$ 3.09$ 92.34$ ATPBbinding$ABC$transporter$protein$$
Smlt3443$ 29.89$ 4.63$ 138.5$ ATPBbinding$protein$$
Smlt4339$ 29.89$ 3.75$ 112.05$
branchedBchain$alpha$keto$acid$dehydrogenase$E1$
beta$subunit$$
smmF% 29.89$ 1.27$ 38.1$ ca5on$efflux$system$protein$$
traA% 29.89$ 1.44$ 43.03$ conjugal$transfer$protein$TraA$$
Smlt3472$ 29.89$ 1.04$ 31.04$ conserved$hypothe5cal$exported$protein$$
Smlt0332$ 29.89$ 3.56$ 106.37$ conserved$hypothe5cal$protein$$
Table 9 ctd. Up-regulated S. maltophilia K279a genes when grown in the presence of P. 
aeruginosa 2192 in liquid log conditions compared to monoculture ( >25-fold increase).  
  
76 
 
 
Gene$ Fold$change$ SM$means$ SM+PA$means$Annota5on$
Smlt2198$ 29.89$ 2.23$ 66.59$ conserved$hypothe5cal$protein$$
Smlt4090$ 29.89$ 8.29$ 247.76$ conserved$hypothe5cal$protein$$
Smlt4243$ 29.89$ 4.36$ 130.36$ conserved$hypothe5cal$protein$$
Smlt4383$ 29.89$ 1.48$ 44.32$ conserved$hypothe5cal$protein$$
cbsB% 29.89$ 2.92$ 87.28$ cystathionine$betaGsynthase$$
Smlt0567$ 29.89$ 3.07$ 91.7$ DGamino$acid$dehydrogenase$small$subunit$$
Smlt4341$ 29.89$ 2.86$ 85.6$ dihydrolipoamide$acetyltransferase$component$of$pyruvate$dehydrogenase$complex$$
uvrD% 29.89$ 3.65$ 109.14$ DNA$helicase$II$$
smeP% 29.89$ 1.27$ 37.85$ drugGresistance$cell$envelopeGrelated$protein$$
wbiI% 29.89$ 2.09$ 62.52$ epimerase/dehydratase$polysaccharideGrelated$biosynthesis$protein$$
Smlt3450$ 29.89$ 3.98$ 119.07$ exported$endopep5dase$$
Smlt2308$ 29.89$ 2.13$ 63.62$ flagellar$hookGassociated$protein$$
fdnG% 29.89$ 1.3$ 38.99$ formate$dehydrogenaseGo,$major$subunit$$
fumC% 29.89$ 2.8$ 83.8$ fumarate$hydratase$C$$
Smlt0995$ 29.89$ 5.23$ 156.43$ glutathione$hydrolase$$
Smlt3742$ 29.89$ 2.25$ 67.15$ glycoside$hydrolase$$
Smlt4037$ 29.89$ 2.65$ 79.15$ his5dine$sensor$kinase/response$regulator$fusion$protein$$
Smlt0076$ 29.89$ 8.5$ 254.07$ hypothe5cal$protein$$
Smlt1148$ 29.89$ 1.64$ 49.06$ iron$transport$receptor$protein$$
Smlt0373$ 29.89$ 2.93$ 87.48$ leucine$aminopep5dase$$
hel% 29.89$ 4.33$ 129.51$ lipoprotein$E$precursor$(outer$membrane$protein$p4)$$
Smlt1078$ 29.89$ 2.66$ 79.62$ Major$Facilitator$Superfamily$transmembrane$transporter$protein$$
Smlt0130$ 29.89$ 2.53$ 75.69$ modulator$of$DNA$gyrase$$
smeB% 29.89$ 1.27$ 37.99$ mul5drug$efflux$protein$$
Smlt4280$ 29.89$ 1.24$ 37$ mul5drug$efflux$system$transmembrane$protein$$
glnG% 29.89$ 2.76$ 82.59$ nitrogen$regula5on$protein$nr(i)$$
Smlt1560$ 29.89$ 5.25$ 157.04$ NUDIX$hydrolase$protein$$
Smlt1189$ 29.89$ 2.37$ 70.98$ oxidoreductase$$
ppi% 29.89$ 8.14$ 243.23$ pep5dylGprolyl$cisGtrans$isomerase$$
cdsA% 29.89$ 4.78$ 142.97$ phospha5date$cy5dylyltransferase$$
Smlt0142$ 29.89$ 1.95$ 58.4$ phospholipase$$
Smlt4470$ 29.89$ 4.16$ 124.27$ pyridoxalGphosphate$dependent$enzyme$$
Smlt0044$ 29.89$ 1.97$ 58.75$ RHSGrepeat$protein$$
nrdE% 29.89$ 1.61$ 48.12$ ribonucleosideGdiphosphate$reductase$2$alpha$chain$$
Smlt2055$ 29.89$ 3.32$ 99.23$ SAM$methylase$protein$$
Smlt3525$ 29.89$ 3.4$ 101.76$ thiolase$$
Smlt2845$ 29.89$ 1.52$ 45.54$ TonB$dependent$receptor$$
Smlt1175$ 29.89$ 1.39$ 41.46$ TonB$dependent$receptor$protein$$
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Smlt3446$ 29.89$ 1.42$ 42.39$ TonB$dependent$receptor$protein$$
nusG% 29.89$ 7.14$ 213.31$ transcrip5on$an5termina5on$protein$$
Smlt4572$ 29.89$ 5.02$ 149.96$ transmembrane$acyltransferase$$
Smlt0538$ 29.89$ 3.64$ 108.69$ transmembrane$anchor$protein$$
Smlt0526$ 29.89$ 2.91$ 87.09$
transmembrane$DJserine/DJalanine/glycine$
transporter$$
Smlt2251$ 29.89$ 1.76$ 52.69$
transmembrane$methylJaccep5ng$chemotaxis$
protein$$
Smlt0555$ 29.89$ 2.43$ 72.53$ transmembrane$Na+/H+$an5port$transporter$$
Smlt2804$ 29.89$ 2.21$ 66.04$ transmembrane$protein$$
Smlt2137$ 29.89$ 4.82$ 144$ universal$stress$family$protein$$
map_2% 29.89$ 5.15$ 154.01$ Hypothe5cal$protein$
prfB% 29.89$ 3.56$ 106.28$ Hypothe5cal$protein$
dat% 28.23$ 8.57$ 242.01$ diaminobutyrateJJ2Joxoglutarate$aminotransferase$$
Smlt1498$ 28.23$ 4.92$ 138.84$ outer$membrane$protein$$
pps% 27.4$ 3.49$ 95.59$ 7$phosphoenolpyruvate$synthase$$
Smlt4632$ 27.4$ 2.08$ 56.87$ conserved$hypothe5cal$exported$protein$
Smlt1009$ 27.4$ 1.47$ 40.24$ glycineJrich$autotransporter$protein$$
guaB% 27.4$ 5.49$ 150.47$ inosineJ5'Jmonophosphate$dehydrogenase$$
Smlt1168$ 27.4$ 3.09$ 84.54$ lysineJsensi5ve$aspartokinase$III$$
pheT% 27.4$ 3.36$ 92.1$ phenylalanylJtRNA$synthetase$beta$chain$$
secA% 27.4$ 2.93$ 80.27$ preprotein$translocase$SecA$subunit$$
Smlt1741$ 27.4$ 7.71$ 211.36$ Recombinase$A$
Smlt3805$ 25.74$ 38.13$ 981.4$ outer$membrane$Omp$family$protein$$
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rplK% 119.1' 22.91' 50S'ribosomal'protein'L11'' 2728.58' 71.005'
Smlt0184' 69.08' 64.76' conserved'hypotheLcal'protein'' 4473.62' 66.92'
rplV% 10.12' 114.57' 50S'ribosomal'protein'L22'' 1159.45' 62.345'
acpP_1% 78.6' 44.83' acylNcarrier'protein' 3523.64' 61.715'
metG% 35.73' 79.7' methionylNtRNA'synthetase'' 2847.68' 57.715'
rplS% 98.85' 11.21' 50S'ribosomal'protein'L19'' 1108.11' 55.03'
lpdA% 33.94' 74.72' dihydrolipoamide'dehydrogenase'' 2536.00' 54.33'
gyrA% 88.13' 19.1' DNA'gyrase'subunit'A' 1683.28' 53.615'
smeF% 76.22' 24.91' mulLdrug'resistance'outer'membrane'protein'' 1898.64' 50.565'
lon% 60.74' 39.85' ATPNdependent'protease'' 2420.49' 50.295'
purL% 71.46' 24.91' phosphoribosylformylglycinamidine'synthase'' 1780.07' 48.185'
sucB% 15.96' 74.72' dihydrolipoamide'succinyltransferase'E2'component'' 1192.53' 45.34'
Smlt3703' 43.67' 44.83' pepLdoglycanNassociated'lipoprotein'' 1957.73' 44.25'
Smlt1498' 57.17' 28.23' outer'membrane'protein'' 1613.91' 42.7'
clpB% 24.22' 59.78' heat'shock'chaperone'ClpB'' 1447.87' 42'
rpsM% 29.18' 54.8' 30S'ribosomal'protein'S13'' 1599.06' 41.99'
gyrB% 13.7' 69.74' DNA'gyrase'subunit'B'' 955.44' 41.72'
Smlt0383' 18.46' 64.76' histone'H1Nlike'protein'' 1195.47' 41.61'
accC% 70.27' 12.45' bioLn'carboxylase'' 874.86' 41.36'
sucD% 42.87' 39.85' succinylNCoA'synthetase'alpha'chain'' 1708.37' 41.36'
rplX% 16.87' 64.76' 50S'ribosomal'protein'L24'' 1092.50' 40.815'
rplL% 59.55' 20.64' 50S'ribosomal'subunit'protein'L7/L12'' 1229.11' 40.095'
pheT% 50.02' 27.4' phenylalanylNtRNA'synthetase'beta'chain'' 1370.55' 38.71'
frr% 29.77' 44.83' ribosome'recycling'factor'' 1334.59' 37.3'
pilY1% 39.3' 34.87' PilY1'protein'' 1370.39' 37.085'
groEL% 18.96' 53.97' GroEL'protein'' 1023.27' 36.465'
pnp% 51.21' 20.48' polyribonucleoLde'phosphorylase'' 1048.78' 35.845'
gltA% 11.31' 59.78' citrate'synthase'' 676.11' 35.545'
groES% 25.61' 44.83' 10'kDa'chaperonin'' 1148.10' 35.22'
pps% 42.87' 27.4' 7'phosphoenolpyruvate'synthase'' 1174.64' 35.135'
phaAB% 20.25' 49.81' K(+)/H(+)'anLporter'subunit'A/B'(pH'adaptaLon'potassium'efflux'system'protein'A/B)'' 1008.65' 35.03'
smeH% 35.73' 33.21' mulLdrug'resistance'efflux'pump'' 1186.59' 34.47'
parC% 55.97' 11.96' DNA'topoisomerase'IV'subunit'A' 669.40' 33.965'
exbB1% 18.03' 49.81' biopolymer'transport'exbB'protein'' 898.07' 33.92'
Smlt0716' 42.87' 24.91' ABC'transporter'component'protein'' 1067.89' 33.89'
rpsG% 47.64' 19.93' 30S'ribosomal'protein'S7'' 949.47' 33.785'
rnE% 32.16' 34.87' ribonuclease'E'' 1121.42' 33.515'
smeP% 36.92' 29.89' drugNresistance'cell'envelopeNrelated'protein'' 1103.54' 33.405'
Table 10. Averages of up-regulated S. maltophilia K279a genes when grown in the presence of 
P. aeruginosa 2192 in liquid log and plated conditions compared to monoculture ( >25-fold 
increase).  
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Feature'ID'
Fold'
Change'
(plated)'
Fold'
Change'
(log'liquid)'
Feature'ID' Plated*log' Average'(plated/log)'
dnaX% 41.68' 24.91' DNA'polymerase'III'subunit'Tau'' 1038.25' 33.295'
nusA% 24.22' 42.34' N'uKlizaKon'substance'protein'A' 1025.47' 33.28'
Smlt3905' 10.89' 54.8' TonB'dependent'receptor'' 596.77' 32.845'
pdhB% 17.86' 47.32' dihydrolipoamide'acetyltransferase'component'of'pyruvate'dehydrogenase'complex'' 845.14' 32.59'
guaB% 37.52' 27.4' inosineS5'Smonophosphate'dehydrogenase'' 1028.05' 32.46'
alaS% 51.21' 13.7' alanylStRNA'synthetase'' 701.58' 32.455'
nusG% 34.54' 29.89' transcripKon'anKterminaKon'protein'' 1032.40' 32.215'
nuoN% 24.41' 39.85' NADH'dehydrogenase'I'chain'N'' 972.74' 32.13'
e3S% 39.3' 24.91' electron'transfer'flavoprotein'subunit'beta'' 978.96' 32.105'
Smlt0198' 22.63' 39.85' electron'transfer'flavoproteinSubiquinone'oxidoreductase'' 901.81' 31.24'
Smlt4670' 27.39' 34.87' ABC'transporter'ATPSbinding'protein' 955.09' 31.13'
Smlt4687' 15.48' 44.83' conserved'hypotheKcal'protein' 693.97' 30.155'
Smlt0654' 15.48' 44.83' helicase'' 693.97' 30.155'
dnaJ% 45.26' 14.94' chaperone'DnaJ'protein'' 676.18' 30.1'
glyA% 45.26' 14.94' serine'hydroxymethyltransferase'' 676.18' 30.1'
dxs% 25.01' 34.87' 1SdeoxySdSxyluloseS5Sphosphate'synthase'' 872.10' 29.94'
Smlt3472' 29.77' 29.89' conserved'hypotheKcal'exported'protein'' 889.83' 29.83'
qoxA% 47.64' 11.62' transmembrane'ubiquinol'oxidase'subunit'2'precursor'' 553.58' 29.63'
Smlt3859' 23.82' 34.87' conserved'hypotheKcal'protein'' 830.60' 29.345'
icd% 33.74' 24.91' isocitrate'dehydrogenase'' 840.46' 29.325'
Smlt4339' 28.58' 29.89' branchedSchain'alpha'keto'acid'dehydrogenase'E1'beta'subunit'' 854.26' 29.235'
fdnG% 28.58' 29.89' formate'dehydrogenaseSo,'major'subunit'' 854.26' 29.235'
rpsN% 38.11' 19.93' 30S'ribosomal'protein'S14'' 759.53' 29.02'
atpF% 38.11' 19.93' ATP'synthase'B'chain'' 759.53' 29.02'
Smlt3167' 17.59' 39.85' NADSdependent'glutamate'dehydrogenase'' 700.96' 28.72'
gcvT% 27.39' 29.89' aminomethyltransferase'' 818.69' 28.64'
leuS% 33.74' 23.25' leucylStRNA'synthetase'' 784.46' 28.495'
mdh% 11.91' 44.83' malate'dehydrogenase'' 533.93' 28.37'
rplJ% 38.41' 18.01' 50S'ribosomal'subunit'protein'L10'' 691.76' 28.21'
moaA% 30.96' 24.91' molybdenum'cofactor'biosynthesis'protein'A' 771.21' 27.935'
Smlt0982' 40.49' 14.94' isocitrate/isopropylmalate'dehydrogenase'' 604.92' 27.715'
RRM1% 15.48' 39.85' ribonucleosideSdiphosphate'reductase'large'subunit'' 616.88' 27.665'
Smlt0891' 15.48' 39.85' transmembrane'preprotein'translocase'subunit''616.88' 27.665'
fusA% 41.85' 13.43' elongaKon'factor'G'' 562.05' 27.64'
maeB% 16.08' 37.36' NADPSdependent'malic'enzyme'' 600.75' 26.72'
Table 10 ctd. Averages of up-regulated S. maltophilia K279a genes when grown in the 
presence of P. aeruginosa 2192 in liquid log and plated conditions compared to monoculture 
( >25-fold increase).  
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Feature'ID'
Fold'
Change'
(plated)'
Fold'
Change'
(log'liquid)'
Feature'ID' Plated*log' Average'(plated/log)'
Smlt3796' 30.96' 22.42' conserved'hypotheHcal'exported'protein'' 694.12' 26.69'
smeE% 40.69' 12.57' acriflavin'resistance'protein'B'' 511.47' 26.63'
Smlt3210' 27.39' 24.91' outer'membrane'anHgen'protein'' 682.28' 26.15'
accD% 32.16' 19.93' acetylPcoenzymeAcarboxylase'carboxyl'transferase'subunit'beta'' 640.95' 26.045'
Smlt1368' 36.92' 14.94' conserved'hypotheHcal'protein'' 551.58' 25.93'
acnB% 19.4' 32.38' aconitate'hydratase'2'' 628.17' 25.89'
atpD% 35.13' 16.6' ATP'synthase'beta'chain'' 583.16' 25.865'
rpoC% 38.31' 13.11' DNAPdirected'RNA'polymerase'beta'chain'' 502.24' 25.71'
Smlt4656' 11.51' 39.85' conserved'hypotheHcal'protein' 458.67' 25.68'
secA% 23.82' 27.4' preprotein'translocase'SecA'subunit'' 652.67' 25.61'
Smlt0387' 19.65' 30.89' conserved'hypotheHcal'protein'' 606.99' 25.27'
Table 10 ctd. Averages of up-regulated S. maltophilia K279a genes when grown in the 
presence of P. aeruginosa 2192 in liquid log and plated conditions compared to monoculture 
( >25-fold increase).  
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This could be the case because S. maltophilia K279a may need additional protein 
products to aid in persistence when grown in co-culture.  
 
Genes up-regulated in P. aeruginosa 2192 in response to co-culture with S. maltophilia 
K279a 
Genes that were differentially regulated in P. aeruginosa 2192 when grown in the 
presence of S. maltophilia K279a were also identified using CLC Genomics Workbench. 
In this comparison the co-culture of P. aeruginosa 2192 and S. maltophilia K279a also 
yielded genes in P. aeruginosa 2192 that were up-regulated when compared to 
monoculture conditions. The same threshold of a fold change of 25 or higher was not 
used in this in silico experiment because there were no genes that exceeded that limit. 
Instead the fold-change threshold was set at a ten-fold increase but the significance value 
threshold remained the same with p-values of <0.05. There were 20 up-regulated genes of 
P. aeruginosa 2192 in co-culture growth with S. maltophilia K279a compared to 
monoculture growth in the liquid log condition (Table 11). That there were only 20 genes 
up-regulated at less than half of the fold change cutoff speaks to how much less P. 
aeruginosa 2192 changes its transcriptional profile when grown in co-culture with S. 
maltophilia K279a. This may be because P. aeruginosa 2192 is a CF isolate and is used 
to growing in co-culture therefore not needing to up-regulate many genes.  Another 
reason may be because of the production of alginate by P. aeruginosa 2192 that could 
cause shrouding of sensory mechanisms.  Or, another possibility for the comparatively 
low increase in comparison to S. maltophilia K279a could be that it is naturally a more 
virulent bacteria and expresses co-culture virulence genes at all times. The few annotated 
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genes that were up-regulated mostly encoded membrane proteins. It would be expected 
that membrane protein associated genes would be up-regulated when grown in these co-
culture experiments. The same combination experiment in the plated condition also 
yielded 20 upregulated genes with a threshold often-fold increase (Table 12). These 
however were not the same 20 genes as in the liquid log condition, and only 
PA2G_01660 (a paralog of the gene encoding the TerC family integral membrane protein 
in P. aeruginosa PAO1) was up-regulated in both plated and liquid log samples as 
highlighted in Tables 11 and 12. We can conclude from these data that P. aeruginosa 
2192 does not have as large of a response in genetic up-regulation in both plated and log 
liquid conditions as does S. maltophilia K279a when grown in combination. The caveat 
to this is that there was only one read for each gene in co-culture that was upregulated.  
 
Genes down-regulated in P. aeruginosa 2192 in response to co-culture with S. 
maltophilia K279a 
In contrast with S. maltophilia K279a, P. aeruginosa 2192 grown in combination with S. 
maltophilia K279a did have genes that were significantly down-regulated in both plated 
and liquid log conditions with p-values of <0.05. A five-fold decrease was once again 
used as the down-regulation threshold and 27 genes were found to be down- regulated in 
the liquid log condition which included genes encoding proteins linked to 
dehydrogenases, proteases and carboxylase, but most were hypothetical proteins (Table 
13). In the plated condition, 26 genes had more than a five-fold decrease in transcription 
which included genes encoding multiple types of transferases, membrane-associated 
proteins and other enzymes (Table 14).   
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Table 11. Up-regulated P. aeruginosa 2192 genes when grown in the presence of S. maltophilia 
K279a in liquid log conditions compared to monoculture ( >10-fold increase).  
  
Gene$ Fold$change$ #SM$means$ SM+*PA$means$ Annota7on$
PA2G_01388$ 23.02$ 22.41$ 515.87$ hypothe7cal$protein$
PA2G_03990$ 19.39$ 11$ 213.35$ hypothe7cal$protein$
PA2G_02538$ 19.39$ 18.48$ 358.23$ hypothe7cal$protein$
PA2G_01660$ 18.17$ 14.23$ 258.64$ integral$membrane$protein,$TerC$family$
PA2G_04621$ 15.75$ 12.29$ 193.56$
Phosphopantothenoylcysteine$synthase/(R)Q4'Q
phosphoQNQpantothenoylcysteine$
decarboxylase$
PA2G_05742$ 14.54$ 9.45$ 137.41$ hypothe7cal$protein$
PA2G_03684$ 13.33$ 10.69$ 142.46$ hypothe7cal$protein$
PA2G_02756$ 12.12$ 12.7$ 153.86$ hypothe7cal$protein$
PA2G_04292$ 12.12$ 24.52$ 297.05$ hypothe7cal$protein$
PA2G_02034$ 12.12$ 16.29$ 197.38$ hypothe7cal$protein$
PA2G_03328$ 12.12$ 17.88$ 216.62$ shortQchain$dehydrogenase$
PA2G_03871$ 12.12$ 14.4$ 174.43$ TonB$protein$
PA2G_05634$ 12.12$ 36.41$ 441.2$ stringent$starva7on$protein$B$
PA2G_00167$ 10.9$ 11.33$ 123.58$ C4Qdicarboxylate$transport$protein$
PA2G_02898$ 10.9$ 18.52$ 202.01$ hypothe7cal$protein$
PA2G_05080$ 10.9$ 17.2$ 187.51$ hypothe7cal$protein$
PA2G_00206$ 10.9$ 12.83$ 139.91$ membraneQbound$ly7c$murein$transglycolase$A$
PA2G_03715$ 10.9$ 17.69$ 192.87$ permease$of$ABC$transporter$
PA2G_04001$ 10.9$ 14.19$ 154.74$ hypothe7cal$protein$
PA2G_05173$ 10.9$ 26.2$ 285.73$ hypothe7cal$protein$
* PA- P. aeruginosa 2192; #SM- S. maltophilia K279a; $
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Table 12. Upregulated P. aeruginosa 2192 genes when grown in the presence of S. maltophilia 
K279a in plated conditions compared to monoculture ( >10-fold increase).  
  
Gene$ Fold$change$ SM#$means$ SM+PA*$means$ Annota7on$
PA2G_01387$ 30.17$ 14.17$ 427.39$ hypothe7cal$protein$
PA2G_05590$ 28.28$ 15.56$ 439.96$ superoxide$dismutase$
PA2G_01385$ 24.51$ 22.19$ 543.95$ hypothe7cal$protein$
PA2G_01660$ 18.86$ 27.36$ 515.82$ integral$membrane$protein,$TerC$family$
PA2G_08034$ 17.91$ 253.86$ 4,547.44$ hypothe7cal$protein$
PA2G_01939$ 15.08$ 15.95$ 240.54$ hypothe7cal$protein$
PA2G_01389$ 14.61$ 24.65$ 360.17$ hypothe7cal$protein$
PA2G_02251$ 13.2$ 5.28$ 69.69$ hypothe7cal$protein$
PA2G_03181$ 13.2$ 22.35$ 294.96$ hypothe7cal$protein$
PA2G_04461$ 11.31$ 9.82$ 111.15$ hypothe7cal$protein$
PA2G_05322$ 11.31$ 20.08$ 227.22$ hypothe7cal$protein$
PA2G_00275$ 11.31$ 12.9$ 145.94$ cobalamin$(5'Qphosphate)$synthase$
PA2G_00414$ 11.31$ 6.58$ 74.48$ twoQcomponent$sensor$
PA2G_02321$ 11.31$ 6.82$ 77.21$ conjugal$transfer$protein$TrbL$
PA2G_02339$ 11.31$ 4.75$ 53.74$ hypothe7cal$protein$
PA2G_03732$ 11.31$ 6.46$ 73.12$ cardiolipin$synthase$
PA2G_05769$ 11.31$ 3.43$ 38.85$ twoQcomponent$sensor$
PA2G_00773$ 10.37$ 14.29$ 148.24$ hypothe7cal$protein$
PA2G_05417$ 10.37$ 14.23$ 147.57$ twoQcomponent$response$regulator$PilR$
PA2G_01386$ 10.37$ 26.12$ 270.86$ hypothe7cal$protein$
* PA- P. aeruginosa 2192; #SM- S. maltophilia K279a; $
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Of these down-regulated genes in P. aeruginosa 2192 when grown in co-culture with S. 
maltophilia K279a, there were no common genes that existed between the plated and 
liquid log conditions. These data suggest that although there are genes that are down-
regulated when grown in the presence of S. maltophilia K279a, P. aeruginosa 2192 does 
not have a specific group of down-regulated genes in co-culture growth. The combination 
of all up and down-regulation data generated here leads us to focus our analysis on the 
common genes that were up-regulated in S. maltophilia K279a.  When grown in co-
culture with P. aeruginosa 2192, S. maltophilia K279a in the plated and liquid log 
conditions displayed a global response. Having no highly down-regulated genes indicates 
that in co-culture growth S. maltophilia K279a predominantly up-regulates gene 
transcripts. With only little up-regulation by P. aeruginosa 2192 the genetic response 
comes mainly from S. maltophilia K279a. For this reason as well as the sheer total 
number of up-regulated genes S. maltophilia K279a genes will be investigated for future 
mutations.  
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Table 13. Down-regulated P. aeruginosa 2192 genes when grown in the presence of S. 
maltophilia K279a in liquid log conditions compared to monoculture ( >5-fold decrease).  
  
Gene$ Fold$change$ SM$means$ SM+PA$means$ Annota5on$
PA2G_02948$ <5.36$ 92.37$ 17.22$ prophage$protease$subunits$of$ATP<dependent$proteases$
PA2G_01749$ <5.78$ 51.51$ 8.92$ hypothe5cal$protein$
PA2G_01805$ <5.78$ 86.23$ 14.93$ hypothe5cal$protein$
PA2G_02355$ <5.78$ 50.39$ 8.72$ hypothe5cal$protein$
PA2G_02458$ <5.78$ 46.72$ 8.09$ two<component$sensor$
PA2G_02557$ <5.78$ 107.66$ 18.63$ NAD$dependent$epimerase/dehydratase<like$protein$
PA2G_02820$ <5.78$ 56.21$ 9.73$ hypothe5cal$protein$
PA2G_04034$ <5.78$ 253.03$ 43.8$ hypothe5cal$protein$
PA2G_04782$ <5.78$ 104.41$ 18.07$ similar$to$c4<dicarboxylate<binding$protein$
PA2G_05883$ <5.78$ 68.87$ 11.92$ hypothe5cal$protein$
PA2G_00970$ <5.78$ 22.72$ 3.93$ hypothe5cal$protein$
PA2G_02185$ <5.78$ 134.36$ 23.26$ hypothe5cal$protein$
PA2G_01612$ <6.6$ 707.46$ 107.15$ hypothe5cal$protein$
PA2G_03864$ <6.6$ 151.79$ 22.99$ short<chain$dehydrogenase$
PA2G_04024$ <6.6$ 110.66$ 16.76$ hypothe5cal$protein$
PA2G_00864$ <6.6$ 377.31$ 57.15$ hypothe5cal$protein$
PA2G_02927$ <6.6$ 363.47$ 55.05$ hypothe5cal$protein$
PA2G_04425$ <6.6$ 80.2$ 12.15$ c<type$cytochrome$
PA2G_06158$ <6.6$ 47.16$ 7.14$ usher$CupC3$
PA2G_02057$ <7.43$ 68.57$ 9.23$ acetyl<CoA$carboxylase,$bio5n$carboxylase$
PA2G_06183$ <8.25$ 69.16$ 8.38$ pimeloyl<CoA$synthetase$
PA2G_01264$ <8.25$ 70.75$ 8.57$ hypothe5cal$protein$
PA2G_02563$ <9.08$ 279.36$ 30.77$ bacterial$transferase$hexapep5de<like$protein$
PA2G_02642$ <9.08$ 90.79$ 10$ hypothe5cal$protein$
PA2G_03559$ <9.08$ 131.26$ 14.46$ hypothe5cal$protein$
PA2G_00639$ <9.08$ 110.72$ 12.2$ hypothe5cal$protein$
PA2G_05449$ <9.35$ 455.07$ 48.65$ hypothe5cal$protein$
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Table 14. Down-regulated P. aeruginosa 2192 genes when grown in the presence of S. 
maltophilia K279a in plated conditions compared to monoculture ( >5-fold decrease).  
  
Gene$ Fold$change$ SM$means$ SM+PA$means$ Annota5on$
PA2G_03283$ ;5.3$ 94.16$ 17.76$ hypothe5cal$protein$
PA2G_01889$ ;5.3$ 661.09$ 124.66$ hypothe5cal$protein$
PA2G_01923$ ;5.3$ 83.43$ 15.73$ hypothe5cal$protein$
PA2G_02055$ ;5.3$ 57.49$ 10.84$ propionyl;CoA$carboxylase$
PA2G_02562$ ;5.3$ 89.05$ 16.79$ hypothe5cal$protein$
PA2G_03849$ ;5.3$ 142.09$ 26.79$ hypothe5cal$protein$
PA2G_04766$ ;5.3$ 233.33$ 44$ hypothe5cal$protein$
PA2G_02028$ ;5.3$ 38.09$ 7.18$ transporter$
PA2G_04727$ ;5.83$ 127.39$ 21.84$ hypothe5cal$protein$
PA2G_01258$ ;5.83$ 97.23$ 16.67$ hypothe5cal$protein$
PA2G_02511$ ;5.83$ 201.77$ 34.59$ General$secre5on$pathway$outer$membrane$protein$H$precursor$
PA2G_04827$ ;5.83$ 73.18$ 12.54$ two;component$response$regulator$NtrC$
PA2G_06034$ ;5.83$ 58.47$ 10.02$ ATP;binding/permease$fusion$ABC$transporter$
PA2G_03660$ ;6.36$ 113.67$ 17.86$ phenazine;specific$methyltransferase$
PA2G_03825$ ;6.36$ 146.46$ 23.01$ hypothe5cal$protein$
PA2G_04440$ ;6.63$ 170.24$ 25.68$ nitric;oxide$reductase$subunit$B$
PA2G_02894$ ;6.89$ 278.73$ 40.43$ rhamnosyltransferase$chain$A$
PA2G_03246$ ;6.89$ 163.05$ 23.65$ type$4$fimbrial$biogenesis$protein$PilF$
PA2G_00339$ ;7.42$ 167.64$ 22.58$ short;chain$dehydrogenase$
PA2G_04592$ ;7.96$ 123.63$ 15.54$ rubredoxin$reductase$
PA2G_03464$ ;8.49$ 237.25$ 27.96$ hypothe5cal$protein$
PA2G_03362$ ;9.02$ 290.03$ 32.17$ $molybdopterin$biosynthe5c$protein$B1$
PA2G_03822$ ;9.02$ 998.98$ 110.81$ hypothe5cal$protein$
PA2G_03376$ ;10.61$ 188.88$ 17.81$ cyanide$insensi5ve$terminal$oxidase$
PA2G_03592$ ;15.91$ 951.97$ 59.83$ hypothe5cal$protein$
PA2G_01154$ ;19.09$ 198.67$ 10.41$ carbamoyl$transferase$
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Gene selection 
 To refine our list of candidate S. maltophilia K279a genes for further experiments, 
the predicted subcellular localization of all the proteins within the S. maltophilia K279a  
genome was generated via PSORTb (Figure 6A). This software uses twelve different 
algorithms to predict whether proteins will be located in the cytoplasm, cytoplasmic 
membrane, periplasm, outer membrane or extracellular space, or it will return an 
unknown value. It has a limited value for proteins located in multiple locations in the 
cells and lipoproteins (Yu, 2010). These data allowed us to identify the genes that may 
potentially aid in persistence of S. maltophilia K279a based on where their corresponding 
proteins are used in the cell. The PSORTb data show that when grown in co-culture with 
P. aeruginosa 2192 in plated and liquid log conditions, S. maltophilia K279a transcribed 
a significant increase of genes coding for proteins associated with the cytoplasm and 
outer membrane. This was compared to all predicted proteins in the reference genome of 
S. maltophilia K279a. Under these same conditions, there was a decrease in cytoplasmic 
membrane associated proteins. This may be as a result of up-regulation of other defense 
and sensing mechanisms possessed by S. maltophilia K279a. It may also be necessary for 
S. maltophilia K279a to express genes encoding outer membrane and cytoplasmic 
proteins in order to compete (Cystic Fibrosis Foundation Patient Registry: Annual Data 
Report, 2013). Inversely, when P. aeruginosa 2192 was compared to co-culture with S. 
maltophilia K279a, expression of genes encoding cytoplasmic and outer membrane-
associated proteins decreased while genes encoding membrane proteins significantly 
increased (Figure 6B). This, once again suggests a high level of  
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Figure 6. Subcellular localization predictions for proteins up-regulated in co-culture for 
(A) S. maltophilia K279a in response to co-culture with P. aeruginosa 2192 or (B) in P. 
aeruginosa 2192 in response to co-culture with S. maltophilia K279a.  The genes 
predicted to encode proteins localized in the cytoplasm, cytoplasmic membrane, 
periplasm, outer membrane, extracellular, or unknown were tabulated in PSORTb 
software and compared between this data set versus all the proteins predicted from the 
entire genome. ***-p-value < 1e-10, *-p-value = 0.001 
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transcription for membrane-associated defense and sensing mechanisms when 
these are grown in co-culture.  
Cluster of Orthologous Gene (COG) functional classifications were made from 
gene annotations in S. maltophilia K279a when it was grown in co-culture with P. 
aeruginosa 2192. In S. maltophilia K279a these classifications showed a global increase 
in genes encoding metabolic factors, specifically amino acid, nucleotide, lipid and 
inorganic ion transport and metabolism proteins (Figure 7A). This may have been the 
case because of the increased competition for metabolites in a co-culture environment 
and the need for S. maltophilia K279a to increase its ability to obtain them. There was a 
mixed response in cellular processes and signaling associated proteins with increases in 
signal transduction mechanisms and defense mechanisms, and decreases in cell motility 
and intracellular trafficking proteins. The increase of transcripts for these proteins suggest 
that the response to co-culture growth increases sensing and defense as well as 
modification of intercellular trafficking while possibly conserving energy by decreasing 
the abundance of proteins used in motility (Figure 7A).  When P. aeruginosa 2192 was 
grown in co-culture with S. maltophilia K279a, there was no trend in functional up-
regulation of P. aeruginosa 2192 genes with exceptions in the cellular processing and 
signaling categories. These included genes encoding proteins involved in motility and 
signal transduction (Figure 7B). The increase of metabolism-associated genes points to S. 
maltophilia K279a actively transcribing genes that change the catabolism of substrate 
into usable cellular products that may heighten the ability for S. maltophilia K279a to 
survive when grown in co-culture with P. aeruginosa 2192.  
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Figure 7. Cluster of orthologous gene distribution of proteins encoded by genes induced 
in (A) S. maltophilia K279a in response to co-culture with P. aeruginosa 2192 or (B) P. 
aeruginosa 2192 in response to co-culture with S. maltophilia K279a.  COG designations 
are as follows: RNA processing and modification (A); Chromatin structure and dynamics 
(B); Translation, ribosomal structure and biogenesis  (J); Transcription (K); Replication, 
recombination and repair (L); Cell cycle control, cell division, chromosome partitioning 
(D); Cell wall/membrane /envelope biogenesis (M); Cell motility (N); Post-translational 
modification, protein turnover, and chaperones (O); Signal transduction mechanisms (T); 
Intracellular trafficking, secretion, and vesicular transport (U); Defense mechanisms (V); 
Extracellular structures (W); Nuclear structure (Y); Cytoskeleton (Z); Energy production 
and conversion (C); Amino acid transport and metabolism (E); Nucleotide transport and 
metabolism (F); Carbohydrate transport and metabolism (G); Coenzyme transport and 
metabolism (H); Lipid transport and metabolism (I); Inorganic ion transport and 
metabolism (P); Secondary metabolites biosynthesis, transport, and catabolism (Q); 
General function prediction only (R); Function unknown (S). * - Chi squared distribution 
p-value <0.05. 
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These data provide not only predicted locations, but also cellular processes that we can 
use to identify the importance of each gene response to co-culture growth. For further 
study, genes associated with up-regulation in S. maltophilia K279a were chosen as there 
were 84 genes that were up-regulated in both liquid log and plated conditions. P. 
aeruginosa 2192 only had one gene in common in up-regulation between the two 
conditions which indicates that there is a higher transcriptional response in S. maltophilia 
K279a when grown in co-culture compared to P. aeruginosa 2192. From these data, 
selections of genes were made by identifying genes that might be necessary for S. 
maltophilia K279a to persist in co-culture growth with P. aeruginosa 2192. 
 
Quantitative Real-Time Polymerase Chain Reaction  
Before mutants were constructed, the accuracy of the sequencing data was 
confirmed by quantitative real-time polymerase chain reaction (qRT-PCR). Standard 
curves were made for each gene using optimized concentrations of forward and reverse 
primers to which mRNA samples would then be compared to obtain absolute values 
(rather than relative abundance to another transcript). The expected outcome for all up-
regulated genes in S. maltophilia K279a was a positive fold change verified by qRT-
PCR.  
Based on PSORTb and COG classifications of protein function of differentially 
regulated gene products, sequences for qRT-PCR primers (Supplementary Table 7) were 
constructed based on the selected gene targets (Table 15). Eight of the genes verified the 
sequencing data. These were genes primarily encoding membrane proteins, as is the case 
for smlt0278, Smlt3905, exbB1, pilY1, cyoA, wzt and Smlt1471, or possible cellular  
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Table 15. S. maltophilia K279a genes selected for further study.  
Gene$ID$ Protein$ID$
COG*$
designa3on$
RNA7seq$
Average$Fold$
Increase$
(plated/log)$
Smlt0278$
two$component$regulator$sensor$his3dine$kinase$
transmembrane$transcrip3onal$regulatory$protein$$
T$ 18.3$
Smlt3905$ TonB$dependent$receptor$$ P$ 32.845$
exbB1& biopolymer$transport$exbB$protein$$ U$ 33.92$
Smlt0184$ conserved$hypothe3cal$protein$(QS)$ S$ 66.92$
Smlt1471$ ABC$transporter$$ V$ 18.895$
pilY1& PilY1$protein$$ NU$ 37.085$
wzt& ABC$transporter$component,$polysaccharide$related$$ GM$ 20.09$
cyoA& cytochrome$O$ubiquinol$oxidase$subunit$II$$ C$ 24.74$
Smlt4670$ ABC$transporter$ATP7binding$protein$ Q$ 31.13$
Smlt0716$ ABC$transporter$component$protein$$ R$ 33.89$
Smlt3703$ pep3doglycan7associated$lipoprotein$$ M$ 44.25$
lon& ATP7dependent$protease$$ O$ 50.295$
smeH& mul3drug$resistance$efflux$pump$$ N/A$$ 34.47$
smeF& mul3drug$resistance$outer$membrane$protein$$ MU$ 50.565$
cydA& cytochrome$D$ubiquinol$oxidase$subunit$I$$ C$ 14.13$
* - Clusters of Orthologous Groups (COG)$
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communication in the case of Smlt0184. Primer optimizations were performed before 
each gene was quantified by testing each primer at three differing concentrations. These 
optimized concentrations provided the best concentration of each primer for optimal 
melting temperature of a standard concentration of template (104 copies). Quantitative 
assessment in tandem with standard curves for each gene provided a copy number value 
for each gene transcribed in co-culture samples which were each repeated to generate 
transcript mRNA. These values were compared to transcripts from monoculture growth 
in the same condition. While the fold changes were different between the RNA-seq and 
qRT-PCR for any given gene, the trend of up-regulation under co-culture conditions was 
positive for all genes which is consistent with other research that verifies that trend 
increases of transcripts is sufficient to verify sequencing fold increase of target genes. 
Differences of magnitude seen in the data are specific to the increased sensitivity of 
RNA-seq methods in comparison to the less sensitive qRT-PCR method. This was shown 
by the values that were > 1 for the average fold-change increase of co-culture transcripts 
when compared to monoculture transcripts (Figure 8, Supplementary Table 8). With data 
consistent with RNA-seq analysis we can conclude from the qRT-PCR analysis that S. 
maltophilia K279a up-regulates our selected genes in response to co-culture with P. 
aeruginosa 2192. To test the hypothesis that these genes play some role in co-culture 
viability for S. maltophilia K279a, mutants with deletions of these genes will be 
constructed and tested for ability to persist in our co-culture model. 
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Figure 8. Up-regulation of select S. maltophilia K279a genes. Quantitative real-time 
PCR was used to assess the absolute quantities of Smlt0278, Smlt3905, exbB1, pilY1, 
cyoA, wzt, Smlt0184 and Smlt1471 in comparison to the fold change of RNA-seq 
experiments.  Error bard indicate one standard deviation. 
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Construction of mutant plasmids  
 In order for genetic mutants to be constructed, primers that flank the genes exbB1, 
cyoA, wzt, Smlt4670, lon, pilY1, and Smlt3905 needed to be generated by overlap 
extension techniques (Horton, 1990) which results in a complete and markerless gene 
deletion. The construction of these primers (Supplementary Table 9) was done by 
selecting sequences that were 500 base pairs (bp) upstream of the coding sequence, 500  
bp downstream from the stop codon of the gene, and identifying primer binding sites with 
melting temperatures between 60 and 65°C that flank these regions. Primers that lie on 
the interface with the gene sequence were concatenated from chimeric primers that could 
hybridize to each other. The first round of PCR generated two fragments of DNA 
corresponding to the 500 bp upstream and 500 bp downstream of each gene. These 
products were purified and used a templates for the second round of PCR which yielded a 
1000 bp DNA fragment that was introduced into the plasmid pEX18Tc (Supplementary 
Figure 3) at the EcoR1 and BamH1 restriction sites. To verify that this ligation was 
successful, each plasmid containing the 1000 bp insert was sequenced via Sanger 
sequencing yielding individual nucleotide sequences of submitted samples. Using 
BioEdit Biological Sequence Alignment Editor, the sequences were compared to the 
theoretical nucleotide sequence of what the plasmid vector construct should contain (a 
500 bp upstream sequence followed by a 500 bp downstream sequence of the gene of 
interest inserted into the multiple cloning site of pEX18Tc). A percent correlation 
between the sequenced and theoretical nucleotide showed each construct that was 
successfully introduced into pEX18Tc (Table 16), all of which were over a 97% match. 
The reason why each gene did not have a 100% match was from some deletions in the  
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Table 16.  Percent match of 500 bp flanking sequences used for gene deletion constructs. 
Gene$ Number$of$bases$matching$reference$$
Total$bases$in$
reference$$
Percent$match$for$
knockout$inser7on$
sequence$
exbB1$ 1049$ 1080$ 97.13%$
cyoA) 1198$ 1198$ 100%$
wzt) 1150$ 1160$ 99.14%$
smlt4670$ 1083$ 1110$ 97.57%$
lon) 1133$ 1160$ 97.67%$
pilY1) 1160$ 1161$ 99.91%$
smlt3905$ 1127$ 1146$ 98.34%$
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connection between the 500 bp regions. This should have little effect in future 
experiments as the intent is to delete the gene, and these inserts still have high enough 
homology to their intended genomic targets to allow recombination to occur.  Then only 
genes that had mutations in their 500 bp flanking sequences were exbB1 and smlt4679 
which will be excluded for gene further gene deletion experiments. 
Introduction of the pEX18Tc was attempted by tri-parental bacterial conjugations 
(Ditta, 1980) using the lower efficiency construct spot mating method, as well as 
transformation using electrocompetent S. maltophilia K279a (Ye, 2014). Both of these 
methods used to introduce the plasmids into S. maltophilia K279a were repeated at least 
three times for each gene using tetracycline as selection for successful integration. 
Neither of the methods was provided significant evidence that introduction of pEX18Tc 
with our insertion sequences into S. maltophilia K279a occured. This was because 
obtaining pure monoculture of the recipient bacteria on selective media plates containing 
the conjugation mixture was not possible due to background growth. For this reason we 
could not be sure that the colonies that grew were the donor, helper or recipient strains.  
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DISCUSSION 
Identifying growth inhibition is fundamental to how the co-culture growth model 
is assessed. Proximal growth tests have been one way in which this was done. In those 
tests, our data showed no growth inhibition when strains were grown in the proximal 
growth zone. However, this may not indicate that there are not diffusible inhibitory 
effects between strains.  There has been work showing that P. aeruginosa PAO1 
facilitates the colonization of S. aureus (Yang, 2011), whereas other research contends 
that S. aureus is outcompeted by established P. aeruginosa growth (Baldan, 2014).  
Further research showed that there were distinct differences in biofilm growth when S. 
maltophilia K279a and P. aeruginosa PAO1 were grown together because of a diffusible 
signaling factor (DSF) produced by S. maltophilia K279a (Ryan, 2008). This supports the 
premise that growth inhibition can be a key indicator to polymicrobial growth research of 
S. maltophilia K279a. This makes sense because the detection of biofilm morphology in 
P. aeruginosa PAO1, as previously referenced, was done via confocal laser microscopy. 
Our observations were made from colony formation and growth inhibition that was 
macroscopic in nature and did not detect such differences at that scale.  In fact, our data 
indicating that P. aeruginosa PAO1 inhibited the growth of P. aeruginosa 2192 in the 
combined test only corroborates the notion that bacterial proximity may be a significant 
conditional factor influencing growth inhibition. This is because of the ability that P. 
aeruginosa 2192 had to grow in proximal growth zone, but not in combination with P. 
aeruginosa PAO1. The co-culture lawn inhibition tests showed no zones of inhibition 
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detected surrounding growing bacteria on low density bacterial lawns (Figure 2); 
indicating that even if DSFs were produced, they had little to no effect on growth 
inhibition of surrounding bacteria under our conditions or at least did not travel through a 
nutrient agar medium. On the other hand, if DSFs were produced they may have not 
diffused through the medium, but still may have had an effect on the bacterial lawn that 
they were in direct contact with. For this purpose, we conducted further co-culture 
experiments in liquid media where all bacteria and exogenous molecules would have 
direct contact to eliminate some of these variables. The focus of our research then shifted 
from identifying DSFs such as antibiotics, quorum sensing molecules, toxin or colicin-
like production, to extracellular sensing involving proteins such as outer membrane 
proteins, transporters and receptors. To identify the effect of these proteins on co-culture 
growth we chose to use the most sensitive and informative method available – RNA-seq.  
We chose to focus our co-culture experiments on three bacteria, S. aureus NRS77, S. 
maltophilia K279a and P. aeruginosa 2192. The reason for including S. aureus NRS77 
after not researching them in proximal tests and excluding Burkholderia species is 
because S. aureus is more often found in the CF lung than the B. cepacia complex 
members. Not only that, but most CF patients are initially colonized by Staphylococcus 
species at a young age (Pernet, 2014). Recent research has also shown that P. aeruginosa 
and S. aureus are often associated in co-culture when isolated from CF patients which 
makes S. aureus a good addition to our co-culture experiments (Baldan, 2014; 
Korgankar, 2013).   
With the increasing level of sophistication in genomic data quantification and 
multiple comparison software capabilities, the most statistically powerful type of 
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transcriptomics is next-generation sequencing (Liu, 2012).  In order to understand which 
genes were up-regulated in each bacterial strain during co-culture, transcripts isolated 
from monocultures within the same condition were used as the reference for each gene’s 
expression. In the past, when looking at the levels of transcription of specific genes, 
microarrays were used (Malone, 2011; Yoder-Himes, 2010; Nookaew, 2012), but with 
the advent of high-throughput sequencing and the increased capacity for its computation, 
obtaining millions of reads corresponding to transcripts is not only useful, but is 
becoming increasingly practical (Liu, 2012; Zhao. 2014).  For this reason we used 
Illumina HiSeq, which is a synthesis sequencing method that costs about seven cents per 
million bases read (Ross, 2013). RNA-seq data that comes from purified nascent mRNA 
allows researchers to identify which genes are being transcribed in real time for each 
bacterial strains, and is being done in much of the current co-culture research (Goddard, 
2012; Duan, 2003; Harris, 2007; Liu, 2012; Ross, 2013). This method has limitations 
though. Despite the cost being relatively low, it still is not inexpensive and isolating 
enough quality mRNA can be difficult. RNA is also difficult to manipulate. RNA is a 
relatively fragile molecule because it is readily degraded by cellular or extracellular 
RNases that are ubiquitous. Additionally special treatment of all instruments, reagents, 
and working surfaces must be used such that they are meticulously sterilized to prevent 
degradation of samples. Despite these limitations, RNA-seq is the most sensitive 
technique available for examining whole cell responses to changes in conditions and thus 
we feel it was the best approach for our research questions. The co-culture methods we 
employed result in a comparison between two conditions. With so much data being 
generated, there needs to be an analysis tool that can handle these multiple comparisons.  
105 
For this reason we used the bioinformatic analysis program CLC Genomics Workbench, 
which can take millions of pieces of data, in this case gene reads, and compare them with 
other samples. 
The results of our sequencing data varied depending upon condition and culture 
combination (Table 4).  S. aureus NRS77 proved difficult to obtain sufficient reads 
aligned to a its reference monoculture by being least represented in all combinations and 
conditions. Because this is a Gram-positive bacterium, the lysis of S. aureus NRS77 is 
more difficult than P. aeruginosa 2192 and S. maltophilia K279a. Isolation of S. aureus 
NRS77 mRNA was attempted multiple times.  Even after these attempts, the highest 
yield samples did not produce enough quality mRNA to provide sufficient sequencing 
reads. Indeed this has been seen in other studies as well (Zhao, 2012). There could have 
been the possibility also that P. aeruginosa 2192 and S. maltophilia K279a were 
inhibiting its growth in co- and tri-culture and there was not a sufficient amount of cells 
to harvest mRNA from.  This possibility is strengthened by the data showing sufficient 
reads aligned to the S. aureus NRS77 genome in mono-culture in two of the three 
conditions.  
Reads of P. aeruginosa 2192 monoculture growth were aligned to S. maltophilia 
K279a when P. aeruginosa 2192 was grown in monoculture.  It is not certain why this 
was the case.  In most cases, the reads from a mono-culture of P. aeruginosa 2192 would 
not have been aligned to the genome of any other organism.  We did this because of the 
low number of reads in samples containing S. aureus NRS77 and as a verification step as 
to the validity of each sample.  We can only ascertain that because of the close 
phylogenetic relationship between S. maltophilia and P. aeruginosa (both Gram-negative 
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bacteria in the Gammaproteobacteria class), there may be some genes that are 
evolutionary conserved between the two species and that a bias in how we process the 
data in the genomics software leads to a false positive result in these cases. However, 
when we generated a list of the unmapped reads we BLASTed the sequences against the 
NCBI genome databases and found that that overwhelming majority were associated with 
P. aeruginosa species. Furthermore, there were sufficient reads that matched the expected 
transcriptome for each condition of P. aeruginosa 2192 monocultures to use for 
comparison in in silico experiments. There is also variability in reads across condition, 
particularly for S. aureus NRS77. For instance, when compared between the plated and 
liquid log conditions of growth in the S. maltophilia K279a and S. aureus NRS77 there 
was a 10 fold difference in reads aligned to the S. aureus NRS77 genome. This can be 
attributed to either sequencing shortfalls or a lack of quality mRNA harvested from each 
sample. Whatever the case there were some data that met our criteria for analysis.  The 
data that exceeded our standards came from a single co-culture mixture and monocultures 
- P. aeruginosa 2192 and S. maltophilia K279a under liquid log and plated conditions. As 
mentioned in the Results section of this work, only S. maltophilia K279a genes were 
chosen for mutant construction. Mixtures containing S. aureus NRS77 were not analyzed 
further because of the underrepresentation of S. aureus-associated reads in the co-culture 
sequencing data (Tables 4, 5 and 6).  
Based on the sequencing data, PSORTb sub-cellular location and COG functional 
analyses (Figures 6 and 7), 15 genes were chosen for mutant construction. Although 
empirical, the selection of genes that were responsible for membrane associated defense, 
sensing and transport proteins as well as those associated with drug resistance were of 
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primary interest. We chose genes that we thought might be playing a role in S. 
maltophilia K279a persistence in co-culture growth in either defensive or offensive 
capacities. The gene smlt0184 is a hypothetical gene that is associated with QS systems 
in other bacteria. It was chosen because of the importance that QS plays in co-culture 
growth. A previous study examined its importance in S. maltophilia for the secretion of 
outer membrane vesicles (Devos, 2015), which shows that these DSF’s are important 
signaling molecules in QS (Ryan, 2008).  Also chosen for this reason Smlt0278, a 
predicted sensor kinase/response regulator chimera, was another possible quorum 
sensing-based choice, but also chosen because of the critical roles that these proteins play 
during extracellular environmental sensing which can change transcription accordingly.  
Transporters, receptors and pumps are the selective barriers of the cell, which is the 
reason why Smlt3905, exbB1, Smlt1471, wzt, Smlt4670, Smlt0716, and smeH were 
chosen for total gene deletions. Variable control of these genes can produce more or less 
of the proteins that regulate what goes into and comes out of the cell, which can be of 
interest when pathogens are growing in co-culture. The genes cyoA and cydA, which 
encode cytochrome bo terminal oxidase subunit II and cytochrome bd-I terminal oxidase 
subunit I respectively, were chosen because their encoded components of ubiquinol 
oxidase possesses the ability to protect the bacterial cell membranes from peroxidation 
(reference). Finally, pilY1, Smlt3703, and smeF were selected because of the potential 
roles that they could play in intercellular communication via membrane-bound protein 
interaction (Table 14).  
To verify RNA-seq data, transcript levels were assessed via qRT-PCR. In all 
selected genes, the averages of liquid log and plated transcripts in the RNA-seq data were 
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confirmed by the positive increase of transcription values by qRT-PCR (Figure 8). 
Frequently the fold changes observed by qRT-PCR are muted compared to those 
observed by RNA-seq though the fold change trends are the same (Yoder-Himes, 2009; 
Harris, 2007; Grasso, 2015). For CF pathogens it has been shown that qRT-PCR values of 
fold change are consistently less than half when compared to molecular quantification 
techniques like microarrays and RNA-seq (Harris, 2007; Oh, 2010). Such has also been 
the case when compared to microarrays, although not to the same degree (Yoder-Himes, 
2010; Malone, 2011; Nookaew, 2012). The gene exbB1 in qRT-PCR fold change was 
shown to be up-regulated about 3 times more than the sequencing data.  This was 
probably due to one replicate value being significantly larger than the other values. Had 
that sample been excluded, the other values would be more consistent with data from 
other measured genes (Table 15). In each case however, there was a positive fold change 
value in the qRT-PCR data, which was consistent with the RNA-seq data.  
 Not all genes selected for complete gene deletions were successfully inserted into 
pEX18Tc. Successful mutant construction required ligating whole gene deletion 
sequences into the vector and uptake of the resultant plasmid by S. maltophilia K297a 
through conjugation or transformation. Only seven of the selected gene deletion 
sequences could be successfully integrated into pEX18Tc (Table 17). The reasons for not 
being able to successfully integrate the other eight sequences could be attributed to PCR 
failure of primers self annealing or being nonspecific, degradation of the DNA, or primer 
design errors. To mitigate the possibility of improper lab technique each integration 
protocol was repeated at least three times before a construct was excluded. 
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 S. maltophilia K279a did not take up pEX18Tc by transformation of 
electrocompetent cells or through tri-parental conjugation. Despite the failure to 
transform S. maltophilia K279a into pEX18Tc bearing the constructed gene deletion 
sequences, the work completed here will be of use in the future. With further 
optimization of a conjugation protocol to get S. maltophilia K279a to take up the plasmid 
vectors, there will be opportunity to see how S. maltophilia K279a interacts with P. 
aeruginosa 2192. This can be done by using the methods outlined previously in this work 
to grow mutants in co-culture with P. aeruginosa 2192 and assess S. maltophilia K279a 
mutant growth via isolation on selective media. With the methods described in this work, 
the S. maltophilia K279a mutants can be grown, and observations made according to 
their fitness, growth, morphology and potential virulence in the co-culture model with P. 
aeruginosa 2192.  This research also provides a potential model for future work to be 
done using next generation sequencing methods to further characterize polymicrobial 
interactions between various bacterial species which is a upcoming field in microbiology 
due in large part to the knowledge gained in the Human Microbiome Project studies.  
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FUTURE DIRECTIONS 
 The work outlined in this thesis can be used for other research in the future. First, 
it can act as a model for co-culture experiments, specifically transcriptomics studies. Due 
to the optimization of the bacterial culturing conditions, co-culture experiments with 
other bacteria can be performed to assess the transcript changes when grown in co-
culture. This work can also be used as a basis for growth models involving more than two 
bacteria grow together. In the case of sequencing and analysis of raw data, we have 
developed a pipeline that can be used for other organisms, not only of interest for CF 
researchers, but for those looking into polymicrobial interactions with respect to 
transcriptional changes induced by other bacteria.  
 Second, the data generated from this work has also allowed other work to be 
initiated with P. aeruginosa 2192. Currently, our lab is looking at a few selected genes 
that were upregulated in P. aeruginosa 2192 using these data as reference. As was done 
with S. maltophilia K279a, complete gene deletions can be made in these bacteria and 
observations made when re-introduced into the co-culture growth model.  
 Furthermore, from the genes that were up-regulated in our data sets, future work 
can look into the specificity of their up-regulation in co-culture growth of other bacterial 
strains not tested here. This would allow us to understand if the up-regulated genes are 
generic or co-culture specific. Furthermore, if there are S. maltophilia K279a genes that 
are necessary for bacterial viability in co-culture, future work can look at paralogs of that 
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gene and orthologs in other bacteria. With those identifications this method can be used 
to identify their contribution to virulence that they play when grown in co-culture with P. 
aeruginosa 2192. Personally I would like to continue using this research as a model to 
identify possible virulence linked genes within the oral microbiome while attending 
dental school at the University of Kentucky. Overall, this work can contribute to the field 
of polymicrobial communities by displaying a model system by which interactions can be 
quantified based on the genes expressed in each strain. It will also allow researchers to 
identify bacteria that are more persistent by trends in their transcription profiles being 
differentially regulated. 
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LIST OF ABBREVIATIONS  
 
 
°C degrees Celsius 
AHL acyl homoserine lactone 
AI autoinducer  
AIP autoinducing peptides 
AQ alkyl quinolones  
ATP adenosine triphosphate  
BMI body mass index 
bp base pair 
Carb carbenicillin  
cDNA complementary deoxyribonucleic acid 
CF cystic fibrosis 
CFRD cystic fibrosis-related diabetes  
CFTR cystic fibrosis transmembrane conductance regulator 
COG clusters of orthologous gene 
DNA deoxyribonucleic acid 
DSF diffusible signal factors 
FEV1 forced expiratory volume  
g  gram 
GlcNAc N-acetyl-D-glucosamine 
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Kan kanamycin 
L liter 
LB Luria broth Lennox formulation 
M molar 
mg milligram 
mL  milliliter 
mM millimolar 
mRNA messenger ribonucleic acid 
MRSA methicillin-resistant S. aureus  
MSCRAMM microbial surface component recognizing adhesive matrix molecules 
MSSA methicillin-sensitive S. aureus 
ng nanogram 
nm nanometers 
O.D.600 optical density @ 600 nm 
Oligo oligonucleotide   
PCR polymerase chain reaction 
PTSA pyrogenic toxin superantigens 
PVL Panton-Valentine leukocidin 
qRT-PCR quantitative real-time polymerase chain reaction 
QS quorum sensing 
rDNA ribosomal deoxyribonucleic acid 
RNA Ribonucleic acid  
RNA-seq ribonucleic acid sequencing  
132 
rpm revolutions per minute 
rRNA ribosomal ribonucleic acid 
SCFM synthetic cystic fibrosis medium 
SCIN staphylococcal complement inhibitor  
SEM soil extract medium 
SOE (PCR) overlap extension polymerase chain reaction 
sPLA2-IIA type-II-secreted phospholipase A2 
TCS two-component system 
Tet tetracycline  
TSA tryptic soy agar 
TSS toxic shock syndrome 
µL         microliter 
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Supplementary Table 1. Optical densities at 600 nm indicating growth for P. aeruginosa 2192, S. 
aureus NRS77 and S. maltophilia K279a in artificial CF sputum medium. 
 
Strain 
Ti
m
e 
(h
ou
rs
) 
 P. aeruginosa 2192 S. maltophilia K279a S. aureus NRS77 
 Rep. 1 Rep. 2 Rep. 3 Avg. St. dev. Rep. 1 Rep. 2 Rep. 3 Avg. 
St. 
dev. Rep. 1 Rep. 2 Rep. 3 Avg. 
St. 
dev. 
0 0.171 0.171 0.171 0.171 0.000 0.098 0.098 0.098 0.098 0.000 0.025 0.026 0.02 0.023 0.014 
1 0.171 0.151 0.156 0.159 0.010 0.182 0.182 0.186 0.183 0.002 0.012 0.014 0.01 0.012 0.002 
2 0.394 0.366 0.380 0.380 0.014 0.262 0.272 0.276 0.270 0.007 0.018 0.018 0.011 0.016 0.004 
3 0.534 0.541 0.573 0.549 0.021 0.387 0.380 0.371 0.379 0.008 0.018 0.014 0.01 0.014 0.004 
4 1.264 1.371 1.369 1.335 0.061 0.611 0.632 0.641 0.628 0.015 0.015 0.012 0.013 0.013 0.002 
5 1.534 1.654 1.637 1.608 0.065 0.838 0.808 0.796 0.814 0.022 0.011 0.018 0.015 0.015 0.004 
6 2.127 2.283 2.338 2.249 0.109 1.337 1.295 1.381 1.338 0.043 0.006 0.017 0.014 0.012 0.006 
7 2.165 2.360 2.408 2.311 0.129 1.738 1.763 1.764 1.755 0.015 0.009 0.016 0.015 0.013 0.004 
24 2.333 2.472 2.472 2.426 0.080 2.134 2.147 2.300 2.194 0.092 0.01 0.019 0.015 0.015 0.005 
135 
 
 
 
 
 
 
 
 
 
 
 
Strain 
 P. aeruginosa 2192 S. aureus NRS77  S. maltophilia K279a 
Ti
m
e 
(h
ou
rs
) 
 Replicate 1 
Replicate 
2 Average St dev 
Replicate 
1 
Replicate 
2 Average St dev 
Replicate 
1 
Replicate 
2 Average St dev 
0 0.226 0.223 0.225 0.002 0.305 0.295 0.300 0.007 0.266 0.209 0.238 0.040 
1 0.390 0.378 0.384 0.008 0.270 0.287 0.279 0.012 0.306 0.233 0.270 0.052 
2 0.519 0.542 0.531 0.016 0.232 0.271 0.252 0.028 0.342 0.251 0.297 0.064 
3 0.664 0.674 0.669 0.007 0.219 0.300 0.260 0.057 0.382 0.293 0.338 0.063 
4 0.791 0.786 0.789 0.004 0.248 0.321 0.285 0.052 0.467 0.336 0.402 0.093 
5 0.813 0.813 0.813 0.000 0.264 0.281 0.273 0.012 0.529 0.410 0.470 0.084 
6 0.863 0.876 0.870 0.009 0.265 0.299 0.282 0.024 0.610 0.490 0.550 0.085 
7 0.902 0.898 0.900 0.003 0.308 0.314 0.311 0.004 0.670 0.498 0.584 0.122 
24 1.017 1.016 1.017 0.001 0.276 0.301 0.289 0.018 0.705 0.559 0.632 0.103 
Supplementary Table 2. Growth curve for P. aeruginosa 2192, S. maltophilia K279a and S. aureus 
NRS77 in soil extract medium supplement with 30 mM glucose. 
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Supplementary Table 3. Optical densities at 600 nm indicating growth for P. aeruginosa 2192, S. 
aureus NRS77 and S. maltophilia K279a in LB medium. 
Strain 
Ti
m
e 
(h
ou
rs
)  
 P. aeruginosa 2192 S. aureus NRS77  S. maltophilia K279a 
 Replicate 1 
Replicate 
2 Average St dev. 
Replicate 
1 
Replicate 
2 Average St dev. 
Replicate 
1 
Replicate 
2 Average St dev. 
0 0.210 0.213 0.212 0.002 0.200 0.200 0.200 0.000 0.213 0.213 0.213 0.000 
1 0.231 0.230 0.231 0.001 0.220 0.210 0.215 0.007 0.309 0.308 0.309 0.001 
2 0.958 0.955 0.957 0.002 0.300 0.302 0.301 0.001 1.024 0.991 1.008 0.023 
3 2.360 2.350 2.355 0.007 0.568 0.566 0.567 0.001 2.076 2.053 2.065 0.016 
4 2.990 3.000 2.995 0.007 1.010 0.998 1.004 0.008 2.668 2.645 2.657 0.016 
5 4.550 4.510 4.530 0.028 1.400 1.430 1.415 0.021 4.360 4.260 4.310 0.071 
6 4.880 4.590 4.735 0.205 1.700 1.740 1.720 0.028 4.890 4.960 4.925 0.049 
24 5.11 5.19 5.15 0.056 5.84 5.83 5.835 0.007 2.88 2.79 2.835 1 
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Sample'ID* Date'Prepared Concentra3on'(ng/µL) A260 A280 260/280 260/230 
Pl
at
ed
 
PA 11/18/2013 197.7 4.942 2.855 1.73 1.82 
SA 11/18/2013 192.4 4.809 2.431 1.98 1.98 
SM 11/18/2013 117 2.924 1.419 2.06 2.27 
PA+SA 11/18/2013 802.3 20.058 9.668 2.07 2.19 
PA+SM 11/18/2013 218.4 5.46 2.708 2.02 2.12 
SM+SA 11/18/2013 1615.3 40.383 20.414 1.98 1.98 
PA+SM+SA 11/18/2013 1340.2 33.506 16.153 2.07 2.17 
Lo
g'
liq
ui
d  
SA 11/18/2013 30.8 0.769 0.374 2.06 2.17 
SA 11/18/2013 162.1 4.051 1.942 2.09 2.23 
PA 11/18/2013 858.1 21.452 10.285 2.09 2.22 
PA 11/18/2013 820.5 20.512 9.919 2.07 2.24 
SM 11/18/2013 248.6 6.215 2.984 2.08 2.18 
SM 11/18/2013 322.2 8.055 3.895 2.07 2.16 
PA+SA 11/18/2013 627.2 15.68 7.55 2.08 2.24 
PA+SA 11/18/2013 554.7 13.867 6.717 2.06 2.14 
PA+SM 11/18/2013 589.2 14.729 7.068 2.08 2.26 
PA+SM 11/18/2013 723.3 18.083 8.689 2.08 2.24 
SM+SA 11/18/2013 140.7 3.518 1.714 2.05 2.2 
SM+SA 11/18/2013 238.8 5.971 2.87 2.08 2.23 
PA+SM+SA 11/18/2013 326.9 8.173 3.986 2.05 2.17 
PA+SM+SA 11/18/2013 636.4 15.91 8.212 1.94 2.09 
Lo
g'
st
a3
on
ar
y  
PA 11/18/2013 598.1 14.953 7.657 1.95 2.06 
PA 11/18/2013 835.3 20.883 10.434 2 2.17 
SA 11/18/2013 27.3 0.684 0.352 1.94 2.33 
SA 11/18/2013 26.6 0.665 0.37 1.8 2.24 
SM 11/18/2013 1186.2 29.656 14.776 2.01 2.15 
SM 11/18/2013 1222.3 30.557 15.249 2 2.14 
PA+SA 11/18/2013 569.7 14.243 7.391 1.93 2.12 
PA+SA 11/18/2013 1390.3 34.758 17.378 2 2.18 
PA+SM 11/18/2013 880.8 22.019 10.889 2.02 2.13 
PA+SM 11/18/2013 835.5 20.889 10.323 2.02 2.15 
SM+SA 11/18/2013 239.3 5.983 3.015 1.98 2.09 
SM+SA 11/18/2013 321 8.026 4.047 1.98 2.06 
PA+SM+SA 11/18/2013 642.8 16.069 8.043 2 2.1 
PA+SM+SA 11/18/2013 564.7 14.117 7.044 2 2.13 
* PA- P. aeruginosa 2192; SM- S. maltophilia K279a; SA- S. aureus NRS77.  
Supplementary Table 4. Total RNA concentration and quality data from cells harvested 
under mono-, co-, and tri-culture samples in plated, liquid log and stationary liquid growth 
conditions. 
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Supplementary Figure 1. Electrophoresis of DNAse-treated RNA samples. RNA gel 
electrophoresis on a 1% agarose gel using SYBR Gold stain to indicate presence of total 
RNA in samples from the plated condition. Lanes: (1) 1 kilobase (kb) ladder, (2) P. 
aeruginosa 2192 monoculture, (3) S. aureus NRS77 monoculture, (4) S. maltophilia 
K279a monoculture, (5) P. aeruginosa 2192 and S. aureus NRS77 co-culture, (6) P. 
aeruginosa 2192 and S. maltophilia K279a co-culture, (7) S. maltophilia K279a and S. 
aureus NRS77 co-culture, (8) P. aeruginosa 2192, S. maltophilia K279a, and S. aureus 
NRS77 tri-culture. 
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Primer Barcode Sequence Name* Condition Lane for Illumina 
1 CAAGCAGAAGACGGCATACGAGATCGTGATGTGACT
GGAGTTCAGACGTGTGCTCTTCCGATC 
PA Plated 1 
1 CAAGCAGAAGACGGCATACGAGATCGTGATGTGACT
GGAGTTCAGACGTGTGCTCTTCCGATC 
PA Liquid Log 2 
1 CAAGCAGAAGACGGCATACGAGATCGTGATGTGACT
GGAGTTCAGACGTGTGCTCTTCCGATC 
PA Liquid Stationary 3 
2 CAAGCAGAAGACGGCATACGAGATACATCGGTGACT
GGAGTTCAGACGTGTGCTCTTCCGATC 
SM Plated 1 
2 CAAGCAGAAGACGGCATACGAGATACATCGGTGACT
GGAGTTCAGACGTGTGCTCTTCCGATC 
SM Liquid Log 2 
2 CAAGCAGAAGACGGCATACGAGATACATCGGTGACT
GGAGTTCAGACGTGTGCTCTTCCGATC 
SM Liquid Stationary 3 
3 CAAGCAGAAGACGGCATACGAGATGCCTAAGTGACT
GGAGTTCAGACGTGTGCTCTTCCGATC 
SA Plated 1 
3 CAAGCAGAAGACGGCATACGAGATGCCTAAGTGACT
GGAGTTCAGACGTGTGCTCTTCCGATC 
SA Liquid Log 2 
3 CAAGCAGAAGACGGCATACGAGATGCCTAAGTGACT
GGAGTTCAGACGTGTGCTCTTCCGATC 
SA Liquid Stationary 3 
4 CAAGCAGAAGACGGCATACGAGATTGGTCAGTGACT
GGAGTTCAGACGTGTGCTCTTCCGATC 
PA+SA Plated 1 
4 CAAGCAGAAGACGGCATACGAGATTGGTCAGTGACT
GGAGTTCAGACGTGTGCTCTTCCGATC 
PA+SA Liquid Log 2 
4 CAAGCAGAAGACGGCATACGAGATTGGTCAGTGACT
GGAGTTCAGACGTGTGCTCTTCCGATC 
PA+SA Liquid Stationary 3 
5 CAAGCAGAAGACGGCATACGAGATCACTGTGTGACT
GGAGTTCAGACGTGTGCTCTTCCGATC 
PA+SM Plated 1 
5 CAAGCAGAAGACGGCATACGAGATCACTGTGTGACT
GGAGTTCAGACGTGTGCTCTTCCGATC 
PA+SM Liquid Log 2 
5 CAAGCAGAAGACGGCATACGAGATCACTGTGTGACT
GGAGTTCAGACGTGTGCTCTTCCGATC 
PA+SM Liquid Stationary 3 
6 CAAGCAGAAGACGGCATACGAGATATTGGCGTGACT
GGAGTTCAGACGTGTGCTCTTCCGATC 
SA+SM Plated 1 
6 CAAGCAGAAGACGGCATACGAGATATTGGCGTGACT
GGAGTTCAGACGTGTGCTCTTCCGATC 
SA+SM Liquid Log 2 
6 CAAGCAGAAGACGGCATACGAGATATTGGCGTGACT
GGAGTTCAGACGTGTGCTCTTCCGATC 
SA+SM Liquid Stationary 3 
7 CAAGCAGAAGACGGCATACGAGATGATCTGGTGACT
GGAGTTCAGACGTGTGCTCTTCCGATC 
PA+SA
+SM Plated 1 
7 CAAGCAGAAGACGGCATACGAGATGATCTGGTGACT
GGAGTTCAGACGTGTGCTCTTCCGATC 
PA+SA
+SM Liquid Log 2 
7 CAAGCAGAAGACGGCATACGAGATGATCTGGTGACT
GGAGTTCAGACGTGTGCTCTTCCGATC 
PA+SA
+SM 
Liquid 
Stationary 3 
Supplementary Table 5. NEBNext Multiplex Oligos (Index Primer Set 1) with 
corresponding condition and combination designations. 
* PA- P. aeruginosa 2192; SM- S. maltophilia K279a; SA- S. aureus NRS77. Underlined sequence- Illumina 
barcode.  
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ID Conditions Concentration (ng/µl) A260 A280 260/280 260/230 
Lane for 
Illumina 
sequencing 
P. aeruginosa 2192 plated 24.9 0.499 0.285 1.75 -5.08 1 
S. aureus NRS77  plated 13.2 0.265 0.16 1.65 -1.49 1 
S. maltophilia K279a  plated 15.4 0.307 0.176 1.75 -2.83 1 
P. aeruginosa 2192 + S. 
aureus NRS77  plated 69.2 1.385 0.778 1.78 2.89 1 
P. aeruginosa 2192 + S. 
maltophilia K279a   plated 37 0.739 0.414 1.79 14.31 1 
S. maltophilia K279a + 
S. aureus NRS77  plated 27.5 0.55 0.355 1.55 1.89 1 
P. aeruginosa 2192 + S. 
maltophilia K279a + S. 
aureus NRS77  
plated 37.8 0.756 0.412 1.84 14.09 1 
P. aeruginosa 2192   liquid-log 39.6 0.792 0.47 1.68 2.27 2 
S. aureus NRS77   liquid-log 64.7 1.294 0.892 1.45 0.99 2 
S. maltophilia K279a   liquid-log 17.3 0.346 0.189 1.83 1.4 2 
P. aeruginosa 2192 + S. 
aureus NRS77   liquid-log 11.5 0.229 0.135 1.7 -1.12 2 
P. aeruginosa 2192 + S. 
maltophilia K279a   liquid-log 23.2 0.463 0.256 1.81 -4.1 2 
S. maltophilia K279a + 
S. aureus NRS77   liquid-log 12.4 0.247 0.158 1.56 5.37 2 
P. aeruginosa 2192 + S. 
maltophilia K279a + S. 
aureus NRS77   
liquid-log 33.9 0.678 0.377 1.8 7.32 2 
P. aeruginosa 2192   stationary 38.7 0.774 0.437 1.77 9.62 3 
S. aureus NRS77   stationary 10.7 0.213 0.114 1.87 -0.98 3 
S. maltophilia K279a   stationary 31.6 0.632 0.412 1.53 1.39 3 
P. aeruginosa 2192 + S. 
aureus NRS77   stationary 22.9 0.458 0.252 1.82 1.77 3 
P. aeruginosa 2192 + S. 
maltophilia K279a   stationary 32.9 0.657 0.419 1.57 1.57 3 
S. maltophilia K279a + 
S. aureus NRS77   stationary 11 0.22 0.129 1.71 -1.28 3 
P. aeruginosa 2192 + S. 
maltophilia K279a + S. 
aureus NRS77   
stationary 40.6 0.811 0.42 1.93 14.06 3 
Supplementary Table 6. cDNA quality assessment for submission for Illumina sequencing. 
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Supplementary Figure 2. Bioanalyzer results of submitted libraries for Illumina 
sequencing. Ten microliters of each cDNA library was assayed on the Agilent 2100 
Bioanalyzer to assess the quality of the cDNA submitted for Illumina sequencing. DNA 
ladder sizes shown on the left in both panels. (A) Sample ID designations: (2) P. 
aeruginosa 2192 plated, (5) S. aureus NRS77 plated, (8) S. maltophilia K279a plated, 
(11) P. aeruginosa 2192 + S. aureus NRS77 plated, (17) S. maltophilia K279a + S. 
aureus NRS77 plated, (14) P. aeruginosa 2192 + S. maltophilia K279a plated, (20) P. 
aeruginosa 2192 + S. maltophilia K279a + S. aureus NRS77 plated, (23) S. aureus 
NRS77 log liquid, (24) P. aeruginosa 2192 log liquid, (27) S. maltophilia K279a log 
liquid, (28) P. aeruginosa 2192 + S. aureus NRS77 log liquid. (B) Sample ID 
designations: (31) P. aeruginosa 2192 + S. maltophilia K279a log liquid, (33) S. 
maltophilia K279a + S. aureus NRS77 log liquid, (35) P. aeruginosa 2192 + S. 
maltophilia K279a + S. aureus NRS77 log liquid, (37) P. aeruginosa 2192 stationary 
liquid, (38) S. aureus NRS77 stationary liquid, (41) S. maltophilia K279a stationary 
liquid, (43) P. aeruginosa 2192 + S. aureus NRS77 stationary liquid, (44) P. aeruginosa 
2192 + S. maltophilia K279a stationary liquid, (47) S. maltophilia K279a + S. aureus 
NRS77 stationary liquid, (48) P. aeruginosa 2192 + S. maltophilia K279a + S. aureus 
NRS77 stationary liquid.  Material at ~ 2000 bp possibly indicating remnant rRNA.  
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Primer&name& Sequence&
Smlt0278_SC_up- TGATGTCCGGCCGTCTGTGGTT-
Smlt0278_SC_down- AGCGGTCGCGGGTGAGTCG-
Smlt0278_INT_up- CCGCGTCCGTGGGTCTGG-
Smlt0278_INT_down- GGTTCGCCTTCGCCGTATCG-
Smlt3905_SC_up- CCGC-TC-GGTGGATGTGGA-
Smlt3905_SC_down- GAAGTTCTTGCGCAGGATGATGTTGA-
Smlt3905_INT_up- GGCGGGCACCCAGACCTTCA-
Smlt3905_INT_down- GACGTACTGGCCGCCCTGTTCC-
exbB1_SC_up- CCGGCGGCGTGGGTGAG-
exbB1_SC_down- -GGTCGCGCTGTTGATCTTGCTGAA-
exbB1_INT_up- CCGTCACCCGCGAAAGCAACA-
exbB1_INT_down- GCCCCACACGGTACCCAGCAGA-
PilY1_SC_up- -GGGCGCCCGGATCAACACTA-
PilY1_SC_down- GCCGGTACCGTCATCCCTTCCTG-
PilY1_INT_up- GGCGCCCGGATCAACAACTACAA-C-
PilY1_INT_down- CGTGCGAACCCGAAGACATCCA-
cyoA_SC_up- A-CGCCACCCCGCAGGAAATCTC-
cyoA_SC_down- GAAGCCGGCCAGGGTCAG-
cyoA_INT_up- GCAGGCGGCGATGGACACG-
cyoA_INT_down- CAGGGCGAAGAAGGCGATGAGGTA-
wzt_SC_up- GCCAGCCCGGATCGAGAAGGAC-
wzt_SC_dpwn- GGGCAGCAGCGGCAGAGTGAAC-
wzt_INT_up- CGCGCATGATCCCCTGACGAGT-
wzt_INT_down- GGCGGCTGGATATAGGTGTAGGTGTG-
Smlt0184_SC_up- CCTGGGTCTTCTGGCTGCTC-
Smlt0184_SC_down- CATTCTTGAACTTGTCGGTCTCCTG-
Smlt0184_INT_up- -CCGACGGCTGGAA-GGTGAAGG-
Smlt0184_INT_down- GCTGTAGTCGCCGAAGATGTGGAAGT-
Smlt1471_SC_up- TGCTGCTGGCCACGCTCAT-
Smlt1471_SC_down- GACCATCTGCACCGCCGACTC-
Smlt1471_INT_up- CAGCCCGGTGCCGACTTCTT-
Smlt1471_INT_down- GCACGATGGCCTGGTTGAC-
Supplementary Table 7.  Primers used for qRT-PCR  of S. maltophilia K279a in co-culture 
growth. 
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Supplementary Table 8. Average up-regulation of S. maltophilia K279a genes measured by 
qRT-PCR in liquid log and plated conditions. 
Gene$name$$ RNA$seq$fold$increase$plated$
RNA$seq$fold$
increase$liquid$
qRT7PCR$fold$
increase$plated$
qRT7PCR$fold$
increase$liquid$
AVG$qRT7PCR$
fold$increase$in$
both$condi=ons$
Smlt0278$ 16.67$ 16.94$ 7$ 9.18958684$ 4.414272075$
$ $$ $$ 0.466516496$ 1.414213562$ $$
$ $$ $$ 7$ 2.639015822$ $$
Smlt3905$ 10.89$ 8.47$ 3.732131966$ 7.464263932$ 4.414620965$
$$ $$ $$ 2$ 2.29739671$ $$
$$ $$ $$ 0.535886731$ 3.482202253$ $$
exbB1& 18.3$ 14.12$ 0.757858283$ 2.29739671$ 53.96129387$
& $$ $$ 0.933032992$ 157.5864849$ $$
& $$ $$ 7$ 2$ $$
pilY1& 39.3$ 20.82$ 0.870550563$ 6.964404506$ 3.500150665$
&& $$ $$ 0.933032992$ N/A$ $$
&& $$ $$ 0.870550563$ 0.035896824$ $$
cyoA& 34.54$ 1.88$ 0.406126198$ 13.92880901$ 6.518186064$
&& $$ $$ 2.639015822$ 2.143546925$ $$
&& $$ $$ 2.143546925$ 3.482202253$ $$
wzt& 20.25$ 6.59$ 2.462288827$ 5.656854249$ 2.926299011$
&& $$ $$ 1.741101127$ 0.659753955$ $$
$$ $$ $$ 0.076946526$ 2.462288827$ $$
Smlt0184$ 39.08$ 31.06$ 7$ 1.319507911$ 1.419115785$
$$ $$ $$ 0.707106781$ 1.071773463$ $$
$$ $$ $$ 7$ 1.866065983$ $$
Smlt1471$ 17.86$ 15.06$ 0.267943366$ 1.148698355$ 1.652592282$
$$ $$ $$ 1.148698355$ 0.076946526$ $$
$$ $$ $$ 1.231144413$ 3.732131966$ $$
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Primer&
name& Sequence& Descrip0on&
cyoA_1# ATATATGGATCCCGCCTGCAGGTAGGCCGG# for making knockout in Stenotrophomonas maltophilia K279a of cyoA 
cyoA_2# CCCTCGCAATTGGATCGACCGACATGTTGGGAAAACTCTCTCTTGAGTCGATC#
for making knockout in Stenotrophomonas 
maltophilia K279a of cyoA 
cyoA_3# GATCGACTCAAGAGAGAGTTTTCCCAACATGTCGGTCGATCCAATTGCGAGGG#
for making knockout in Stenotrophomonas 
maltophilia K279a of cyoA 
cyoA_4# ATATATGAATTCGGCAGCGAACTCACCGATCCAC#
for making knockout in Stenotrophomonas 
maltophilia K279a of cyoA 
exbB1_1# ATATATGGATCCGTCGCCGCCGAAGCCGT# for making knockout in Stenotrophomonas maltophilia K279a of exbB1 
exbB1_2# ATCACCACACACAACAAAGGTAAGCGTCTTGCGGCGCGCGTC#
for making knockout in Stenotrophomonas 
maltophilia K279a of exbB1 
exbB1_3# GACGCGCGCCGCAAGACGCTTACCTTTGTTGTGTGTGGTGAT#
for making knockout in Stenotrophomonas 
maltophilia K279a of exbB1 
exbB1_4# ATATATGAATTCGAATGCCATGGCTTATTGCCCCTTTTC#
for making knockout in Stenotrophomonas 
maltophilia K279a of exbB1 
pilY1_1# ATATATGGATCCCGTACGCAGCAGCGCGG# for making knockout in Stenotrophomonas maltophilia K279a of pilY1 
pilY1_2# GTTTTCAAGCTTTGAGGAACCCGGTCCGAAGACATGCCCATGAGCCTG#
for making knockout in Stenotrophomonas 
maltophilia K279a of pilY1 
pilY1_3# CAGGCTCATGGGCATGTCTTCGGACCGGGTTCCTCAAAGCTTGAAAAC#
for making knockout in Stenotrophomonas 
maltophilia K279a of pilY1 
pilY1_4# ATATATGAATTCTGAGCTATTCGGGCGGGGAG#
for making knockout in Stenotrophomonas 
maltophilia K279a of pilY1 
wzt_1# ATATATGGATCCCGGCAATGCCAGCTACGTCAAA#
for making knockout in Stenotrophomonas 
maltophilia K279a of wzt 
wzt_2# CTATGTCTGCTTCCACAAAATGCGCCGGGCGCATCGCAGGGACCG#
for making knockout in Stenotrophomonas 
maltophilia K279a of wzt 
wzt_3# CGGTCCCTGCGATGCGCCCGGCGCATTTTGTGGAAGCAGACATAG#
for making knockout in Stenotrophomonas 
maltophilia K279a of wzt 
wzt_4# ATATATGAATTCCCAGCTCCACCAGGCAATCG#
for making knockout in Stenotrophomonas 
maltophilia K279a of wzt 
Smlt1471_1# ATATATGGATCCGCTGGCCGGCTACACAGGC#
for making knockout in Stenotrophomonas 
maltophilia K279a of Smlt 1471 
Smlt1471_2# GCTAAAGATGGCGAGGGAATGCGTCGCTTCGGGGTCGGATCCC#
for making knockout in Stenotrophomonas 
maltophilia K279a of Smlt 1471 
Smlt1471_3# GGGATCCGACCCCGAAGCGACGCATTCCCTCGCCATCTTTAGC#
for making knockout in Stenotrophomonas 
maltophilia K279a of Smlt 1471 
Smlt1471_4# ATATATGAATTCCCAGCGGCATGCGCTGTTC# for making knockout in Stenotrophomonas maltophilia K279a of Smlt 1471 
Supplementary Table 9.  Primers used for mutant construction for S. maltophilia K279a. 
Underlined	  regions-­‐	  Restriction	  site	  sequence	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Primer&
name& Sequence& Descrip0on&
Smlt3905_1+ ATATATGGATCCGCAGCGTGACCTGGCCGA+ for making knockout in Stenotrophomonas maltophilia K279a of Smlt3905 
Smlt3905_2+ CGCTACTAACACGTACCTTGGAGAGATTGTCCATCGAAGCCTGAAGGCAAG+
for making knockout in Stenotrophomonas 
maltophilia K279a of Smlt3905 
Smlt3905_3+ CTTGCCTTCAGGCTTCGATGGACAATCTCTCCAAGGTACGTGTTAGTAGCG+
for making knockout in Stenotrophomonas 
maltophilia K279a of Smlt3905 
Smlt3905_4+ ATATATGAATTCCCGCAGTGGCGCGAACATG+
for making knockout in Stenotrophomonas 
maltophilia K279a of Smlt3905 
Smlt4670_1+ ATATATGGATCCGCCTGGTACAGCTTCCAGTGC+
for making knockout in Stenotrophomonas 
maltophilia K279a of Smlt4670 
Smlt4670_2+ CGATGTCTAAAAAACGTTAATGGTGCCCTGCCGTTCGTCCAAGCCAC+
for making knockout in Stenotrophomonas 
maltophilia K279a of Smlt4670 
Smlt4670_3+ GTGGCTTGGACGAACGGCAGGGCACCATTAACGTTTTTTAGACATCG+
for making knockout in Stenotrophomonas 
maltophilia K279a of Smlt4670 
Smlt4670_4+ ATATATGAATTCCACGTGCACGGCCTCGAAGTAG+
for making knockout in Stenotrophomonas 
maltophilia K279a of Smlt4670 
Smlt0716_1+ ATATATGGATCCGGCGGTGCCGGGCG+ for making knockout in Stenotrophomonas maltophilia K279a of Smlt0716 
Smlt0716_2+ GCGCCTACGGAGACCGCGGCAACCGGAAAGGCCGC+
for making knockout in Stenotrophomonas 
maltophilia K279a of Smlt0716 
Smlt0716_3+ GCGGCCTTTCCGGTTGCCGCGGTCTCCGTAGGCGC+
for making knockout in Stenotrophomonas 
maltophilia K279a of Smlt0716 
Smlt0716_4+ ATATATGAATTCCAGCGATGAGGGAATACCCGATACC+
for making knockout in Stenotrophomonas 
maltophilia K279a of Smlt0716 
Smlt3703_1+ ATATATGGATCCCGAGCCGACCTGGGCGC+ for making knockout in Stenotrophomonas maltophilia K279a of Smlt3703 
Smlt3703_2+ CTAGGAGCCACAAAGGTATCGCCTCCATGCGCATTGGCATCAAACTGATGC+
for making knockout in Stenotrophomonas 
maltophilia K279a of Smlt3703 
Smlt3703_3+ GCATCAGTTTGATGCCAATGCGCATGGAGGCGATACCTTTGTGGCTCCTAG+
for making knockout in Stenotrophomonas 
maltophilia K279a of Smlt3703 
Smlt3703_4+ ATATATGAATTCTGCGCCGAATCATCGTACTTGCC+
for making knockout in Stenotrophomonas 
maltophilia K279a of Smlt3703 
lon_Sm_1+ ATATATGGATCCGTGGTGGCGACCCTGGAGG+
for making knockout in Stenotrophomonas 
maltophilia K279a of lon_Sm 
lon_Sm_2+ GATGCCCTCCCGGAGGCGGCGCGCGCTGTCCAATGGC+
for making knockout in Stenotrophomonas 
maltophilia K279a of lon_Sm_ 
lon_Sm_3+ GCCATTGGACAGCGCGCGCCGCCTCCGGGAGGGCATC+
for making knockout in Stenotrophomonas 
maltophilia K279a of lon_Sm 
lon_Sm_4+ ATATATGAATTCAGCGAGCCGCTTAGTTTACAGCATCCTT+
for making knockout in Stenotrophomonas 
maltophilia K279a of lon_Sm 
Supplementary Table 9 ctd.  Primers used for mutant construction for S. maltophilia K279a. 
Underlined	  regions-­‐	  Restriction	  site	  sequence	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Primer&
name& Sequence& Descrip0on&
smeF_1# ATATATGGATCCGCGGCCCCGCTGGG# for making knockout in Stenotrophomonas maltophilia K279a of smeF 
smeF_2# CCTGCCATCCGGCAGTACCGAGGACAGCCGGCCAGCG#
for making knockout in Stenotrophomonas 
maltophilia K279a of smeF 
smeF_3# CGCTGGCCGGCTGTCCTCGGTACTGCCGGATGGCAGG#
for making knockout in Stenotrophomonas 
maltophilia K279a of smeF 
smeF_4# ATATATGAATTCGTACGAAACCTGTTCAATACGATCGCCAAGAAG#
for making knockout in Stenotrophomonas 
maltophilia K279a of smeF 
smeH_1# ATATATGGATCCGTGCGGTGTCGTTGCGC# for making knockout in Stenotrophomonas maltophilia K279a of smeH 
smeH_2# CAAGCAGTAACGGGAACCTTCCGTCTCCAGCGGTGAACTGAAACGAGAAAG#
for making knockout in Stenotrophomonas 
maltophilia K279a of smeH 
smeH_3# CTTTCTCGTTTCAGTTCACCGCTGGAGACGGAAGGTTCCCGTTACTGCTTG#
for making knockout in Stenotrophomonas 
maltophilia K279a of smeH 
smeH_4# ATATATGAATTCGGCATTCCCGCTCCTTGGTCG#
for making knockout in Stenotrophomonas 
maltophilia K279a of smeH 
cydA_1# ATATATGGATCCGCGGCCCCGCTGGG# for making knockout in Stenotrophomonas maltophilia K279a of cydA 
cydA_2# CCTGCCATCCGGCAGTACCGAGGACAGCCGGCCAGCG#
for making knockout in Stenotrophomonas 
maltophilia K279a of cydA 
cydA_3# CGCTGGCCGGCTGTCCTCGGTACTGCCGGATGGCAGG#
for making knockout in Stenotrophomonas 
maltophilia K279a of cydA 
cydA_4# ATATATGAATTCGTACGAAACCTGTTCAATACGATCGCC#
for making knockout in Stenotrophomonas 
maltophilia K279a of cydA 
Supplementary Table 9 ctd.  Primers used for mutant construction for S. maltophilia K279a. 
Underlined	  regions-­‐	  Restriction	  site	  sequence	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Supplementary Figure 3.  Plasmid map for pEX18Tc.  Sewing by Overlap Extension 
(SOE) fragments for S. maltophilia  K279a genes of interest have been cloned into the 
BamHI/EcoRI sites of the multiple cloning site and sequenced using Sanger sequence to 
ensure no mutations have occurred. 
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